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SUMMARY
Currently available evidence suggests that 
ÿ-aminobutyric acid is the major inhibitory neuro- 
transmitter in the mammalian central nervous system.
As such, a fuller knowledge of the functional role 
played by GABAergic neurotransmission would increase 
our understanding of the complexities of brain activ­
ity, Three approaches were employed to analyse 
GABAergic influences in cerebral function; 1) 
systemic administration of GABA agonists (muscimol 
and THIP) or related compounds (benzodiazepines),
2) specific lesioning of a known GABAergic pathway 
(from caudate nucleus) with subsequent pharmacological 
challenge and 3) local intracerebral injection of a 
GABA agonist (muscimol) into a region with known GABA 
synaptic mechanisms (caudate nucleus). All experi­
ments were performed on restrained, conscious animals, 
using principally the 2-deoxyglucose quantitative 
autoradiographic approach to measure cerebral function 
(as it is reflected in rates of glucose utilisation).
The intravenous administration of muscimol and 
THIP resulted in a heterogeneous pattern of signifi­
cantly reduced glucose utilisation in the CNS, The 
regional hierarchy of changes in glucose utilisation 
was similar for both muscimol and THIP in all regions 
(with the exception of the superior colliculus), with 
muscimol being approximately six times more potent 
in all regions investigated. The regions in which 
glucose utilisation was extremely sensitive to change,
displaying reductions of approximately hO^/o following 
muscimol (l.5 mg/kg) or THIP (10 mg/kg), included the 
neocortex and thalamic areas. In contrast, in a
large number of areas, including cerebellum and 
related motor nuclei, hypothalamus, lateral habenula 
and amygdala, there were only minimal reductions in 
glucose use following muscimol and THIP. Regions
displaying moderate reductions in glucose utilisation 
included most extrapyramidal regions and a number of 
cortical and subcortical limbic areas. In no region 
of the 60 CNS areas measured was a significant increase 
in glucose utilisation observed with any concentration 
of either muscimol or THIP. The regional distribut­
ion of alterations in glucose utilisation following 
muscimol and THIP, which do not correspond to the 
known topography of GABAergic neurons and receptors, 
provided a comprehensive description of the functional 
alterations, as reflected in rates of glucose utilis­
ation, which occur in conscious rats following systemic 
administration of these two putative GABAergic agonists.
Although benzodiazepines are thought to be active 
at the GABA receptor site, the response in terms of 
glucose use following diazepam was markedly different 
from thai following GABA agonists. In particular,
the degree of heterogeneity of depression in glucose 
use was less and the hierarchy of responsiveness in 
diverse brain areas was different, suggesting that the 
responses to GABA agonists were not merely a function 
of susceptibility to depression in general.
The relationship between local cerebral blood 
flow (measured with iodoantipyrine) and glucose use 
was analysed in two groups of rats. Both blood flow 
and glucose use decreased in parallel in the 38 areas 
of the brain analysed following muscimol administrat­
ion i.v,, thus maintaining the relationship observed 
in control rats. These studies offered no evidence 
for a direct vasodilatatcry action for muscimol 
(reported by others in vitro) in the intact, conscious 
rat, but pointed to underlying metabolic activity as 
the primary determinant of cerebral blood flow.
Local cerebral glucose use was measured 10 days 
after the unilateral injection of the neurotoxin, 
kainic acid, into the striatum. The stereotactic 
infusion of kainic acid resulted in lesions localised 
to the caudate nucleus. Rates of cerebral glucose 
use were most markedly affected ipsilateral to the 
infusion site in areas which normally receive input 
from the caudate nucleus. In globus pallidus and 
substantia nigra pars reticulata, increases in glucose 
use of 82^ and respectively, were measured when
compared with controls. Significant increases were 
also measured in contralateral pallidus and substantia 
nigra pars reticulata (l6^ and 20^, respectively).
Of the brain structures examined, significant unilat­
eral increases from control were observed in ipsi­
lateral habenula (23^) , ventrolateral thalamus {l3°/o) , 
contralateral substantia nigra pars compacta (l4^) 
and sensory-motor cortex (l5^). Symmetrical, bilateral
increases in glucose use were found in the nucleus 
accumbens (l5^), ventral tegmental area (24^) and red 
nucleus (17^). Only in the ipsilateral caudate nuc­
leus was any decrease in glucose use observed, although 
the association of this change with an area of histo­
logically definable cell damage demands that this 
result be treated with caution.
The increases in functional activity following 
striatal lesion provide an insight into the mechanisms 
by which overt motor behaviour returns to normal a 
short time after the removal of striatal interneurons 
and efferent perikarya. Of particular interest are 
the responses observed contralateral to the affected 
striato-nigral system in view of the proposed inter­
action between the two sides of the brain.
Following systemic administration of muscimol 
(1.3 mg/kg) the increases in functional activity 
observed following striatal lesions in both hemi­
spheres were either substantially attenuated or com­
pletely eliminated, suggesting that the effects of 
lesioning were due to loss of mainly GABAergic pro­
jection neurons. The loss of these neuronal systems 
also markedly altered the responses to the dopamin­
ergic agonist, apomorphine, observed in the conscious 
animal. Thus, within the ipsilateral extrapyramidal 
system, striatal lesions attenuated the apomorphine- 
induced increases in glucose use observed in ento- 
peduncular nucleus, but potentiated the increase 
observed in substantia nigra pars reticulata. In
areas outwith the extrapyramidal system, the loss of 
striatal efferents apparently resulted in attenuation 
of apomorphine-induced increases in parafascicular- 
ventromedial complex in the thalamus as well as 
attenuation of the decreases in lateral habenula 
following apomorphine. Thus, it would appear that 
many of the effects of dopaminergic manipulation in 
intact, conscious animals require integrity of cell­
ular function in the striatum.
Localised unilateral application of the GABA 
agonist, muscimol (500 ng), into the striatum resulted 
in decreased glucose use within this nucleus {-33fo) ,
This apparent reduction in striatal functional activ­
ity resulted in increased rates of glucose use in 
ipsilateral areas receiving primary striatal project­
ions; globus pallidus (+29^)? entopeduncular nucleus 
i + 33fo) and pars reticulata of substantia nigra (+46%) . 
Within the regions to which these extrapyramidal nuclei 
in turn send projections, decreases in glucose use were 
measured in subthalamic nucleus (-18%), superior collic­
ulus stratum profundum (-18%) and ventrolateral thalamus 
(-40%). In contrast, a significant increase in glucose 
use was observed within the lateral habenula (+l6%), 
Thus, it would appear that intrastriatal GABAergic 
neurons may, by their activation, affect functional 
activity in striatal projection pathways, and these 
effects may be manifest also in secondary projection 
areas.
The data from this thesis provide a comprehensive
description of GABAergic influences in the brain in 
general and the extrapyramidal system in particular, 
and provide some insight into the role of GABAergic 
inJiibition in the organisation of integrated cerebral 
function.
PREFACE AND DECLARATION
This thesis presents the results from studies of 
cerebral GABA systems using, exclusively, quantifiable 
autoradiographic techniques. As these methods are 
relatively new, the method^ section describes in some 
detail both practical and theoretical considerations. 
Possible modifications to the 2-deoxyglucose technique 
are critically examined.
Three methods of stimulating GABA systems were 
used: systemic drug administration; striatal lesion
followed by systemic drug administration; intra­
striatal drug injection. These three approaches are 
presented and discussed individually.
In the final discussion I haVe attempted to show 
that the 2-deoxyglucose technique, which is used 
extensively in these studies, provides insight into 
not only specific cerebral GABA systems, but also into 
the general principles of functional organisation in 
'the mammalian brain.
This thesis comprises my own original studies, 
and has not been presented previously as a thesis in 
any form.
CHAPTER I
INTRODUCTION
1. Principles of Cerebral Organisation
Almost a century has elapsed since Cajal embarked 
upon the elegant microscopic analysis of the nervous 
system which culminated in his two-volume opus describ­
ing, in exhaustive detail, the complexity of cellular 
organisation in the mammalian brain (Cajal, 19H).
WlT.il st most organs of the body are made up of cells 
which are relatively simple in form, and are similar, 
or at least complementary in the roles which they 
subserve, the cellular units of which the brain is 
comprised present a bewildering array of cytoarchi- 
tectural differences whose relation to different 
functional activities is not immediately apparent.
The regional heterogeneity of cerebral function assoc­
iated with complex cytoarchitectonie subdivisions of 
the brain has constituted a considerable barrier to 
the elucidation of general principles underlying 
integrated cerebral activity.
The integrated function of any bodily organ must 
inevitably depend upon the co-ordinated action and 
interaction of its constituent cells. From the histo­
logical observations of interneuronal connections made 
by Cajal and his contemporaries and the classical
description of the reflex arc, upon which Sherrington 
based his book "The Integrative Action of the Nervous 
System" (1906), have arisen modern concepts of neuronal 
organisation. In the brain, neurons constitute the 
functionally operative cellular units, but it is the 
synapse, in allowing neuronal interaction to take place, 
which represents the essential structural unit of cere­
bral function. Moreover, despite the profound inter­
regional differences in structure and function found in 
the brain, the synapse, with certain similarities in 
structural patterns and functional properties, provides 
a common background against which the welter of regional 
dissimilarities may be assessed an.d possibly rational­
ised, Perhaps the greatest single factor common to 
synaptic function is provided by the chemical nature of 
synaptic transmission (Krnjevic, 1974) and, although the 
number of putative neurotransmitter substances is ever 
widening (iversen, 1978), those candidates continue to 
form a very small fraction of the variety of neurochem­
icals conceivably available for use in this way. Thus, 
experimental analysis of single neurotransmitter systems 
in regions of the brain with diverse functional roles 
has added further to our understanding of the unifying 
principles of organisation common to all brain regions. 
Almost without exception, neurons in every part of 
the mammalian brain have been shown to be sensitive to 
some degree to the inhibitory action of the short chain 
Q, CO-amino acid, Y -aminobutyric acid (GABA) (Krnjevic, 
1974, for review). Since GABA is ubiquitously distributed
in the brain in relatively high concentrations (Fahn , 
1976) but is required in only minute amounts to elicit 
neuronal inhibition (Salmoiraghi , I967), it is reason­
able to postulate, in the light of accumulating evid­
ence (Krnjevic, 197^), that GABA is likely to be an 
inhibitory neurotransmitter used extensively in the 
brain (Curtis, 1979; Enna and Maggi, 1979)- The 
concept of disinhibition as a governing principle in 
cerebral function, which has recently been proposed, 
requires the widespread distribution of tonic inhibit­
ory neurons (Maynard, 1972; Roberts, 1976), The 
potency and ubiquity of GABA systems could meet the 
requirements necessary for such a mechanism (Roberts, 
1976). Certainly, the apparent unbridled excitation 
which results from release from endogenous GABA influ­
ences (Roberts, 1976) lends support for such a view.
Wliether GABA releasing neurons form only one part 
of the many putative neurotransmitter systems, or are 
indeed responsible for the integration of cerebral 
function-in a wider, global sense, analysis of GABA- 
mediated neurotransmission is undoubtedly of interest 
in furthering our comprehension of the workings of the 
brain. The importance attached to the examination of 
GABA influences in the brain is reflected in the number 
of studies of the mechanisms of GABA neurotransmission 
and their consequences (Roberts et al. 1976; Kr^gsgaard- 
Larsen et al, 1979; Lai et al. I98O). Some salient 
features from currently available data are presented 
in the following short review (Fig. l), but are also
Figure 3
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discussed, where applicable, in the commentaries on the 
experiments which make up this thesis.
2. GABA Synthesis and Release
The main metabolic pathway for the biosynthesis of 
GABA in nervous tissue involves the decarboxylation of 
L-glutamate. This transformation is catalysed by the 
enzyme, glutamic acid decarboxylase (GAD), with a co­
enzyme requirement for pyridoxal phosphate (Wu and 
Roberts, 197^). In vitro studies have shown that GAD 
is subject to substrate induced inactivation through 
the formation of the apoenzyme (Miller et al. 19?S).
A supply of pyridoxal phosphate is necessary to allow 
continuous regeneration of the haloenzyme and, there­
fore, maintenance of a constant level of enzyme activ­
ity. Since GAD is the rate-limiting enzyme in the 
synthesis of GABA, these enzymic processes determine 
the steady state levels of GABA in brain.
There is considerable evidence that GAD activity 
may act indirectly as a regulatory mechanism of excit­
ation in the brain (Wood and Peesker, 197^)* Effect­
ive GAD activity may be reduced by competitive inhibit­
ion by substrate analogues of glutamate with, for 
example, mercapto-propionic acid (Horton and Meldrum, 
1973; Tapia, 1975) or by interference with the co­
enzyme system by hydrazides and other carbonyl trapping 
agents (Vu anci Roberts, 197^; Tapia, 1975). Reduct­
ion of GAD activity below threshold levels results in 
a convulsive response in vivo (Tapia and Sandoval, 1975), 
sugge51 i ]ig a relatively high turnover rate for GABA
available for neurotransmission, It is perhaps worth
emphasising, however, that the results of experiments 
in which GABA metabolism is manipulated must be inter­
preted with a degree of caution, bearing in mind the 
dual role of this pathway in intermediary metabolism 
as well as in neurotransmitter synthesis (van der Berg 
et al. 1975).
Although GAD has been localised to nerve terminals 
where it is associated with the synaptosomal fraction 
(iversen and Neal, I968), following axotomy GAD accum­
ulates in the proximal portion of putatively GABAergic 
neurons (Storm-Mathisen, 1975). Similarly, colchicine 
treatment, by inhibiting microtubule formation, leads 
to an accumulation of GAD in neuronal cell bodies (Ribak, 
1978). These observations are consistent with the syn­
thesis of GAD being localised to the cell body before 
subsequent removal to terminal sites by axoplasmic trans­
port systems.
A specific synaptosomal population for the storage 
of GABA has been identified (Kuhar et al. 1971) and, 
although GABA levels in nerve terminals may not be exten­
sive, the amounts present in cortical synaptosomes are 
sufficient to produce significant inhibition when 
released from suspensions directly on to cortical cells 
(Krnjevic and Whittaker, I965). Moreover, the in vivo 
release of endogenous GABA from cerebral cortex has been 
shown to be markedly increased by electrical stimulation 
(iversen et al. 197l) at a rate which elicits an inhibit­
ion of cortical neurons (Mitchell and Srinivasan , 1969).
Similarly, stimulation of inhibitory input arising from 
distant sites also increased the measured GABA efflux 
(iversen et al, 197l). Reinforcement of the suggest­
ion that synaptic GABA release vas responsible for the
+ +inhibitory responses was provided by the action of Ca - 
free superfusion medium in abolishing the stimulus- 
evoked efflux (iversen et al. 197l)* The results of 
these studies must, however, be viewed with a degree 
of circumspection. GABA is accumulated by cells other 
than neurons, and release from these elements may also 
be produced by depolarisation. Recently, however, 
using pure cultures of dissociated cortical neurons, a 
K^-evoked release of GABA was observed which was sig­
nificantly reduced by the removal of Ca^ "*" from the 
bathing medium (Hauser et al, I98O). This highly 
controlled in vitro study confirmed the conclusions 
of the in vivo work that GABA release was mediated by 
the mechanisms usually associated with synaptic trans­
mission. The mechanisms by which GABA efflux is 
coupled to the neuronal stimulus in vivo remain to be 
fully determined.
Several agents have been demonstrated to have an 
effect upon the synaptic release of GABA. Imipramine, 
chlorpramazine, diazepam, haloperidol and baclofen 
inhibit the stimulus-evoked release of GABA from synapt­
osomes (Olsen et al. 1977) whilst, in certain regions of 
the brain at least, dopamine enhances synaptic GABA re­
lease (Reubi et al, 1977). Elucidation of the mechan­
isms underlying these interactions may allow a greater
understanding of the stimulus-coupling of GABA release.
3. The Ionic Basis of GABA Action
The electrophysiological basis of GABAergic action 
in synaptic neurotransmission was initially most success­
fully characterised in the invertebrate, crayfish stretch 
receptor preparation (see Otsuka, 1976, for historical 
review), In this preparation the post-synaptic response 
to the application of mammalian brain extracts containing 
GABA closely paralleled that observed following activat­
ion of inhibitory neurons (Plorey and McLennan, 1959). 
Subsequently, synaptic release of endogenous GABA was 
found in response to stimulation of inhibitory neurons 
(iversen et al. 1966). Techniques of microapplication
and simultaneous post-synaptic electrophysiological 
recording within the mammalian brain have also shown a 
close relationship between the actions of exogenous 
GABA and naturally occurring inhibition (Salmoiraghi and 
Steiner, I967).
Initial experiments reported that iontophoretic 
application of GABA at synaptic sites induced a hyper­
polarisation of the post-synaptic cell from its resting 
potential level (Curtis and Johnston, 197^). If the 
negativity of the resting potential was artificially 
increased, or if the post-synaptic cell was subject to 
IPSPs induced by pre-synaptic inhibitory cell activity, 
then the hyperpolarising response to exogenous GABA 
administration was reduced until the response was 
reversed and GABA elicited a depolarising response 
(Levy, 1977). A purely depolarising post-s>naptic
action of GABA has also been reported (bevy, 1977j 
Misgeld et al. I982), Recent investigations have 
described a biphasic (hyperpolarisation followed by 
depolarisation) response to a single GABA administrat­
ion in tissue slice preparations (Alger and Nicoll,
1979; Mayer et al, I98I), but both phases are inhibit­
ory. It would appear, therefore, that the inhibitory 
action of GABA is mediated not merely by the induction 
of hyperpolarising currents, but rather by the clamping 
of the membrane potential at a level just below the 
resting potential. In neurons with high resting 
negativity, the effects of clamping produce a depolar­
ising effect. The reversal level at which the action 
of GABA switches from a hyperpolarising to a depolaris­
ing influence corresponds closely to the equilibrium 
potential for chloride ions. This evidence, together 
with the observed attenuation of GABA effects in prepar­
ations with artificially reduced extracellular, or 
increased intracellular levels of chloride (Curtis and 
Johnston, 197^), indicate that the post-synaptic action 
of GABA is mediated via an increased membrane permeabil­
ity to chloride ions (Curtis and Johnston, 197^).
Although some controversy surrounded initial reports 
of a pre-synaptic electrophysiological action of GABA 
(Curtis and Ryall, I966; Galinda, I969), evidence con­
tinues to accumulate that GABAergic effects may be 
manifest pre-synaptically (Pickles, 1976, 1979). The 
underlying ionic mechanism again appears to be an incr­
eased membrane permeability for chloride which results,
in this instance, in an efflux of the anion from the 
terminal region. Action potentials arriving at the 
already depolarised terminal are reduced in the magni­
tude of their effects and, therefore, the quantal 
release of transmitters is correspondingly lower.
4. pQst-synaptic GABA Binding - The GABA Receptor
The triggering of post-synaptic electrophysiolog­
ical events by chemical neurotransmitters is dependent 
upon the reversible binding with sub-synaptic membrane 
recognition sites which are associated with trans­
mitter receptors (Krnjevic, 1974). In mammalian CNS, 
receptors for acetylcholine (Burgen et al. 1974;
Yamamura et al. 197^), serotonin ( Bennett and Snyder,
1975) and glycine (Young and Snyder, 1973) have been 
characterised biochemically. A complete chemical 
characterisation of GABA receptors is not yet avail­
able. Currently, information must be derived from 
binding techniques or electrophysiological analysis 
(Nistri and Constanti, 1979).
In the absence of selective post-synaptic GABA 
receptor antagonists which could be readily radio­
labelled to high specific activities, labelled GABA 
itself was used as the ligand in initial receptor 
binding studies (Zukin et al. 197^; Enna and Snyder,
1975). The main problem to be circumvented with this 
approach is that GABA binding to crude synaptic mem­
brane preparations reflects the total population of 
recognition sites, only a fraction of which are recep­
tor associated. To study the GABA receptor in isolation
requires the membranes to be repeatedly frozen, thawed 
and washed (Enna and Snyder, 1977) before the binding 
studies are performed in Na^-free medium (Young et al.
1976). The concentration of specific binding sites 
apparent from these preparations (0,7 pmole/mg protein) 
was approximately equal to non-specific binding, but 
whilst the former system was saturable by increasing 
GABA concentrations, with a dissociation constant of 
0.37 pM, non-specific binding was not saturable (Young 
et al. 1976),
Further analysis of the membranes, prepared as 
described above but with an incubation with Triton 
X-100, revealed a population of GABA recognition sites 
which had an affinity for GABA ten times greater than 
that observed previously (Massotti, 1979). The demon­
stration of this second recognition site led to spec­
ulation that the GABA receptor formed a complex which 
included a protein entity capable of modulating high 
affinity GABA binding (Toffano et al. 1976). Electro­
physiological evidence also suggested that the complex 
is operationally coupled to a Cl ionopore by means of 
which 01 conductance could be influenced (Nistri et 
al, 1980), Of these subunits, only the modulator 
protein (GABA-modulin) has been isolated and character­
ised (Toffano et al. 197#).
The mechanism of interaction between the GABA 
receptor complex and the ionopore remains to be fully 
elucidated. However, results from invertebrate 
species suggest that more than one GABA molecule
binding to the active site is required before the GABA 
receptor is functionally effective in eliciting con­
ductance changes (Brookes and Werman, 1973; Takeuchi, 
1976). Although a similar plienouienon is likely to be 
involved in higher phyla, sucli a luechanisin has not been 
demonstrated to date.
The use made of radioligand binding to GABA recep­
tors has allowed their cellular localisation to be 
visualised with both light and electronic microscopic 
analysis of autoradiographic emulsions (Chan-Palay,
1978). Within the cerebellum, GABA receptor sites 
were localised to the plasma membranes between synaptic 
elements of both axodendritic and axosoniatic synapses 
(Chan-Palay, 1978 ). bsi ng tliis tecinii que, it proved 
impossible to de term i ne whether the radioligand binding 
was associated with pro- or post-synaptic membranes. 
With a more biochemical approach in which post-synaptic 
membranes were separated by density gradient centrifug­
ation, the experimental data was concluded to be in 
keeping with a predominantly post-synaptic GABA recep­
tor localisation (Bittiger, 1979).
The somewhat disruptive approaches used to prepare 
GABA receptor sites (Enna and Snyder, 1977) may result 
in the loss of some of their native properties. Thus, 
the observation of an apparent activation of GABA 
receptor binding by diazepam in fresh brain membranes 
(Guidotti et al. 1978) could not be repeated with
frozen and thawed, tlioroughly washed preparations 
(Olsen et al. 1978a,b). Cnri’ont evidence suggests
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that the benzodiazepine receptor is yet another fract­
ion of the GABA receptor complex (see Olsen, I98I, for 
review), although the possibility that these drugs may 
interact with a modulator protein to regulate GABA 
binding remains to be fully verified (Toffano et al. 
1978; Olsen et al. 198O). In contrast, the reverse 
interaction of some GABA agonists in promoting benzo­
diazepine binding is well documented (see Olsen, I981). 
Although there is considerable overlapping of GABA and 
benzodiazepine receptor distributions in the brain 
(Mohler and Okada, 1977; Squires and Braestrup, 1977; 
Young an_d Kuhar, 1979), the patterns are not identical, 
iVliether benzodiazepine receptors are to be found in 
locations which are lacking in GABA receptors remains 
an open question.
5. GABA Receptor Pharmacology
The two most extensively studied antagonists of 
GABAergic effects upon neurons are the potent convuls­
ants, bicuculline and picrotoxin (Johnston, 1976). 
Although both agents antagonise GABAergic inhibition 
of neuronal firing rates (Curtis et al. 1971; Curtis 
and Johnston, 197^), they appear to have different 
mechanisms of action (Olsen et al. 1978). Competit­
ive inhibition of GABA binding by bicuculline has been 
observed with various brain cell membrane preparations 
(Zukin et al. 1974; Enna and Snyder, 1975). The con­
centrations of bicuculline required to inhibit GABA 
binding in these studies were considerably higher than 
those reported to antagonise GABA inhibitory effects.
Moreover, as the regional distributions of GABA and 
bicuculline binding are not identical, it seems likely 
that not all agonist and antagonist sites are identical 
(Enna and Snyder, 1977). In contrast to the action of 
bicuculline at the GABA recognition site on the recep­
tor, picrotoxin does not influence the binding of GABA 
to synaptic membranes, although it does inhibit GABA- 
induced increases in chloride permeability (Ticku and 
Olsen, 1977.) . Thus, it appears that the antagonist 
effects of picrotoxin are mediated via interaction with 
the mechanism controlling chloride permeability, the 
ionophore, or with the functional linkage between recep­
tor and ionophore. It is interesting, in view of the 
differential actions of the "classical" GABA antagon­
ists, that the antagonism of GABA-induced chloride 
conductance by penicillin compounds is due to an action 
both at the receptor recognition, site for GABA (weak) 
and at the ionophore (strong) (Hochner et al, 1976).
Three criteria have been clearly established as 
requisite properties of true GABA agonists: they must
evoke a bicuculline-sensitive inhibition of neuronal 
firing; they must compete in a competitive manner with 
labelled GABA for Na^-independent binding sites in 
brain membrane preparations; they must produce the 
sajTie neurological effects as GABA itself when applied 
locally to neurons. If, as appears likely, more than 
one population of GABA receptors co-exist in the brain 
(Olsen et al. 1979) with different patterns of regional 
distribution (Guidotti et al, 1979), one might expect
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agents which meet the preconditions as agonists for one 
receptor type to be inappropriate at other receptors.
To date such possible diversity of receptor-agonist 
characteristics remains poorly determined.
The naturally occurring psychotomimetic agent, 
muscimol, has proved to be a potent GABA agonist 
(Curtis et al, 1971; Johnston, 1976). This confirm- 
ationally restricted structural analogue of GABA shows 
a remarkable selectivity, binding to GABA receptors 
with an affinity greater than that of the endogenous 
ligand (Enna et al. 1977). Whilst muscimol inhibits 
Na*^-independent binding in nanomolar concentrations 
(Enna et al, 1977; Kr^gsgaard-Larsen and Johnston, 
1978; Olsen et al. 1978), in contrast, millirnolar
concentrations are required to inhibit GABA transport 
systems (Er^gsgaard-Larsen and Johnston, 1978; Olsen 
et al. 1978). A good correlation exists between the
potency of muscimol in binding to GABA receptors and 
its activity in inhibiting neuronal cell firing 
(Kr^gsgaard-Larsen and Johnston, 1978).
The potential use which may be made of muscimol 
as a pharmacological tool in manipulating central GABA 
systems is eiihanced by its ability to cross the blood- 
brain barrier, which is relatively impermeable to GABA 
itself (Naik et al. 1976). Within the brain, muscimol 
is only slowly metabolised (Baraldi et al. 1979), but 
it is rapidly broken down in the periphery (Baraldi et 
al, 1979; Maggi and Enna, 1979) such that, following 
systemic administration, only 0.02^ of the initial
amount injected can be recovered from brain tissue in 
its native form. It has been suggested that this 
amount of muscimol would be sufficient to elicit GABA 
mimetic effects (Baraldi et al. 1979), although.the 
possibility exists that the total response observed 
could also be due, to some extent, to active metabol­
ites, No such GABA mimetic metabolites have, however, 
been identified. Recent investigations have suggested 
that the anticonvulsant effects observed following 
systemic administration of muscimol are due solely to 
the unmetabolised agonist in the brain (Enna at al.
I98O; Matthews et al. I981), aird pharmacological 
inhibition of peripheral degeneration of muscimol has 
been proposed as a method of enhancing the GABA-mirnetic 
properties of muscimol (Enna et al. I98O). Although
muscimol metabolites do not exert any influence at the 
GABA receptor, it is possible that they are responsible 
for the side effects of this drug reported in humans 
(Waser, I967; Tarnminga et al. 1978). Reduced levels 
of circulating metabolites could conceivably expand 
the therapeutic uses to which muscimol may be applied 
(Enna et al. I980).
The extremely potent GABA-agonist properties of 
muscimol have provided a yardstick against which other 
laboratory-synthesised, putative agonists may be meas­
ured, as well as providing a structural model from which 
a variety of related mono- and bicyclic compounds have 
been systematically developed (Kr^gsgaard-Larsen et al.
1979). Dihydromuscimol and thiomuscimol are approximately
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equipotent with muscimol in inhibiting GABA binding to 
rat brain membranes (Krj^gsgaard-Larsen et al. 1979), 
but the structures of these compounds render them as 
susceptible to metabolic transformation as the parent 
compound. Of the many other compounds examined, to 
date only ^,5,6,7-tetrahydroisoxazolo L 5 , pyridin-
3-ol (THIP) and isoguvacine have proved to be specific 
and potent GABA agonists (Krjzfgsgaard-Larsen et al,
1981). Although both of these GABA agonists have 
been shown to inhibit neuronal firing in vivo (Polc,
1979), isoguvacine had no effect upon seizure respons­
es when delivered systemically (Anlezark et al. 1977). 
THIP, in contrast, appears to be pharmacologically 
active in a variety of animal models (Christensen et 
al. 1979; Fuxe et al. 1980; Meldrum and Horton,
1980). It is of interest that, in spite of the 
structural similarities between the two GABA agonists, 
THIP apparently penetrates the blood-brain barrier 
more readily than isoguvacine.
As well as providing a possible therapeutic agent 
(Hill et al. I981), examination of the properties of 
THIP has been useful to further elucidate the biochem­
ical characteristics of the GABA receptor. A recent 
study of labelled THIP binding to synaptic membranes 
in vitro suggested that the experimental data best 
fitted a receptor model based on three receptor types 
(Palch and Kr^gsgaard-Larsen, 1982). Moreover, the 
density of THIP-receptive GABA receptor sites was 
remarkably low in all of the brain regions studied,
with, the exception of cerebellum. One possible explan­
ation is that THIP may bind selectively to only one 
receptor-type population (Falch and Kr/gsgaard-Larsen,
1982), a suggestion which could open up possibilities 
for differential, possibly regionalised, GABA receptor 
activation,
6. GABA Uptake and Degradation
Evidence is accumulating that termination of the 
interaction of GABA and its post-synaptic receptor is 
brought about by high affinity GABA transport mechan­
isms located in pre-synaptic nerve terminals and peri- 
synaptic astroglial cells (Schousboe, I980). The
GABA recognition sites for these uptake processes are 
both sodium dependent and temperature sensitive (Martin 
et al. 1976). Astrocytic GABA transport is dependent
upon the simultaneous exchange of one sodium ion per 
molecule of GABA, but is independent of potassium and 
calcium ions (Hertz et al, 1978). The neuronal GABA 
transport system displays both a greater affinity for 
GABA ajid a higher capacity for GABA uptake than is 
found in the glial system (Hertz, 1979; Schousboe,
1979; Hertz and Schousboe, I980). On the basis of 
in vitro studies, some recent experiments in vitro 
have suggested that high affinity GABA uptake into 
synaptosomal fractions is due mainly to a homoexchange 
on a one for one basis with the endogenous pool (Levi 
and Raiteri, 1974). In vivo, however, there does 
appear to be a net inward transport of GABA (Sellstrom 
et al. 1976), with a translocation of two or more sodium
ions per GABA molecule (Simon et al. 1974). GABA 
transport across glial membranes represents a net 
inward transport (Hertz et al. 1978).
By making use of the range of GABA analogues 
developed to characterise post-synaptic receptor agon­
ists (Schousboe et al. 1979) it has been possible to 
identify differences in substrate specificity in glial 
and neuronal transport systems. It is thus possible 
to selectively inhibit to some degree either of the two 
systems alone (Schousboe et al. I980). Using these 
compounds as pharmacological tools, it may be that 
future studies will be able to determine the relative 
importance of the two systems in the termination of 
post-synaptic GABA effects,
GABA is catabolised in the brain by transamination 
with Q-ketoglutarate to produce succinic semialdehyde, 
a reaction catalysed by GABA transaminase (GABA-T). 
Subsequent oxidation catalysed by succinic semialdehyde 
dehydrogenase returns succinate to the tricarboxylic 
acid cycle. The predominantly mitochondrial localis­
ation of GABA-T (Hyde and Robinson, 1976) separates the 
synthetic (GAD) and degradative enzymes in both neuronal 
and glial elements (iversen and Kelly, 1975). Moreover, 
the mitochondria derived from glial cells are much richer 
in GABA-T than are those derived from pre-synaptic nerve 
endings, although GABA-T activity in astrocytes repre­
sents only a third of that of the whole brain (Schousboe 
et al. 1980). Thus, not only is GABA breakdown compart­
mentalised within cellular organelles, but it also appears
to be to some extent separated in different cell types 
from neuronal GABA synthesis. Again, however, the 
relative importance of neuronal and glial systems for 
GABA breakdown remains to be determined. To date no 
specific antagonists have been developed to distin­
guish between the two systems, and their similarity 
probably excludes such a possibility. However, sel­
ective inhibition of the specific uptake mechanisms 
(Schousboe et al. I980) indicates that both degradative 
processes contribute significantly to GABA inactivation,
7. Distribution of Cerebral GABA Systems
Several methods exist to measure the relative 
distributions of GABA neurotransmitter mechanisms in 
different regions of the brain. In essence, these 
techniques measure concentrations of the elements at 
each stage of GABA neurotransmission (Fig. l), or the 
rates of activity of the enzymes involved.
Measurement of the concentrations of GABA itself 
is perhaps the most obvious index of the relative 
importance of this mode of neurotransmission in any 
given region (Okada et al. I97I). Recently developed
techniques have overcome the problems of post mortem 
increases in brain tissue GABA content (van der Heyden 
and Korf, 1978) and have provided a fluorometric assay 
method which, according to the authors, is quick, 
simple, and requires little by way of specialised 
equipment (van der Heyden and Korf, 1978). There are, 
however, two major limitations to this methodological 
approach. Firstly, the GABA content of brain is not
necessarily of neuronal origin (Baxter, 1976) and, 
secondly, GABA content has been shown to be dependent 
upon the functional state of the brain prior to 
sacrifice (Killam et al. I960), Although the incon­
sistencies in GABA content refer in this instance to 
convulsive states, it is not unreasonable to assume 
that less extreme circumstances may also affect GABA 
levels.
As GAB is the rate limiting enzyme in the syn­
thesis of GABA, it has been proposed that the presence 
and activity of this enzyme will reflect directly upon 
the availability of GABA for neurotransmission. GAD 
activity may be demonstrated using carboxy-labelled 
glutamate (Albers and Brady, 1959) and measuring the 
enzymic production of either CO^ or GABA (MacDonnell 
and Greengard, 1975» Fahn, I976; Tappaz et al. 1976; 
Nieoullon and Busticier, I981). The specificity of 
these assays for neuronal GAD has been enhanced by the 
recognition of different kinetic properties for GAD 
from non-neuronal sources (Hoker et al. 1970). Thus, 
the GAD assays are sensitive and allow quantitative 
comparisons between brain regions, although these 
approaches do not allow any insight into the cellular 
localisation of GAD. To meet this requirement, immuno- 
histochemical methods have been developed which allow 
visualisation of GAD distribution at both the light and 
electron microscopic levels (see Roberts, 1978). The 
antibodies raised specifically against neuronal GAD dis­
play no cross reaction with GAD from non-neuronal sources
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(Vu, 1980), It should be stressed, however, that the 
specificity of GAD antibodies may vary in different 
laboratories, depending upon the rigour with which they 
are prepared. Moreover, verification of experimental 
results is not possible unless access is allowed to the 
same batch of antibodies. Despite these reservations, 
the studies which have been performed with this approach 
have provided information about the localisation of this 
enzyme at the cellular and sub-cellular level (Wood et 
al. 1976; Ribak, 1978), as well as allowing the mapping
of GABA neuron circuitry within and between regions of 
the brain (Ponnum et al. 1978; Ribak, 1978),
Approaches similar to those used for localising 
GAD have been employed to study the distributions of 
the GABA degradative enzyme, GABA-T (Pitts, I965;
Waksman et al. I968; Barker and Saito, 1976), However, 
unlike GAD, non-neuronal GABA-T has not been specific­
ally characterised. Although it is possible that some 
brain regions contain only minimal concentrations of 
GABA-T from glial sources (Vincent et al. I981), this
has not been proven for all areas. The criticisms of 
GABA-T as a generalised marker for GABA neurotransmission 
throughout the brain (Storm-Mathisen, 1976) have not been 
adequately answered.
Whilst the techniques described so far have been 
limited by the fact that GABA may be involved in inter­
mediary metabolism, without any neurotransmitter role, 
the mapping of high affinity GABA receptors reflects 
directly upon the mechanism of neurotransmission.
The high degree of specificity associated with muscimol
binding to these receptors (Snodgrass, 1978) has added
a further refinement to the biochemical localisation of
GABA systems in the brain (Beaumont et al. 1978), The
use of these techniques is limited by the poor spatial
resolution resulting from the necessity for large tissue
samples to be used (Penney et al, I981). The use of 
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H-labelled muscimol and tritium-sensitive film has not 
only enabléd GABA receptor distributions to be visual­
ised with a high degree of resolution, but also to be 
fully quantified (Palacios et al, I98O, I98I: Penney
et al. 1981).
Although the mapping of cerebral GABAergic markers 
has undoubtedly provided useful indices of the import­
ance of GABA neurotransmission to the integrated funct­
ion of different areas of the brain, one must always be 
careful to avoid attributing a functional role to those 
mechanisms purely on the basis of their existence within 
an area. It is becoming apparent that even the pres­
ence of specific receptors does not mean that the rest 
of the transmitter system is available.
8, GABA Systems in Cerebral Function
Specific regulatory functions involving GABAergic 
neurons have been identified in the control of sleep 
(Poddar et al. I980), food intake (Kelly and Grossman, 
I98O; Meeker and Meyers, I980), parasympathetic 
activity (Gale et al. 1980), cardiovascular control
(Billingsley et al. I98O; Hamilton and Gillis, I98O;
Snyder and Antonaccio, I98O), an.d hormone release
(chase and Tarnminga, 1978). However, the ubiquitous 
distribution of GABAergic neurotransmitter systems in 
the brain suggests a global role for GABA neurons in 
the control of excitatory influences (Roberts, 1979).
A complete understanding of these wider influences of 
GABA requires not only a full description of the cell­
ular morphology and distributions of GABAergic neurons 
themselves, but also a detailed knowledge of the 
organisation of these neurons with respect to other 
neurotransmitter systems.
Attempts to elucidate the functional role of 
GABAergic neurons from a synthesis of biochemical and 
histological data have been concentrated to a large 
extent upon the cerebellum, hippocampus and extra- 
pyramidal motor system. In the cerebellum the exact 
distribution of GABAergic inhibitory neurons (Hokfelt 
and Ljungdahl, 1971; Storm-Mathisen, 1976; Chan-Palay, 
1978) has been added to the already detailed knowledge 
of cellular morphology and interconnections (Eccles et 
al. 1967) without substantially increasing understanding
of the principles of cerebellar functional processes 
(Roberts, 1979). In contrast, within the caudate 
nucleus where the cellular organisation is less clearly 
defined, biochemical analysis of the interaction between 
GABAergic neurons and cholinergic (Scatton and Bartholini,
1980) and dopaminergic neurotransmitter systems (Racagni 
et al. 1978) has increased awareness, if not yet under­
standing, of the complexity of striatal function. More­
over, animal behaviour models which allow motor functions
to be assessed have revealed two distinct GABA-dopamine 
interactive processes, one of which is responsible for 
controlling the occurrence of locomotor activity, whilst 
the other is involved in stereotypy of motor behaviour 
(Scheel-Kruger et al. 1977). The different anatomical 
origins of these two related motor activities in nucleus 
accumbens and caudate nucleus is indicative of the 
difficulties which may be encountered if the functional 
activity of a single brain area is studied in isolation, 
with no knowledge of events occurring elsewhere.
The purpose of the studies which comprise this 
thesis was to analyse the simultaneous effects of GABA­
ergic manipulation upon the integrated function of 
anatomically discrete and functionally diverse regions 
of the brain with a view to providing a greater under­
standing of the importance of GABA systems, both in 
general and in particular,, in the integrated activity 
of the brain as a whole.
CHAPTER II
METHODS
I • General
Several factors were common to all the experimental 
approaches used in these studies; the animals and their 
preparation for experiments, and the form in which 
experimental data were generated and handled prior to 
analysis. These elements are dealt with in this first 
section,
1.1 Animals: All experiments were performed on male
rats (Rattus norvégiens, var, albinus) of the Sprague- 
Dawley strain. The rats used weighed between JOO and 
450g, which corresponds to a post-weaning age of approx­
imately 5 lo 8 months (cf. 50^ survival age of 30 to 32 
months). Animals are expected to lose up to 3^ /0 of 
body weight in transit from supplier, and to avoid the 
possibility of starvation-induced physiological changes, 
rats were allowed to become re-acclimatised to their 
new^  surroundings for at least 2 days ( 3 nights) before 
being used for any experimental purposes. Food and 
water were freely available to all animals until the 
day of the experiment. Room temperature and lighting 
cycle were not strictly controlled in the holding area, 
although ambient temperature was maintained at approx­
imately 21^0, The rats were exposed to a natural
day / ni gilt cycle, and all experiments were performed 
between IO.3O and 13-30 hours ruider constant laboratory 
lighting. Body temperature 'was maintaijned at 37^0, 
using heat lamps where necessary.
1.2 Standard surgical animal preparation: For the
necessary surgical preparation the animals were placed 
in a perspex box into which an anaesthetic gas mixture 
(70^ nitrous oxide: 30 o^ oxygen, containing 3^ halothane)
was flowing. Anaesthesia was maintained by means of 
a face mask through which a l^ o halothane mixture was 
delivered.
Small incisions (l cm, or less) were made at the 
groin on either side of the animal and, taking care aiot 
to injure nerve fibres in this area, the femoral vess­
els were exposed. Polythene cannulae (Portex; internal 
diameter O .38 mm, external diameter 0,96 mm) 13 cm long 
and filled with heparinised Ringer’s solution (10 loU/ 
ml) were inserted retrogradely into both femoral arter­
ies and one femoral vein to a depth of 3 cm from the 
point of entry. The patency of the cannulae was 
tested before the protruding ends were blocked with 
sealed needles. The cannulae were tied in place and 
the wounds sutured closed, infiltrated with local anaes­
thetic, and covered with gauze pads. A plaster of 
Paris bandage (Gypsona, width 7.5 cm) was applied 
around the lower abdomen, pelvis and hindquarters, 
thus immobilising the rear legs. The plaster and 
feet were taped to a lead weight to completely immobil­
ise the lower parts of the animal. Anaesthesia was
then withdrawn. All experiments were performed on 
conscious rats.
1.3 Experimental sample analysis; Common to all tech­
niques used is the requirement for liquid scintillation 
analysis of blood-borne tracer and the measurement of 
tracer accumulation in brain tissues at the end of the 
experimental period, for which quantitative autoradio­
graphic techniques were used,
1 .3.1 Liquid scintillation analysis (lSA); Plasma 
samples containing C labelled tracer were pipetted 
into 1 ml of distilled water in plastic scintillation 
vials. The water was drawn up into the pipette and 
expelled into the vial several times to rinse out 
thoroughly any residual tracer and to ensure that any 
dead space in the tip contained only minimal amounts 
of dilute plasma.
Whole blood samples containing tracer were bleached 
with the addition of 0.5 ml hydrogen peroxide (27.5%'w/v) 
to reduce the possibility of colour quenching. Vials 
were left at room temperature for at least 2 hours for 
the bleaching to proceed.
To each counting vial, containing either plasma or 
whole blood samples, was added 10 ml of a proprietary 
scintillation cocktail (Packard Instagel), chosen for 
its miscibility with aqueous samples. The vials were 
placed in a refrigerated scintillation counter and 
allowed to e q u i l ib r a t e  to 4°C before each sample
sample was counted for 4 minutes. Three temporally
spaced cou3it.i.ng periods were used in the calculation of 
counts per minute. The raw count data were converted 
to disintegrations per minute, using the external stand­
ard channels ratio method (P<nig, 1977) together with a 
standard quench correction calibration curve. The
accuracy of the computerised correction was monitored 
in two vials from each experiment which were subjected 
to the internal standard method (Peng, 1977).
1 .3.2 Preparation of autoradiograms from brain 
sections: At the end of the pre-determined period
(see appropriate protocol description) the rats wore 
killed by decapitation. Dissecting from the supra- 
occipital bone, the dorsal cranium w^ as removed, the 
underlying dura reflected, and the whole brain removed 
intact to be frozen in isopentane pre-cooled to -45°C,
The time from sacrifice to freezing of the brain did 
not exceed 3 minutes. The brain was mounted in cryo- 
matrix by its rostral extremities on to a microtome 
chuck over a bed of solid CO^. Sections of the brain,
20 microns thick, were cut on a rotary microtome in a 
cryostat maintained at a maximum temperature of -22°C.
Of the serial sections cut, 3 consecutive sections were 
picked up on to thin glass coverslips and rapidly dried 
on a hotplate (6 o °c ) ,  whilst the intervening 10 sections 
were discarded. The coverslips were glued into posit­
ion on thin card and, together with a set of epoxy resin 
standards (Spurr’s Resin containing O - I88O pCi/g 
tissue equivalents of ^^C-benzoic acid) (see Appendix l), 
were applied to x-ray film (Kodak SB-3) in a light-tight
X-ray cassette for between 7 ajid l4 days routinely 
(longer if tissue levels were predictably low).
Tlie exposed plates were processed according to tb.e 
manufacturer's instructions, following standard radio­
logical practice.
1/4
C was the isotopic label used throughout because 
the onergy of emission is high enough to penetrate to 
the film emulsion, but low enough to allow good spatial 
resolution.
1 .3.3 Quantitative densitometrie image analysis;
Analysis of the resultant images on the X-ray film was
performed using a computer-based micro-densitometer
(Quantimet 720, Cambridge Instruments), The effective
field of the video detection system covered an area of
2
film approximately 18 cm which, magnified by a factor 
of 3*6, was projected on to a visual display unit.
The field could be varied down to an area of 2.3 ^ 10 ^
2 _ 2 
cm in decrements of 3 ^ 10 cm along each axis. The
densitometer digitised the X-ray images in 'picture 
point' units, one picture point covering 2 x 10  ^ cm^, 
allocating each picture point to one of 6k grey levels 
on a densitometric scale according to the optical dens­
ity of the film in the light path of each picture point. 
The range of absolute optical densities covered by the 
6k levels could be varied. The densities at each 
picture point within the field were added to give the 
integrated density of the area and each density measure­
ment was the mean of 3 scans.
For each area of brain, 12 bilateral density readings
were made on 6 consecutive sections in which the struc­
tures could be defined anatomically by reference to 
stereotaxic atlases (Zeman and Innes, I963; Konig and 
Klippel, 1967; Pellegrino et al. 19?0)> with the aid 
of cresyl violet stained sections where necessary.
Vliere the brain had been subjected to a unilateral 
stimulus or treatment (e.g., unilateral lesions), 6 
readings were taken on each side with care being exer­
cised to avoid side-to-side differences arising from
asymmetrical mounting of the brain. The size of the
2measuring frame was variable and ranged from 0.02 mm 
2
to 0.25 mm , depending upon the size of the region 
being examined, but was constant for each region 
between animals. The optical densities of the images 
resulting from exposure to the plastic standards were 
measured, providing a calibration curve of density 
versus C concentration from which the tissue isotope 
concentration corresponding to the measured optical 
density could be quantified in absolute terms,
1.4 Statistical analysis; The autoradiographic tech­
niques which are used exclusively in these studies 
present particular problems for statistical analysis. 
The multiple, non-independent measurements made in 
diverse brain areas in each individual animal and the 
multiple treatments to be compared with a distinct con­
trol group demand sophisticated statistical approaches. 
The Bonferroni correction factor, which has been pro­
posed to eliminate the error involved in using multiple 
t-testing (Wallenstein et al, I980), may be used to
allow comparison with control values in man.y regions 
and coînparisons within these regions across multiple 
treatments. However, a degree of experimental bias 
could be introduced merely by reducing the number of 
structures analysed, to increase the probability of 
statistical si gnif icajice , The most appropriate stat­
istical analysis 1ji many of the experiments performed 
waas foirnd to be the Schoffe extension of aiaalysis of 
variance tests (Scheffe, 1959) which permits multiple 
treatment comparisons to be made. The analysis of 
variance is less susceptible than the t-test to errors 
arising from its repeated use for many brain areas in 
the same ajiimals. Furthermore, the Scheffe ajralysis 
is a rather conservative test ajid, therefore, statist­
ical significance accrues greater credibility.
The analysis of blood flow and glucose utilisation 
data together required the development of a novel 
statistical model (McCulloch et al. 1982) to meet the 
particular demands of analysis. This innovative 
statistical test is discussed in the appropriate 
comment ary,
2. Autoradiographic Techniques
As these techniques are relatively recent innovat­
ions, some of the theory behind the experimental proto­
cols will be presented. Most of the experiments to be 
described employed the 2-deoxyglucose (2-DG) technique, 
and greatest emphasis is placed in that section.
2 .1 Measuremejit of local ceirbral blood flow: Local
cerebral ti ssue perfusi on was quant ified using the 
L^^cJ i odoantipyri ne tecinii que (Sakurada et al. 1978).
2.1.1 Theory ; lodoaTit ipyrine is a tracer which is 
freely diffusible across the 1)1 ood-brain interface in 
tlie cerebral vessel wail. Tlie brain tissue to blood 
partition coefficient is 0.79. Because the tracer has 
no diffusion limitations, the equation devised by Kety 
(Xety, i960) relating tissue accumulation of tracers to 
blood flow is wholly applicable:-
Ci(T) = \K F ca e-dT-b
oy
where Ci is the tissue concentration of tracer at time 
T, X is the partition coefficient, and the integral is 
the area under the curve described by the function; 
arterial tracer concentrations (C^) against time from 
onset of tracer circulation. The constant K is an 
entity which incorporates tissue blood flow per uiiit 
weight and a constant, m, representing the extent of 
blood-tissue equilibrium which is attained in a single 
passage :
K = " "F w X
With a freely diffusible tracer m = 1 and K becomes 
flow (f ) per unit weight (W) times the partition co­
efficient. Thus, by measuring the accumulation of 
1^0 iodoantipyrine in regions of the brain on sacrifice 
and by sampling the arterial input of tracer adequately 
throughout the experiment, flow may be derived.
To maximise the power of the procedures employed 
to resolve differences in regional blood flow, arter­
ial tracer concentrations must not reach constant 
levels. This is illustrated in the extreme case
where a relatively long time is interposed between a 
r 14 1
pulse of L C_| iodoantipyrine and sacrifice of the 
animal. Under these circumstances the accumulation 
of isotope in different brain regions is no longer 
flow-limited, but becomes limited only by the part­
ition coefficient (indeed, it is by this method that 
the partition coefficient may be determined). Thus, 
uniform concentrations of tracer are found in areas 
known to be served by widely differing perfusion lev­
els, e.g., white matter and neocortex. Although the 
experimental time interval used in these studies was 
never sufficient to allow full equilibrium to occur, 
it was found that if tracer wns infused at a constant 
rate over 1 minute, the plasma history of tracer lev­
els showed a trend towards equilibrium during the last 
few seconds which could at least result in areas of 
similarly high perfusion becoming indistinguishable. 
This problem may be overcome in two ways; either the 
experimental time can be shortened so that the meas­
urement takes place over the rising phase of the 
input function, or a continuously increasing rate of 
infusion may be employed to eliminate the possibility 
of reaching steady-state blood isotope concentrations. 
The former option was found to be impractical because 
of the difficulty in collecting a large enough number
XJ
of samples In a sliort time to adequately define the 
input function. The latter option proved more accept­
able and became the standard approach.
2,1.2 Practice: Rats were prepared in the standard
manner for conscious animals and the measurement of 
local cerebral blood flow was performed, using the
freely diffusible tracer CJ-labelled iodoanti­
pyrine in conjunction with quantitative autoradio­
graphy (Sakurada et al. 1978). Immediately prior to 
the measurement, a sample of arterial blood was with- 
dra-wn from the femoral artery for the determination of 
blood gas status. Over a 1 minute period the tracer 
(50 pCi in 0.5 ml saline) was infused into the femoral 
vein at a constantly increasing rate while I8 timed 
sample drops of whole arterial blood were collected 
from a freely flowing femoral arterial cannula on to 
pre-weighed filter discs. At the end of the experiment 
the rats were sacrificed and the brains processed for 
quantitative autoradiography. The filter discs were 
tightly capped in scintillation vials to prevent 
evaporation, and re-weighed. From the weight differ­
ence and the specific gravity of whole blood (I.03) 
the sample volume was calculated. The vials were
treated and subjected to LSA as described. The con- 
14
centration of C tracer measured in each sample, 
corrected for sample volume, permitted an accurate 
history of arterial tracer levels at each time point 
of over the minute to be derived.
Ti4 1Local tissue L CJ concentrations were measured
by quantitative densitometric analysis in 39 regions of 
the brain relative to standards of known concen­
tration. Blood flow \:as calculated from the arterial 
tracer profile and tissue levels, employing the
equation derived by Kety (196O) for the measurement of 
tissue perfusion, using freely diffusible tracers.
2.2 The measurement of local cerebral glucose
utilisationi Local cerebral glucose utilisation was 
quantified using the 2-deoxyglucose (2-DG) tech­
nique (Sokoloff et al, 1977).
2.2.1 TheQry; Under normal, non-fasting conditions 
the adult brain uses glucose as the principal substrate 
for the production of high energy phosphate molecules 
with which to fuel the many biochemical reactions 
necessary for cerebral function (Kety, 1948), Although 
some glucose is stored within the tissues of the brain 
in the form of glycogen, the relatively fixed volume 
afforded by the cranial bones and the requirement for 
3g of water for every Ig of glycogen severely limits 
the availability of this energy source to meet total 
energy requirements (Cahill and Aoki, I98O), Thus, 
for the maintenance of function the brain requires the 
continuous supply of blood-borne glucose.
2-Deoxy-D-glucose, a structural analogue of native 
glucose differing only in the hydrogen atom attached 
to the second carbon in place of a hydroxyl group (Fig, 
2), was shown many years ago to be a highly successful 
inhibitor of glucose uptake and phosphorylation in
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cerebral tissue slices. This inhibition was found to 
be accompanied by an accumulation of 2“deoxyglucose-6- 
phosphate (2-DG-6-P) in the tissue (Tower, 1958).
Although the significance of these results was not 
appreciated at the time, this experiment supplies the 
basis for the usefulness of the method developed later 
by Sokoloff and his colleagues (Sokoloff et al. 1977)« 
Sokoloff•s tecîmique relies upon the systems of brain 
uptake and phosphorylation being common to both glucose 
and deoxyglucose, and the inability of the isomerase 
enzyme which converts glueose-6-phosphate to act upon 
the anomalous structure of 2-DG-6-P which, as a result, 
accumulates in the tissue. If the relevant rate con­
stants are Icnown for the steps which take blood-borne 
glucose and 2-DG to phosphorylation in the tissue, and 
the blood concentration of both substances is known, 
then the rate at which 2-DG-6-P accumulates may be 
directly related in a predeterminable fashion to the 
rate at which glucose itself passes through the prelim­
inary stages of the glycolytic pathway, provided that 
the levels of deoxyglucose present are never sufficient 
to act as a competitive inhibitor.
On the basis of the theoretical model (Pig. 2) 
formulated by Sokoloff and his colleagues (Sokoloff et 
al. 1977)) an operational equation was derived (equation 
30 in original text) which described rates of cerebral 
glucose utilisation in terms of the concentration of
ri4 1I Cj-2-deoxyglucose and glucose in arterial plasma over 
the experimental period (C * and C ) and the concentration
of tracers found within the CNS (c^*) (Pig. 3). The 
distribution of tracer between the plasma and brain 
tissue compartments is governed by the kinetic rate
ri4 1
constants for the movement of L CJ-2-deoxyglucose 
into and out of the CNS (k^* and k^*), its phos­
phorylation to 2-deoxyglucose-6-phosphate (k^*) and 
a composite constant which, in simplistic terms, 
reflects the relative preference of glucose transport 
and enzyme system for glucose as opposed to 2-deoxy— 
glucose. Despite the rigour with which these con­
stants were derived, a relatively high degree of 
measurement error is associated with each of them. 
However, within the confines of the original model 
and the operational equation, these errors become so 
small as to be negligible if a suitably long time 
interval is interspaced between a pulse injection of 
2-deoxyglucose and ultimate sacrifice of the animal.
The main limitations of the technique as an 
approach to the measurement of functional activity 
are the degree of restraint necessary for plasma 
sampling and the long time constant required for the 
experimental measurement. The time between the pulse 
of labelled deoxyglucose and sacrifice of the animal 
must be sufficiently long to minimise potential errors 
arising from uncertainty in the model (particularly 
the values for rate constants), but must be short 
enough to limit the depleting effects upon 2-DG-6-P 
of the small amounts of phosphatase known to be pres­
ent in cerebral tissue. An experimental time course
-K V
Figure 3
The operational equation
Ri =
K
C i (T)_  k f e £ c f )  dt
i(Cp/Cp)dt-eC"'+''')" . B C p / C p )
where is the rate of glucose consumption in any
tissue sample of total isotope concentration C|-, C*
and C are the concentrations of 
P
r%4 1
L Cj-deoxyglucose 
and glucose in plasma; and k*, k^ and k* are the 
enzymatic rate constants for bidirection transport 
between plasma and tissue precursor pools, and for 
phosphorylation of deoxyglucose by hexokinase.
The "lumped constant", K, is composed of the relative 
distribution spaces for deoxyglucose and glucose; 
the ratio of the Michaelis - Menten constants and 
maximal velocities of hexokinase for deoxyglucose 
and glucose and the fraction of glucose~-6~phosphate 
which continues via the glycolytic pathway for 
further metabolism (Sokoloff et al. 1977).
of 45 minutes has been found to meet both of these 
requirements. However, the experimental design as 
described originally by Sokoloff and colleagues is 
such that events which occur within the first 10 min­
utes after intravenous isotope delivery carry greater 
weight in their effects upon measured glucose utilis­
ation by virtue of the shape of the arterial input 
function (Fig. 4). Thus, for example, drugs need not 
be infused throughout the whole 45 minutes to ensure 
steady-state conditions.■ Nevertheless, great care 
must be taken to ensure that the relative timings of 
drugs and tracer administration are meaningful in terms 
of the previously reported time course of action for 
the specific agents.
A further limitation of particular relevance in 
the studies reported here is the inability of the model 
as it stands at present to. accommodate hyperglycaemia 
as a reaction to stress. As the classical GABA antag­
onist agents, picrotoxin and bicuculline, are active in 
promoting seizure-like responses which are mrdoubtedly 
stressful, these substances could not be used with the 
fully quantitative approach in conscious animals.
Efforts have been made to overcome some of the 
limiting factors in the original experimental protocol 
and the relatively sophisticated hardware required for 
analysis. Such modifications are examined critically 
in a later section.
% £
Figure 4
Plasma Deoxyglucose Clearance
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Time course of deoxyglucose concentrations in
arterial plasma from a typical control, conscious 
rat injected with isotope over 30 seconds.
2.2.2 Practice ; Measurement of local cerebral glucose 
utilisation, was performed on conscious rats, prepared as
fl4 1described previously, using the [_ Cj-2-deoxyglucose 
method in conjunction with quaint it at ive autoradiography 
(Sokoloff et al. 1977).
Each measurement was initiated with an intravenous 
infusion of ]-2-deoxy~D-glucose (l23 pCi/kg) dis­
solved in saline, injected at a constant rate over 30 
seconds. A total of l4 timed samples of arterial blood 
were withdrawn from the femoral cannula aiod collected 
into plastic centrifuge tubes over the subsequent 43 
minutes according to a predetermined schedule. Five 
samples were taken over the first minute of the exper­
iment at 13 second intervals, the third sample being 
co-ordinated with the end of isotope delivery, thus 
allowing an accurate determination of the history of 
label in plasma during the time at which it is changing 
most rapidly (see Fig, 4), As the rate of clearance 
of isotope from the plasma becomes progressively less, 
the time between successive samples was increased with 
little loss of accuracy to the profile (Fig, 4), In 
order to minimise hypovolaemic stress resulting from 
loss of body fluids and the compromise of the 2-DG 
methodology (see Fig, 3a), each sample was limited to 
around 75 pi of whole blood and was replaced by a 
similar volume of Ringer’s solution.
The cell fraction of each arterial sample was 
separated from the plasma by centrifugation as quickly 
after withdrawal as was possible in order to minimise
% t*
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aFigure Plasma glucose levels in conscious rats
over minutes where (i) whole blood samples 
did not exceed 80 pi and (ii) where whole blood 
samples were l60 pi. Both animals started from 
a plasma glucose level of 8.5 mM. In rat (i), 
the plasma glucose remained within 5^ of the 
starting levels, whereas in rat (ii) plasma 
glucose rose to levels almost twice that of 
starting levels.
Figure 5t> • Measured plasma glucose levels in two con­
secutive samples of blood taken from conscious 
rats. One sample was centrifuged immediately 
(non-haemolysed sample), whilst the other was 
left for 1 minute at room temperature before 
centrifugation, resulting in a degree of 
haemolysis. In every case the measured plasma 
glucose level of haeraolysed blood was less than 
that in non-haemolysed blood (all points on the 
plot fall below the line of identity). This 
potential measurement error could result in an 
under-estimation in cerebral glucose utilisation,
% V
haemolysis (see Fig, jh). Aliquots from each plasma 
sample (20 |il) were pipetted from the centrifuge tubes 
into 1 ml of distilled water in l4 plastic disposable 
scintillation vials. A furtlier aliquot of each
plasma sample (10 pi) was pipetted into a semi-automated 
glucose analyser (Beckman) . The principle wliich allows 
this machine to measure glucose concentrations is based 
upon a glucose oxidase enzyme assay, A sample is 
delivered manually into a chamber containing glucose 
oxidase enzyme reagent and an electrode which is sens­
itive to oxygen concentrations. The rate at which 
oxygen is consumed in the reaction
glucose oxidase^ _glucose + Og ------ ► gluconic acid + H^O^
is monitored by the electrode and is proportional to 
the initial glucose concentration (Kadish, I965).
Glucose levels in the sample may therefore be derived 
from the measurement of the rate of oxygen depletion.
The digital readout indicates plasma glucose levels in 
pmol/ml.
At the end of the 45 minute period, the rats were 
killed by decapitation and the brains processed for 
quantitative autoradiography (see appropriate Methods 
section).
Rates of glucose utilisation within chosen anatom­
ically discrete and functionally diverse regions of the
rat brain were calculated from post-mortem levels of 
l4C measured in tissue by quantitative autoradiography 
which, together with the plasma histories of and
glucose concentrations, were applied to the operational
equation for the technique as characterised by Sokoloff 
and his colleagues (Sokoloff et al, 1977) (see Fig. 3)o 
The values for the rate constants k.^ *, k^^, k^* were 
0 ,189, 0,245 and 0 ,052, respectively, for grey matter
areas, and 0.079, 0.133 and 0.02 for white matter areas.
The value for the "lumped constant" was 0,483 (Sokoloff 
et al, 1977)' These values were used throughout the 
studies cited, whore plasma glucose levels were relat­
ively constant throughout the experiments. A protocol 
was available in cases where the glucose in plasma 
changed dramatically over the measurement period, but 
it was never necessary to use it (Savaki et al. 1980).
To illustrate in a simplistic fashion how the data 
collected during the course of an experiment is applied 
to the determination of glucose utilisation, the operat­
ional equation may be written thus:
l4Rate of glucose _ Total Tissue C - Tissue 2-DG___
utilisation ” Lumped Constant x Integrated plasma
specific activity
l4where total 0 in tissue is measured densitometrically, 
and tissue 2-DG and integrated plasma activity are cal­
culated from plasma histories of 2-DG and glucose. It 
is worthy of note that quantification of the methodology 
by this approach gives an index of the rate of glucose 
utilisation, and not merely of the accumulation of 
tracer which, at the instant of kill, will be present 
both in the form of 2-deoxyglucose and 2-deoxyglucose- 
6-phosphate (the numerator of the equation). The 
implications of this are addressed subsequently.
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2.2,3 An appraisal of 2-DG inethodol ogi cal modifications : 
Simplifying technical modifications have been advanced 
as feasible alternatives to the rigorous 2-DG approach.
Of these, the most widely used are a), the use of free- 
runni]ig animals, -vdiich often precludes the plasma 
sampling protocol and involves a different route for 
tracer admnnistration (Meibach et al, 1980, for review) 
and b) the use of optical density ratios in the semi- 
quantitative analysis of autoradiograms (Brown ajid 
Volfson, 1978; Collins, 1978; Meibach et al. I98O).
The theoretical justification for these modified 
approaches rests upon the fundamental assumptions that 
a) on sacrifice of the animals all isotope in the brain 
tissue is in the form of phosphorylated 2-DG with no 
residual free 2-DG, and b) that a simple correlation 
exists between brain tissue glucose use, total isotope 
concentrations on sacrifice of the animal, and the 
optical densities of resultant images on photographic 
emulsion. These assumptions were tested with a view 
to evaluating the two simplified approaches for poss­
ible use in subsequent studies,
A total of 16 animals were prepared in the stand­
ard manner for conscious animals. Following tracer 
amounts of j^^^cJ-2-DG delivered via either the intra­
venous (n=8), intraperitoneal (n=3) or subcutaneous 
route (n=3), timed arterial blood samples were with­
drawn and treated according to the usual 2-DG experi­
mental protocol. In the i.v. group, 3 animals were 
hyperglycaemic with plasma glucose levels of 17 ± 1 mM
m y
compared to a range of 7,2 to 10.8 mM in the normo- 
glycaemic groups. At 45 minutes after the delivery 
of the isotope the brains were removed from the i.v. 
group and processed for autoradiography. From the 
resultant autoradiograms cerebral glucose utilisation 
was calculated for neocortex (mean of 5 cortical areas) 
and white matter (mean of 4 areas), as well as several 
other grey matter areas including median raphe nucleus, 
substantia nigra pars compacta, and septal nucleus.
Using a simple rearrangement of Sokoloff’s oper­
ational equation (Fig. 6) and the experimentally 
generated arterial plasma histories of glucose and 
^'^cl-2-DG, levels of unphospliorylated [^^cl-2-DG in 
the CNS were calculated and the influences exanined of
a) the rate of regional glucose utilisation itself, b) 
the duration of the experiment, c) the route by which 
the tracer is administered, and d) moderate hyper- 
glycaemia. Under all conditions the values used for 
the required rate constants were those derived for the
Sokoloff model (Sokoloff et al. 1977).
l4Four identical sets of C-containing epoxy resin 
standards were exposed on X-ray film for 3, 5 and 10 
day exposure periods. The standards had been cali­
brated previously (see Appendix l) and ranged from O 
to 1880 pCi/g, At the end of the chosen exposure time 
the plates were processed for tissue autoradiographs, 
but, in this instance, stricter than usual control was 
maintained over the temperature of the processing 
chemicals and the time spent at each of the stages
Figure 6
The concentration in the CNS of unphosphorylated 
2-deoxyglucose C^^ can he described by
C dgct) = kî e^ k|+kl)t
and simple rearrangement in the "operational equation" 
(equation 1) yields
Ci(T,= R i . K . . £(C^/Cp) U
4 - k t  e g(k5+k*3)t
where the nomenclature is .that described in Figure 3. 
Thus, the proportion of the total amount of radioisotope 
present as unphosphorylated DG (i.e., C^j^ (t )/C|-(t ) ) can
be calculated from the rate of glucose utilisation and 
the arterial plasma histories of 2-deoxyglucose and 
glucose over the measurement period, if the values of 
various constants are known.
V  A.
(developer, stop bath, fixatives and wash). The 
optical densities of the resultant images were meas­
ured on the densitometer which had been calibrated 
against a range of filters (Kodak, Vratten gelatin 
filters) rising from 0.1 to 2.0 in steps of 0,1 
optical density units. Optical density ratios of 
neocortex to white matter were calculated, usi]ig the 
tissue concentrations generated autoradiographically 
from the normoglycaemic i.v. injected rats and the 
corresponding densities from the standard isotope 
functions at the 3 exposure times.
2.3 Measurement of local cerebral protein synthesis :
A recently developed autoradiographic technique permits 
local rates of protein synthesis in the nervous system 
to be measured (Smith et al, I980). The use of this
method was limited in these studies; therefore, its 
description will be limited.
2 .3.1 Theory; This approach is very similar to the 
2-DG technique in that a rigorous, empirically based 
model has been developed to describe the kinetics of 
transfer and incorporation of a tracer, in this case 
labelled leucine, from blood into tissue. A 
mathematically derived operational equation defines 
the rate of leucine incorporation into protein in terms 
of the relevant rate constants and experimentally meas­
urable plasma and brain tissue variables.
The model is greatly simplified by the fact that 
the metabolic pathways which determine the fate of the
essential amino acid, leucine, are such that using 
l4 1_carboxyl- Cj leucine ensures that metabolically 
degraded tracer is lost from the system and the 1
tissue pool comprises only free leucine and leucine 
incorporated into protein. By allowing the experi­
ment to run for a relatively long time after the pulse
fl4 1injection of L Cj leucine, free labelled leucine in 
the tissue approaches zero. As for the 2-DG model,
brain uptake of the tracer is intimately linked to 
the relative concentrations of labelled and endogenous 
leucine in the blood. For full quantification of the 
method, therefore, an amino acid analyser is required.
2.3.2 Practice : Conscious animals, prepared in the
standard manner, were injected with a pulse of ^^0 
leucine (25 pCi) over 30 seconds. Timed arterial 
plasma samples were withdrawn over the subsequent 60 
minutes and plasma taken for liquid scintillation 
analysis. No amino acid analysis was available.
At the end of the hour the animals were killed and 
the brains processed for autoradiography. Analysis 
of the autoradiograms was performed in terms of total 
tissue isotope concentrations, and these were compared 
with concentrations of label found after similar treat­
ments in 2-DG experiments.
o  o
3. Experiments Performed
The autoradiographic techniques described were 
used in conjunction with three approaches to allow 
examination of possible GABAergic influences upon 
cerebral function:
a) Following systemic adsninistration of 
agents known to interact pharmacologic­
ally with GABA systems.
b) Following specific lesions of a known 
GABAergic pathway and subsequent 
pharmacological challenge.
c) Following localised injection of the 
neurotransmit ter analogue into a brain 
area of known GABAergic output,
3 .1 Systemic drug administration : Four ph a rin acolo g-
ical agents were studied for their central effects when 
administered intravenously; two GABA agonists, muscimol 
and THIP, picrotoxin, a potent GABA antagonist, and 
diazepam which, as a benzodiazepine, interacts with 
GABA systems. All agents were dissolved in saline 
directly, with the exception of diazepam which was 
first dissolved in 0.1 N HCl, the pH adjusted to 7.4, 
then added ro suitably concentrated saline to make the 
final injeptate isotonic.
Muscimol and THIP were injected into the femoral 
vein 20 minutes prior to the initiation of the 2-DG 
experiment at doses of 0.15 to 5.0 mg/kg (n=15) and
1.0 to 10.0 mg/kg (n=12), respectively.
Picrotoxin was injected i.v. five minutes prior to
D 4
the 2-deoxyglucose experiment at a dose of 2 mg/kg 
(n~l). The animal which received this dose died at 
25 minutes after the delivery of tracer. The convuls­
ions suffered by this conscious animal were deemed to 
contravene the conditions for experimental practice 
laid down by the Home Office, and no further such 
experiments were performed.
Diazepam was injected i.v. 10 minutes before the 
2-deoxyglucose experiment at doses of 0.1, 0.3 and 1.0
mg/kg (n=15).
Contemporaneous control experiments were performed 
in which animals received saline alone. Diazepam con­
trols received appropriate vehicle but, as no difference 
was discernible froin saline controls, statistical compar­
isons were made to the same saline control group for all 
systemic drug studies.
Local cerebral gluco-se utilisation was calculated 
in 60 functionally diverse regions of the brain. This 
relatively large number reflects an appreciation of the 
ubiquity of cerebral GABA systems, all of which will be 
influenced by systemic administration of pharmacological 
agents. No quantification of glucose use in the brain 
of the convulsive animal (picrotoxin 2 mg/kg) was per­
formed because the experimental model was severely 
compromised by the stress-induced hyperglycaemia and 
early demise of the animal.
Local cerebral blood flow was measured in a total 
of 16 rats following O .5 or 1.3 mg/kg muscimol or 0.3 
ml of saline alone injected into the femoral vein 30
g ü
minutes prior to the initiation of the measurement.
The timing was such that the median point of the blood 
flow experiments coincided with that of the 2-DG exper­
iments in the time after delivery of muscimol. .
3.2 Striatal lesioning with kainic acid; Rats were 
anaesthetised with halothane and mounted by ear bars 
into a Trent-¥ells small mammal stereotaxic frajne, A 
midline incision was made to expose the dorsal aspect 
of the skull. The position of bregma was determined 
with the aid of an operating microscope (x4o) and, 
using this as a reference point, a small hole O .9 mm in 
diameter was drilled 1,3 mm anterior and 2,2 rnm lateral 
from bregma (Fig. 7)* The dura was carefully punct­
ured with a hooked needle. A stainles steel cannula, 
diameter 0.3 mm, was lowered 3-3 mm ventral from bregma 
(all co-ordinates modified from Divac et al. 1978).
In 32 rats, 2 pi of mock CSF (Leusen, 1930) containing 
2 pg of kainic acid and adjusted to pH 7.2 was injected 
into the caudate nucleus from a Terumo microsyringe (10 
pi) attached to a Harvard infusion pump at a constant 
rate over 3 minutes, A small amount of tire inert dye, 
Evans blue, was added to the injectate so that it could 
be easily visualised at the end of the cannula. In one 
animal the kainic acid injection was made slightly more 
medially, although otherwise at the same level, thus 
injecting the neurotoxin into the septal nucleus. Mock 
CSF alone, pH 7.2, was injected into 21 animals which 
formed the control groups. The needle was left in situ 
for 10 minutes before being slowly withdrawn. The skull
Figure 7
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was reconstituted with bone cement, the wound held 
closed with sutures and local anaesthetic applied to 
the scalp before the animals were left to recover.
The cannula was checked before and after the inject­
ion to ensure that it remained fully patent.
Four kainic acid-injected rats were taken at 7 
days after the lesioning procedure and prepared in 
the standard manner for conscious rats. At least
2 hours elapsed before the experiments proceeded.
Various physiological parameters were measured from 
these conscious animals; blood gas tension, arterial 
blood pressure and heart rate, haematocrit, and plasma 
glucose levels.
Ten days after the intracerebral injections, 6 
of the control group together with 7 lesioned animals 
(including one septal lesion) were prepared as detailed 
before, and local cerebral, glucose utilisation was 
determined using the 2-DG- method, A further group
of lesioned animals (n=4) were allowed to recover for 
30 days before the 2-deoxygTucose experiments.
Autoradiograms were prepared from frozen tissue 
section and analysed as described previously. However, 
the cryostat protocol was altered slightly in that, at 
each level, a fourth section was taken to be fixed and 
stained for subsequent histological examination. Glu­
cose use was calculated from the autoradiograms for a 
number of structures, discrete measurements being made 
both ipsilateral and contralateral to the site of kainic 
acid injection. Analysis was performed by comparing
o o
the respective sides of lesioned and control ajiimals.
In a parallel study, 5 animals which had been 
lesioned and 3 which had received intrastriatal CSF 
were perfusion-fixed at 10 days with formaldehyde/ 
acetic acid/metbajiol (l;l;8) and the brains subjected 
to conventional light microscopy. The cryostat sect­
ions from the 2-DG experimental animals allowed a 
direct comparison to be made between the autoradiograms 
and the extent of damage, although the resolution was 
much less than in perfusion fixed material.
Two of the lesioned animals were taken 10 days 
after the induction of the lesion, and uptake of j^l-^^cj 
leucine into various brain regions was analysed densito- 
metrically as described.
In the remaining 10 lesioned and 10 sham-lesioned 
cUiimals, 5 from each of the two groups were ascribed at 
random to one of two subgroupings. At 10 days after 
the neurosurgical intervention, the subgroups were 
injected with either muscimol (l.5 mg/kg) 20 minutes 
before the initiation of the 2-DG experiment, or the 
dopaminergic agonist, apomorphine (l.O mg/kg), 10 min­
utes before the start. Thus, four treatments were 
studied; sham lesion plus muscimol, sham lesion plus 
apomorphine, striatal lesion plus muscimol, striatal 
lesion plus apomorphine. Standard 2-DG protocol was 
followed. Autoradiographs were analysed to differ­
entiate ipsilateral from contralateral effects, and 
analysis of the data allowed comparisons between con­
trol and drug treatment in sham-lesioned and lesioned
groups and within drug treatments between sham and 
lesioned groups. Both comparisons were made ipsi­
lateral and contralateral to the intervention site.
3*3 Intrastriatal drug administration; A group of 
15 rats were prepared in the standard manner for 
conscious animal preparation to the stage at which 
the restraining plaster cast was applied. With anaes­
thesia maintained, they were mounted in a stereotaxic 
frame as previously and, using bregma as the zero 
reference point, a hole was drilled in the skull at 
the same co-ordinates used in the lesion studies. A 
stainless steel guide cannula, external diameter 0.6 
mm, had previously been positioned through a hole in 
a square of perspex (23 mm^) such that 2 mm of its 
length protruded in one direction and 5 mm in the 
other direction. Glue was amassed to form a mound 
from the perspex along the longer protrusion (see Fig, 
7). For each guide cannula, a needle was made which
fitted exactly through the bore of the guide can.nula
(0.3 mm). Wlien pushed completely home, this needle 
penetrated 5.5 mm from the base of the perspex plat- 
f orm,
The guide cannula was lowered into the bur hole
until the flat perspex base was in contact with the
skull. At this point the end of the cannula pene­
trated less than 1 mm into cerebral cortex. The
skull around the perspex was thoroughly dried before 
dental cement was applied to hold the cannula in 
position (Fig. 7). Local anaesthetic was administered
D  V
to the scalp which was sutured over the cement once it 
had hardened. Small sponges were used to keep the 
scalp a little away from the protruding cannula, and 
to absorb any seepage from the wound which could clot 
and block the cannula. The animals were mounted on 
to the lead weights and the anaesthesia was withdrawn. 
Because the operating time was approximately one hour 
(cf. less than 30 minutes for standard conscious animal 
preparation), and because of greater possible surgical 
trauma, the rats were left for at least. 4 hours before 
further manipulation.
After the recovery period the injection needle was 
placed in position, attached to a microsyringe. This 
action comprised two steps. Firstly, the needle was 
placed in the guide cannula such that it would not pro­
trude into brain. The proximity of the experimenter 
necessitated by this manoeuvre invariably caused the rat 
to become agitated; therefore, a period of 10 minutes 
was allowed for the rat to settle down before the needle 
was pushed home and the injection started. Over two 
minutes, 2 pi of CSF alone (n=5), or containing 100 ng 
muscimol (n=5) or 500 ng muscimol (n=5), was injected 
by hand at a relatively constant rate. All solutions 
contained Evans blue to allow visualisation of the 
injection site in the brain sections cut subsequently. 
Fifteen minutes after the start of the intrastriatal 
injection, 2-DG experiments were initiated. Standard 
2-DG protocol was followed. When sectioning the brain 
through the caudate nucleus, a fourth section was taken
6 1
at each level for histological examination.
Analysis of the data was performed by comparing 
the respective sides of CSF control and treated brains.
4. Drngs and Tracers
Several pharmacological agents and radioactive 
tracers were used in tliese studies.
The GABA agonist, muscimol, was supplied by Fluka 
AG, Buchs SG (Switzerland); THIP was a gift from 
Professor Kr/gsgaard~Larsen; diazepam (Ro 05-2807) 
was a gift from Roche Ltd.; apomorphine-Hcl and 
kainic acid were supplied by Sigma.
All radiolabelled tracers were supplied by New 
England Nuclear (Boston, Massachusetts); L^*^cJ~2- 
iodoantipyrine (specific activity 49.8 mCi/mmol); 
r^^cj leucine (specific activity 54 rnCi/riimol).
CHAPTER III
RESULTS AND COMMENTARY
1. An Appraisal of 2-DG Modifications
1,1 General results and observations; Physiological 
parameters, body temperature, blood gas tensions, 
haematocrit aiad mean arterial blood pressure were the 
same in all groups. Plasma glucose levels varied
between individuals (from 7.2 to 10.8 mM), despite 
the care taken to standardise possible stress factors 
arising from surgery. However, no pattern of elevated 
plasma glucose concentration and no statistical signif­
icance were found between the designated "normoglycaemic" 
groups. The handling required for i.p. and s.c, inject­
ions of tracer resulted in no apparent stress-related 
hyperglycaemia.
From autoradiographic analysis of the brains, glu­
cose use was calculated using the operational equation 
and found to be 109 i 5 pmol/lOOg/min (mean +_ SEM) for 
neocortex, and 35 +. 2 pmol/lOOg/min for white matter.
The other grey matter areas fell between these two 
extremes at 92 +,2, 70 +. 3 and 51 +. 2 pmol/lOOg/min 
for median raphe, substantia nigra pars compacta and 
septal nucleus, respectively.
r i4 1The total levels of L C J in the individual brains 
of the i.v, tracer group, measured by quantitative
u  u
autoradiography, ranged from 750 pCi/g in noo cortex 
and 250 pCi/g in white matter areas of the animal with 
the lowest ^plasma glucose (7.2 mM) to 520 pCi/g in 
neocurtex and 125 jJCi/g in white matter of the animal 
w i. til the hig]iest plasma glucose (IO.8 mM) , Despite 
tliese marked differences in tissue isotope concentrat­
ions , the relatively low variability in mean glucose 
use calcnlated for these areas is indicative of a high 
degree of accuracy and reproducibility in the method 
when applied in the rigorous majiner described origin­
ally by Sokoloff (Sokoloff et al. 1977).
1,2 Errors associated with the assumption of total 
2-DG phosphorylation: The calculated fraction of
total L^^cJ present at the time of sacrifice in the 
form of residual unphosphorylated 2-DG in any given 
brain region was found to be inversely related to the 
rate of glucose utilisation in that area. In areas 
of relatively high glucose use, such as neocortex, 
only a small fraction of the total radioactivity (6 ^ 
1%) remained in the form of unphosphorylated 2-DG, 45
minutes after the intravenous injection of the isotope 
(Fig. 8a). However, in areas of relatively low rates 
of glucose utilisation - for example, white matter 
tracts at the lowest extreme - the calculated residual 
2-DG concentrations were found to be markedly higher 
(13 i 1%) (Fig. 8a). Moreover, in all areas examined, 
irrespective of rates of glucose use, the fraction of 
unphosphorylated 2-DG was calculated to increase sub­
stantially if the measurement period was shortened from
ura
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V^5 t o 30 in:i nates (Fig. 8a) or if t]ie animals ware sub­
jected to moderate hyperglycaemia (Fig, 8b). Tims,
In white matter areas of moderately hyperglycaemic 
rats, almost 30^ of the total tissue was calcu­
lated to be present in the form of unpliosphorylated 
2-DG after a shorteiujd 30 minute measurement period 
(Fig. 8b). If no account was to be taken of these 
residual 2-DG levels in white matter, and glucose use 
calculated on the assumption of complete phosphorylat­
ion of the tracer, then an over-estimation in the 
order of 100^ would be incurred.
The route by which the isotopic tracer was admi.n- 
istered was found to have a profound influence upon 
the fraction of total found in brain tissue in
the form of unphosphorylated 2-DG, Following both 
i.p. and s.c, injections of the tracer, a very much 
larger part of the total tissue was calculated
to be present as residual 2-DG (approximately double) 
than when the i.v, route was used (Figs, 9a>h), 
irrespective of rates of glucose utilisation. Once 
again the fraction was found to be considerably larger 
when the measurement period was reduced to 30 minutes 
(Figs, 9a,b).
1.3 Errors associated with the use of optical density 
ratios in autoradiogram analysis; The relationship 
between levels in the calibrated epoxy resin
standards and absolute optical densities of the photo­
graphic images they produce was found to be a non-linear 
function (Fig. 10a). Furthermore, the characteristics
of the curve, initial slope ajid point of inflection, 
were observed to alter radically merely from an increase 
in the time for which the films were exposed (Fig. 10a).
The variability in optical densities measured from the
four sets of standards at each time was so small that 
it could Jiot be represented on the graphs.
The effects of this curvilinear relationship upon 
opt i cal den s i ty ratios of grey matter (neocortex) to 
white matter wmre profound. In the animal -where plasma 
glucose concentrations were at the lower end of the normo- 
glycaemic range, the ratios of optical densities result­
ing from tissue r^^C_! concentrations of 750 pOi/g (grey
matter) and 25O pCi/g (white matter), taken from the
standard exposure curves, was increased by around 12^ 
by a lengthening of the exposure time from 3 to 7 days 
(Fig, 10b), However, the difference between the ratios 
at 3 and 10 days exposure wns lower, at around 8^ 0 (Fig, 
10b), If tissue isotope concentrations were decreased 
in a global manner - for example, as the result of 
slightly elevated plasma glucose concentrations - the 
pattern of optical density ratios was radically altered. 
In the animal from the upper end of the normoglycaemic 
range in these experiments, final tissue isotope levels 
were lower both in grey matter (520 pCi/g) and white 
matter (l25 pCi/g). The ratio of grey to white matter 
optical densities taken from the standard exposure 
curves at these tissue levels of isotope increased by 
around 19^ from 3 to 7 days exposure, and again to 26^ 
between 3 and 10 days exposure (Fig, 10b). Moreover,
ü o
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10a. Optical densities of autoradiographic images
resulting from tissue isotope concentrations of 
kk to 1880 pCi/g following 3» 7 or 10 days' 
exposure to X-ray film (Kodak: SB-5).
10b. Optical density ratios arising from fixed
ratios of tissue isotope content. Hollow bars, 
tissue isotope ratio of 3:1; filled bars, tissue 
isotope ratio of 4:1. Both of these ratios were 
derived from values for neocortex and white matter 
in normoglycaemic animals.
a comparison of the difference in ratios elicited by 
changing final tissue isotope levels in tandem showed 
an increase at each exposure time, from U^/o at 3 days 
to 1790 at 10 days (Fig. 10b).
f a.
1. 4 Conimeji t ary ; Wi ili i n the constraints of tlje model 
developed by Sokoloff and colleagues (Sokoloff et al. 
1977)) the 2-DG quantitative autoradiographic method 
has provided an accurate assessment of functional 
activity in tlie brain as reflected in the rate of 
glucose utilisation, under a variety of experimental 
conditions (see Sokoloff, I98I and McGulloch, 1982 
for full reviews). However, at the present time, 
modified forms of the original, rigorous approach to 
the application of 2-DG methods are in widespread use* 
Although each of these modifications has sought to 
reduce the complexity of the experimental protocol 
and the hardware required for full quantification, or 
to expand the applicability of the technique to other 
than restrained animals (Brown and Wolfson, 1978;
Nelson et al. 1978; Collins, 1978; Herkenham, I98I; 
Meibach et al. 198O, for full discussion), it is far 
from assured that all of these experimental models 
provide reliable estimates of local cerebral glucose 
utilisation under the wide variety of circumstances 
in which they are commonly applied.
The desire to couple glucose utilisation as an 
index of cerebral function with behaviour studies to 
examine the externalised consequence of that functional 
activity is thwarted to a large extent if the restrained 
animal preparation is used. However, free-running 
animals make the intravenous injection of tracer and 
subsequent sampling of plasma glucose and 2-DG concen­
trations technically very much more difficult. The use
of free-running animals and the abandonment of any 
effort to sample arterial blood variables is based on 
the assumption that, at the instant of sacrifice, all 
tracer found within the CNS Is present in the form of 
2-DG-6-P, with no residual f m e  2-DG. Justification 
for this assumption arises from biochemical analysis 
of brain tissue subsequent to sacrifice (Meibach et 
al, 1980 ; Sagar and Snodgrass, I98O; Dunn et al.
1980). In contrast, the results from the studies 
described here show that, using radiolabelled 2-DG,
l4the measurement of C accumulation, even if the time 
from a pulse delivery is relatively long, does not 
totally reflect 2-DG-6-P because unphosphorylated 2-DG 
in the brain approaches zero in an exponential fashion. 
The values of residual 2-DG calculated from plasma data, 
and using the rearranged operational equation, are in 
excellent agreement with those values derived directly 
from biochemical analysis of tissue in which chemical 
activity is stopped at the instant of sacrifice with a 
"freeze-blower" device (Hawkins and Miller, 1978).
Unless an instantaneous method is used, the rapid flux 
of substrates through the glycolytic pathway which 
occurs post mortem (Lowry et al. 19^4) will tend to 
result in an underestimation of unphosphorylated 2-DG 
and, therefore, the evidence upon which the modified 
approach is based must remain questionable.
The contribution made by unphosphorylated 2-DG 
present at the instant of sacrifice to total isotope 
concentrations measured after death is an important
factor which must be accommodated if isotope accumulat­
ion is to be related ultimately to functional activity. 
The original highly rigorous approach allows the levels 
of residual 2-DG to be calculated from the experiment­
ally geuerated plasma glucose and tracer profiles and 
the predetermined rate constants. Once quantified, 
this element may be subtracted from the total isotope 
content of tissue and the actual concentrations of 
2-DG-6-P determined. However, despite the rigour of 
the model upon which the teciuiique is based, the rate 
constants which feature in the operational equation 
are subject to a degree of error, although the uncert­
ainty is minimised where the time between the pulse 
injection of 2-DG and sacrifice is relatively long and 
where residual 2-DG in tissue is relatively low, which 
is also time-dependent under steady state conditions.
If the experimental time is shortened, or if residual 
2-DG is elevated as is the case in hyperglycaemia or 
following i.p. or s.c, delivery of the tracer, then the 
certainty with which the calculation may be made will 
diminish. It is worthy of note in this context that 
if only the route of administration of tracer is altered 
whilst the requisite measurements are made of the plasma 
variables over a suitably long time (45 minutes), then 
the final rate of glucose utilisation calculated from 
the operational equation is relatively unaltered, 
particularly for areas of high glucose use. On the 
other hand, if no attempt is made to evaluate levels 
of unphosphorylated 2-DG on the assumption that all
i 4
tissue tracer is in the form of 2-DG-6-P, then the 
factors which we have shown to affect residual 2-DG,
i.e., the route of tracer delivery, the time between 
tracer delivery and sacrifice, the intrinsic metabolic 
rate of the area studied and the relative state of 
plasma glucose, may singly, or in combination, severely 
compromise the putative indices of glucose utilisation 
using such methods.
Although the measurement of total isotope accum­
ulation in tissue is most efficiently made from tissue 
samples suitably treated for pulse counting (Blackwood 
and Kapoor, 1979; Glick et al. 1979, I980), the degree 
of resolution afforded by such an approach, in terms of 
discrete brain structures, will depend heavily upon the 
homogeneity of the sample and the competence and re­
producibility of the dissection technique. It could 
prove extremely difficult, if not impossible, to 
adequately isolate discrete functional units from con­
tamination of surrounding tissue or to detect hetero­
geneity of response within anatomical structures as 
have been described, for example, in the striatum 
(Edvinsson et al. I982).
The advantage of autoradiographic procedures is 
that spatial distributions of isotope are preserved 
and may be visualised with photographic images, per­
mitting a relatively high degree of resolution.
Absolute quantification of autoradiograms is possible 
by comparing the optical density of images on processed 
photographic emulsion which arise from exposure to an
I ü
isotope source of known activity with the optical 
density of images arising from isotope held within 
tissue sections. From the relationship between 
optical density and the concentrations of the stand­
ards, the isotope levels in areas of tissue may be 
deduced. However, using the 2-DG technique, the 
general relationships which exist between the optical 
density of autoradiographic images, tissue isotope 
concentrations and, ultimately, levels of functional 
activity as reflected in the rate at which glucose is 
being used, have apparently been widely misinterpreted. 
It has been proposed that the response to any 
treatment in terms of altered functional activity will 
be reflected in an altered ratio of optical densities 
of affected, relative to supposedly non-affected areas, 
such responses usually being reported as percentage 
change in the ratio from control (Brown and Wolfson, 
1978; Collins, 1978 ; Herkenham, I98I ; Meibach et al. 
1980). The relative stability of glucose utilisation 
in white matter under a variety of circumstances has 
been exploited to provide the standard against which 
changes may be measured (Meibach et al. I980) . '^o
assumptions are implicit to this approach; firstly, 
that a linear relationship exists between isotope con­
centrations and the resultant images on processed 
photographic emulsion; secondly, that relative optical 
densities remain constant and that changes in relativ­
ities are a simple function of changes in the rate at 
which glucose is being utilised.
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As has been shoini, the true relationship between 
isotope concentrations and optical density is curvi­
linear with only a limited part of the function approx­
imating to linearity. Moreover, the exact limits of 
this linear portion change with exposure time. In
general terms, the ratio between the values of any two 
points on a curve is determined by the slope and length 
of the line which may be drawn between tliem. If, as 
is the case in this instance, the relationship is 
described by a non-linear function, optical density 
ratios will depend upon the position of the data relat­
ive to the point of inflection, together with the initial 
slope of the curve. At lower tissue isotope concentrat­
ions , both points will fall within the initial rising 
phase of the curve, but if tissue concentrations rise in 
parallel for both points, and that corresponding to grey 
matter passes the point of.inflection, then the optical 
density ratio will decrease from the previous value.
If both points fall above the point of inflection, a 
further decrease in the ratio is evident. Thus, chang­
ing tissue isotope concentrations in tandem, relative to 
the point of inflection, will in itself radically alter 
the calculated ratios completely independently of any 
underlying change in glucose utilisation. It is note­
worthy that even if the relationship between isotope 
levels and image density was indeed linear throughout 
the entire range, the differential effects of even 
minimal hyperglycaemia upon uptake of 2-DG tracer into 
grey and white matter (750 decreasing by around 30^ to
/ i
520 pCi/g in grey and 250 decreasing by 50^ to 125 pCi/g 
in white matter) could result in a 40^ change in uptake 
ratio without any change in underlying glucose utilis­
ation.
Wliilst errors associated with different lengths of 
film exposure are relatively easy to eliminate by strict 
experimental control (although this is not always
mentioned in methods reports), it could prove much more
difficult to control for absolute levels of isotope
present in the brain on sacrifice of the ajiimals. As
has been illustrated, uptake of labelled 2-DG is influ­
enced by the glycaemic state of the animal, but may 
also be affected by the metabolic rate of other body 
tissues and the total quantity of tracer injected.
These variables will reflect an inter-animal differ­
ence which may be difficult to eliminate, and may even 
be exacerbated by experimental treatments which may 
prove to be inherently stressful (Brown aiod Wolfson, 
1978). Furthermore, tissue isotope content comprises 
both phosphorylated 2-DG and residual 2-DG in the total 
measured densitometrically, and the changes described 
previously in the relative fraction of each in differ­
ent brain areas, and in response to hyperglycaemia, 
cannot be accommodated within a protocol which uses 
an unquantified measure of total 2-DG uptake, as does 
the optical density ratios approach.
Although it is desirable that methods should be 
under continual scrutiny with a view to their possible 
improvement, the modifications to the original 2-DG
( o
technique which have been introduced and are now in 
widespread use are based upon assumptions which, whilst 
appearing to simplify the approach, in fact introduce 
errors which are difficult to control, and therefore 
complicate the interpretation which may be placed on 
the final analysis. The rigorous experimental method­
ology developed by Sokoloff and colleagues must there­
fore remain the most appropriate approach.
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2. Systemic Drug Administration
2.1 General results and observations; The adminis­
tration of muscimol and THIP had little effect upon 
the measured cardiovascular and respiratory parameters 
No significant changes were observed in pCO , pO , pH<C jC
or plasma glucose levels. However, mean arterial
blood pressure, which was 142 Hh 6 mm Hg (mean •+ SEM) 
in control animals, was significantly altered only 
with the highest concentrations of muscimol when it 
was reduced to ll6 jh 9 mm Hg (mean _+ SEM; p < 0 , 0 5 ) .  
With increased doses of both agents, spontaneous 
motor activity and responsiveness to background noise 
were progressively reduced. The grooming, sniffing, 
and movement of the unrestrained head and forelimbs, 
which were displayed by the saline treated rats, were 
totally absent from animals which had received the 
highest concentrations of muscimol and THIP. These 
behavioural changes were relatively constant through­
out the measurement period. Even at the highest 
doses employed the animals retained consciousness and, 
although sedated, remained capable of responding to 
tactile and auditory stimuli. The clearance charac­
teristics of L^^cJ 2-DG from the blood were not 
systematically altered by either of the drug treat­
ments, and thus the plasma histories of 2-DG levels 
were essentially similar in all groups.
The intravenous injection of 2 mg/kg of picro- 
toxin was followed within 2 minutes by the animal
■b u
displaying- seizure-like activities. The eyes closed, 
ears flattened against the head and the animal arched 
its back upward and backward with forelimbs extended 
forward. These bouts, which lasted between 30 seconds 
and 2 minutes approximately, were interposed between 
periods of apparent quiescence of similar duration, 
but which became less frequent and less prolonged as 
the experiment progressed. Mean arterial blood 
pressure was elevated throughout to around 200 mm Hg, 
although during seizures this was further increased, 
with spikes of pressure in excess of 300 mm Hg.
Plasma glucose levels rose to 19.2 mM during the 
experiment. The animal died 20 minutes after the 
injection of picrotoxin. Post mortem examination 
revealed both pulmonary and coronary congestion.
Although it was appreciated that an -understand­
ing of the effects of GABA antagonists upon regional 
cerebral glucose utilisation would form a necessary 
part of any comprehensive pharmacological study of 
GABA systems in the brain, these experiments were 
abandoned at an early stage on two counts. Firstly, 
the degree of suffering experienced by the one animal 
which was used was considered ethically unacceptable. 
Secondly, the stress-induced hyperglycaemia precluded 
any accurate quantification of glucose use in this 
animal model.
Following intravenous diazepam, blood pressure was 
again the only physiological variable which was found 
to alter from control levels. Although no change was
observed following 0,3 mg/kg, a dose of 1,0 mg/kg 
resulted in a reduction to 130 5 mm Hg which was
not statistically significant. No overt behavioural
changes were observed following the administration of 
0.3 mg/kg, but following 1.0 mg/kg sedation, with 
marked reduction in spontaneous motor activity, was 
observed. This apparently reduced state of arousal 
lasted for only around 30 minutes of the experimental 
measurement period, after which the animals became more 
responsive to the environment,
2.2 Local cerebral glucose utilisation following GABA 
agonist administration; The dose-dependent alter­
ations in local cerebral glucose utilisation found to 
be associated with the intravenous administration of 
muscimol and THIP are presented in Appendix II. 
Following the administration of muscimol and THIP, 
reductions in glucose utilisation were evident through­
out the brain. Muscimol was, in general, five to six 
times more potent in inducing the observed changes than 
was THIP. Only one area measured, the cerebellar 
vermis, failed to display a statistically significant 
alteration in glucose use with any concentration of 
muscimol or THIP used. No significant increases in 
glucose use were observed in any of the 6o regions 
examined at any dose of either of the two agonists.
Although; in essence, the observed responses were 
qualitatively similar in all of the brain regions 
investigated (i.e., generalised reductions in glucose 
u s e ) , analysis of the dose-response relationships
(Appendix II: Figs. 11-13) and visual inspection of the 
1^ C autoradiographic pattern from the brain sections 
(Fig. l 4 ) provide evidence for pronounced inter-regional 
differences in the sensitivity of local cerebral glucose 
use to depression by GABAergic manipulation with muscimol 
and THIP. Analysis of the regional responses in terms 
of functional involvement revealed no clear pattern of 
unified responsiveness between functional sub-units 
(see Appendix II). Thus, for example, whilst auditory 
cortex and auditory t ha]am i c nuclei (medial geniculate 
bodies) display at least a moderate degree of sensitiv­
ity to both agonists, more peripherally involved nuclei 
of the primary auditory pathways - for example, the 
cochlear nuclei - were very much less sensitive. Only 
within the primary visual system were all the areas 
involved prone to the action of the GABA agonists, not­
withstanding the differential response of parts of the 
superior colliculus to muscimol and THIP (see later 
discussion).
Ranking the 6o structures analysed according to 
absolute magnitude of response at stipulated dose 
thresholds (i.e., percentage change from control at 
0.5 and 1,5 mg/kg muscimol and 3-0 and 10.0 mg/kg 
THIP, expressed as a mean of the two doses) (Tables 
1 and 3), and also according to the calculated index 
of deviation from control across the dose groups for 
each structure (i.e., F ratio generated from analysis 
of variance) (Tables 2 and 4), revealed a hierarchy 
of sensitivity to GABAergic manipulation which was
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Figure l4
Autoradiograms prepared from coronal sections of rat 
brain at the level of the habenular nuclei.
Saline
Muscimol
r\
THIP
For legend see over.
Legend to Figure l4
Autoradiograms prepared from coronal sections of 
rat brain at the level of the habenular nuclei.
Upper; Control animal. Cerebral cortex (cx), thalamus 
(th) and lateral habenula (ih) display similar levels 
of density.
Middle ; Muscimol (l.5 mg.kg treated animal.
Cerebral cortex and thalamus, whilst still of similar 
densities, both appear much less dense relative to 
lateral habenula.
Lower; THIP (lO mg.kg ^ ) treated animal. A similar 
pattern to that observed following muscimol, with 
cortex and thalamus less dense relative to lateral 
habenula.
Glucose utilisation is proportional to relative optical 
density in these and subsequent autoradiograms.
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LEGENDS TO FIGURES 1-4
Criteria for establishing hierarchies of 
responsiveness to muscimol and THIP
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TABLE 1
Extremely 
sensitive :
Sensitive ;
Moderately 
sensitive ;
Minimally 
sensitive :
Insensitive :
decreases > 20^ at 0,5 mg/kg muscimol
decreases > 159  ^at 0.5 mg/kg muscimol
decreases > 20^ at 1,5 mg/kg muscimol
decreases > 15^ at 1.5 mg/kg muscimol
decreases < 159  ^at 1.5 mg/kg muscimol
TABLE 2
Extremely 
sensitive :
Sensitive ;
Moderately 
sensitive ;
Minimally 
sensitive :
Insensitive :
decreases > 40^ at 10 mg/kg THIP
decreases > 30^ at 10 mg/kg THIP
decreases > 20^ at 10 mg/kg THIP
decreases > 15^ at 10 mg/kg THIP
decreases < 15^ at 10 mg/kg THIP
TABLES 3 and 4
F values generated by analysis of dose response curves 
to muscimol (range 2.5 to 40.0) and THIP (range 0,1 to 
35.0 ) divided into 5 equal interval groups.
y o
relatively constant for both modes of analysis and for 
both agonists used (Tables 1-4). Whilst the thresholds 
for grouping under headingsj from extremely sensitive 
through to insensitive, were somewhat arbitrary for the 
hierarchies based upon magnitude of depression, the 
groupings for hierarchies based upon F-ratios were set 
at equal class intervals across the rajige of values 
generated by these experiments.
The regions of the brain in which glucose utilis­
ation was most sensitive to depression by muscimol 
included most areas of neocortex, primary thalamic 
nuclei and the lateral portion of the caudate nucleus 
(see Fig. 1 for typical dose-response relationships). 
Within neocortex, however, cortical lamina IV was con­
sistently more susceptible to depression than were the 
immediately surrounding layers at any point of measure­
ment (Fig. 15).
The majority of brain regions analysed displayed 
only moderate or minimal sensitivity to the action of 
muscimol. Areas in which this degree of responsiveness 
was apparent included most of the extrapyramidal motor 
system (substantia nigra, globus pallidus, and medial 
portion of the caudate nucleus; Fig. I6), both cortical 
and subcortical limbic areas (cingulate and olfactory 
cortex, hippocampus, anterior thalamus and nucleus 
accumbens), medial habenula, interpeduncular nucleus, 
dorsal tegmental nucleus and median raphe nucleus (see 
Fig. 2 for typical dose-response relationships). The 
contrast in sensitivity between cingulate cortex and
y 4
Figure 15
Autoradiograms prepared from coronal sections of rat 
brain at the level of the caudate nucleus showing 
dorsal and sensory-motor cortex.
Saline
Muscimol
•O . .
THIP
. a
Upper; Control animal. Within cortex the area corres­
ponding to layer IV is evident as a line of elevated 
optical density relative to the rest of the cortex. 
Middle ; Muscimol (1.5 mg.kg ^) and Lower; THIP (10 
mg.kg ^) treated animals. Layer IV no longer discern­
ible in cortex of relatively homogeneous O.D.
y a
Figure l6
Autoradiograms of coronal sections of rat brain cut 
at approximately A7500 (K8nig and Klippel).
S a l i n e
M u s c i m o l
Upper; Control animal. No medial-lateral hetero­
geneity of O.D, in caudate nucleus.
Lower; Muscimol 1.5 mg/kg. Marked medial-lateral 
heterogeneity of O.D. in caudate nucleus.
other, more responsive neocortical areas was apparent 
from the autoradiographic pattern (as seen in Fig, l4). 
The largest single group of structures were those in 
which glucose utilisation was relatively insensitive 
to the action of muscimol. Large concentrations of 
muscimol (0.5 mg/kg) were necessary to elicit quite 
modest reductions in the measured rates of glucose 
use. Included in this group were the cerebellum and 
related motor relay nuclei, such as red nuclei and 
inferior olivary bodies, white matter, the lateral 
habenula (see Fig. l4), pontine reticular formation, 
amygdala, hypothalamus and some brain stem auditory 
relay nuclei (inferior colliculi and superior olivary 
bodies).
The overall pattern of responsiveness to THIP was 
essentially similar to that described in detail follow­
ing muscimol (Figs. 11-15j. Tables 2 and 4), notwith­
standing the five to six-fold difference in potency of 
muscimol over THIP. One notable exception to the 
parallelism of sensitivity of local glucose utilisat­
ion to the action of both agonists was observed in the 
superficial layers of the superior colliculi. The 
qualitative difference in the response of this area 
following muscimol and THIP was immediately apparent 
upon visual inspection of the autoradiograms (Fig. 1?)o 
Quantification confirmed that glucose use in the super­
ficial layers was markedly depressed by muscimol, but 
was unaffected by THIP (Fig. I8). Thus, whilst this 
area was amongst those most sensitive to the action of
Figure 1?
Autoradiograms prepared from coronal sections of rat 
brain at the level of the medial geniculate bodies.
y /
scs SOP
1
Cr esy l  V io le t Sal ine
Muscimol
X.
THIP
Upper right; Differential histological staining of 
superficial (SGS) and deep (SGP) layers of the superior 
colliculi.
Upper left ; Control animal. The superior colliculi
appear relatively homogeneous in optical density.
, -1 \Lower left; Muscimol (,1.5 mg.kg ) treated animal.
The more superficial layers of the superior colliculi 
appear to be less dense than do the deeper layers of 
the same structure.
/ - 1  VLower right ; THIP (10 mg.kg ) treated animal. The 
superficial layers of the superior colliculi appear
more dense than do the deeper layers.
y 6
D)
d)
B
«
o o
0)
<n
oO
<0
_3
3
Ü
"Ô
O
II
Q)>»
CO
(O
00
iH
O
U
•H
Pu
D)Jr:
6
E
CO|s
0)
COo
û
o
CM
o
CO
0 o
^  lO1 I
=> X  
2 t-
3 <0
o
CO
CQ
pîH
g
•H
H
H
o
ü
u
o
•H
u
0
CQ
•H
OCQ
O
ü
0
Ch
O
CQ
CD mo
O
V
(loj^ uoo ujojj abuBi^ ü %) 
uoiJBSfiiin 0soori|0 iBjqajao
Pi CD P A
H CQ CQ 4(-M Pl P
H O Pl
P O
CQ ÈCÛ s
CD cd N
Ph 03
<1
+I1—1 (D pqo CQ
s O cb P
•H TJ O
O 1 p k
CQ ECÛ o P
0 O Pl
E p Plo
o
ü
o p
■p p s• cd o
ri k k
0 p p P
•H rCl COP P CD
cJ •H Pl ÜD
CQ Pl P d
•H '■— E CO1—1 xi
•r! Pc cd ü
P (D
pi CO CD
nJ pi tcû
CD M 0 cd
CQ Pl pO P CD Pl
Ü CD > CD
pi <D Cd ü
P Tj k k
p (D
Xi Pl Qi
Ch d P
0
CD/— \ XI CD
P P P E
•H P
> CD bD CO
•H P Pl cd
P P
•H > xi
CQ Pl O CD
Ü CD P PCD P Pl
CQ cd O 0)
P p CO
H Q)
(Cj P Pl k
•H cd o Qi
P P p
Pi ü p CD
CD P cd k
U P CQ cd
0) Pl p
Ch CD p cd
Ch P p p
•H 0 p cd
P CQ 0 A
y y
muscimol, it vas one of the areas least sensitive to 
THIP. Within the deeper layers of the superior 
colliculi the responsiveness was once again essent­
ially similar with both agents (Fig, 18), and could 
be ranked as minimally sensitive.
2.3 Local cerebral blood flow following GABA agonist 
administration; In none of the 38 areas analysed were 
any significant increases in local cerebral blood flow 
measured following either 0.5 mg/kg or 1,5 mg/kg (see 
Appendix III), At 0,5 mg/kg muscimol, only minor, 
non-significant decreases in blood flow were observed 
in some brain areas, but the majority showed no appar­
ent response.
Following 1,5 mg/kg muscimol, most regions were 
subject to modest decreases in local cerebral blood 
flow, although these changes reached significant levels 
(p<0,05) in only 10 of the areas measured (Appendix 
III). Most of the significant changes were found in 
neocortex, but decreases were also observed in sensory 
relay nuclei of the thalamus, elements of the extra- 
pyramidal system in the telencephalon and the superior 
colliculus (Appendix III), Of the regions to which 
perfusion appeared almost completely unaffected by 
muscimol, many form part of what may be termed the 
limbic system (lateral habenula, amygdala and hippo­
campus, for example), but also mesencephalic areas 
involved in motor function (red nucleus, cerebellum), 
prethalamic nuclei of the auditory pathway (inferior 
colliculus and cochlear nucleus, amongst others) as
•K. V V
well as grey matter areas of diverse functional involve­
ment (pontine reticular formation and hypothalamus) all 
displayed little, if any, response at either dose of 
muscimol (Appendix III). No correlation was evident 
between the responsiveness of local cerebral blood flow 
to alteration by muscimol and either neuroanatomy or 
vascular anatomy.
2.4 Relationship between local cerebral blood flow 
and glucose utilisation; Without further analysis of 
the data it is apparent that, in saline treated control 
groups, a gross relationship exists between local blood 
flow and glucose use within brain regions. Thus, areas 
of highest measured blood flow, primary auditory regions, 
for example, also display the highest rates of glucose 
utilisation, whilst areas of lowest measured blood flow, 
white matter tracts, for example, consistently show 
lowest rates of glucose use (Appendix III),
From a plot of mean control blood flow versus mean 
control glucose use for each area, and taking all areas 
together, the ratio of the two parameters, which may be 
identified from the gradient of the best fitting straight 
line for the data points, is 1,45 (Fig. I9), A similar 
manoeuvre performed on data from muscimol treated groups 
reveals that the ratio increases to 1,55 and 1,75 at O .5 
and 1.5 mg/kg muscimol, respectively (Fig, 19). How­
ever, simple regression analysis is inappropriate in 
this instance to test for significant changes in either 
the overall relationship or the relationship for any 
given structure.
1 0  1
m
'o
( I.UIUJ ,B 0 0 l  'lUJ) AAOTd 0 0 0 1 8  IV O O l
CT\
I—1 
0
&
•H
k
(D
S'
c |U'iu ,.^001 |IU) M O U  00018 IVOOl
fi
0
>
p
o bji
H S
Ch 01
m P
"0 •
O o
O E
1—î
rQ fi)
0
(H #% fi
d 0 P
U fi P
rO •H
0 P p
U d rfi
0 01
ü P
,--s. d
1—1 d fi
d p
ü W) w
o fi
H P
>: fi
Ü O P
d P p
0 P p
e O P
p P
ri e\ p
d 01 01
p 0
fi d fi]
o fi
•H 0
■P 01 fiî
d fi p
w o
■H p p
H ü 0
•H 01
P fi p
fi o fi
ü 0
0 p
m p 70
o o d
ü fi
fi fi W)
H p
W d 0
fi fil
H fi] p
d
fi P
fi] o
0
fi 01 p
0 fi o
ü o Ë
p p
H Èlû ü
d 0 01
ü fi fi
0 E
1—1 0
p W)
d 0 X
d fi
0 Ü fcifl
E 01 E
p
fi •fi lA
0 •
0 P
|5 p
P p
0 d ü
rO ü
p 73
A E fi
•H O d
fiH p
01 d
fi fi p
O d • o
•H E
P 00 p
d cn ü
p w
0 fi fi
p E
-P
O
H
a
rC:
ü
d
0
ho
Ch
( _^6ooi |UJ) M O U  OOOlB IVOOl
The application of a statistical model specifically 
developed for this form of data, and fully described and 
validated by us previously (McCulloch et al. 1982a), 
allowed further appropriate statistical analyses of the 
relationship between blood flow and glucose use to be 
undertaken. The transformation of data to natural
logarithms of the mean values (Fig. 20) alleviates prob­
lems associated with the obvious differences in vari­
ability between observations of high and low numerical 
value (cf. SEM of +_ I3 in control inferior colliculus 
flow with SEM of +. 1 in white matter). Transformation 
of data in this way reveals a linear relationship 
between the two parameters, which is characterised by 
unit slope and intercept, ^  (Fig, 20). It becomes a 
relatively simple matter in comparing treatments to 
analyse the difference between o>C values (McCulloçh et 
al. 1982a). Within the confidence intervals set, the 
relationship defined by the derived line was appropriate 
for all structures within each treatment group - that 
is, no structure showed a significant change in only 
one parameter and not in the other. Furthermore, the 
interaction remained relatively constant between treat­
ment groups. Although Sc changed from 0.39 in saline 
controls, through 0,43 at 0.3 mg/kg muscimol to 0,32 
at 1.3 mg/kg, these changes did not approach significant 
levels (Fig, 20), the F-ratio being considerably below 
the critical value. Thus, the relationship which 
exists between local cerebral blood flow and glucose 
utilisation in conscious control rats remains intact 
and unaltered following muscimol treatment.
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2.5 Local cerebral glucose utilisation following 
benzodiazepine administration; The altered rates of 
local cerebral glucose utilisation measured following 
the intravenous administration of diazepam are present­
ed in Appendix IV. Significant reductions in glucose 
use were evident throughout the brain and, although no 
significant response was observed in any region follow­
ing a dose of 0.1 mg/kg diazepam, none of the areas 
measured failed to display a statistically significant 
reduction at 0,3 mg/kg. No increases in glucose use 
were observed at any dose of diazepam (Appendix IV).
Not only were the observed responses qualitatively 
similar in all of the brain regions investigated (i.e., 
generalised reductions in glucose use), but analysis of 
the dose-response relationships (Appendix IV) also 
revealed that, with few exceptions, the responses were 
remarkably similar in quantitative terms. Thus, the 
autoradiographic pattern of isotope accumulation was 
essentially similar for both control and drug treated 
animals (Fig. 2l), with relativities between areas 
maintained. Equal degress of responsiveness to 
diazepam treatment were apparent in areas of the brain 
with diverse functional roles (Fig. 22). Glucose use 
was decreased by similar extents in area of neocortex 
at all laminar levels, in areas of sensory and motor 
thalamus, most extrapyramidal motor areas, hippocampus 
and brain stem nuclei (Appendix IV).
In contrast to the homogeneity of response obser­
ved in the majority of brain regions following diazepam
I 0 5
Figure 21
Autoradiograms prepared from coronal sections of rat 
brain at the level of the habenular nuclei.
Sal i ne
D i a z e p a m ( 0 . 3 m g / k g )
Upper; Control animal. Cerebral cortex, thalamus 
and lateral habenula display similar levels of density
Lower: Diazepam treated animal. Relative densities
are maintained, although reset at a lower level.
Figure 22
1 U 0
Effects of Benzodiezapines on Local Cerebral Glucose Utilisation
□  Diazepam 0.3m g/kg Diazepam I.Omg/kg
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are moderately sensitive to diazepam.
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administration, the mamillary body, the dorsal teg­
mental nuclei, raphe nuclei, pars compacta of the 
substantia nigra, and posterior cingulate cortex all 
appeared to be very responsive to diazepam (Fig, 22), 
However, the lateral amygdala and, to a lesser extent, 
the medial amygdala, superficial layer of the superior 
colliculus and frontal cortex were less sensitive to 
diazepam (Fig. 23) than the majority of brain regions. 
White matter areas were also relatively unaffected by 
diazepam,
Ranking the 60 studies analysed according to 
absolute magnitude of response at 0.3 mg/kg (i.e., 
percentage change from control at this dose), and also 
according to the calculated index of deviation across 
the dose range (i.e., F-ratio), confirmed the original 
analysis of the data (Tables 5 and 6) above. Both 
methods revealed a similar grouping of structures with 
definite discontinuities in the continuum of respons­
iveness marking the very sensitive and minimally sens­
itive groups, and allowing only four groupings to be 
separated across the range of responses. The majority 
of regions analysed fell within the sensitive and 
moderately sensitive groups.
1 u y
Figure 23
Lateral Amygdala Medial Amygdala Superior
Colliculus (S)
Sal i ne
L a t . A m .
i
D i a z e p a m ( 0 . 3 m g / k g )
Upper; Areas of diverse function which are insensitive 
to diazepam.
Lower; Preservation of glucose use in lateral amygdala,
apparent from autoradiograms.
109
lA
0
H
d
H
H-< L3 tn to
œ CD ro cj
0) m m m
110
VO
0
rH
'S (0 s
D
E
(0 m
•H 3
4J Q)
g JO m r4 m
K E r-4 o X CD
GJ g 3 m c Ê cn CO •H1-4 r—1 Z 4J CD
2 Ü
0 E 3
X) cn o 1-4c h- •H 3 m a
§ CO f- to 0
f4 0 (_) A
r4 r-4 f-4 1-4 o '3
'a O (D (0 CL m 0 0 0 œu M jr A A A 0 CD(D -p 4-> m (0 "S CDx> A 4J
0 3 0 m œ CD 3in to E CL to Q to
LEGENDS TO TABLES 5 AND 6
Criteria for establishing hierarchies of 
responsiveness to diazepam
1 1 1
TABLE 5
Extremely 
sensitive :
Sensitive ;
Moderately 
sensitive ;
Minimally 
sensitive ;
decreases > kOfo at 0,3 mg/kg diazepam
decreases > 30% at 0,3 mg/kg diazepam
decreases > 30% at 1.0 mg/kg diazepam
decreases < 20% at 1,0 mg/kg diazepam
TABLE 6
F values generated by analysis of dose response curves 
to diazepam (range 6 to 32.O) divided into 3 equal 
interval groups. No structures fell within the 
interval between moderately and minimally sensitive 
groups.
1 1 ^
2.6 Commentary ; In keeping with the importance 
increasingly being attached to GABA as the pre-eminent 
inhibitory neurotransmitter substance within the 
mammalian CNS (Krnjevic, 197^j Curtis, 1978), major 
GAB A specific projection pathways have been identified 
which are integral to the normal functioning of the 
brain and, in particular, the activity of the extra- 
pyramidal and limbic systems (Ponnum et al, 1978;
Ribak et al. I98O; Jones and Mogenson, I98O; Walaas 
and Ponnum, 198O ). Moreover, in a number of brain 
areas with a diversity of functional involvement GABA 
neurons have been identified which remain intrinsic to 
their sites of origin. Thus, GABA interneurons have 
been localised within elements of the motor systems 
(McGeer and McGeer, 1975 ; Storm-Mathisen, 1976), 
limbic systems (Storm-Mathisen, 1976; Hokfelt et al.
1977) and visual systems (Okada, 197^; Kayama et al.
1980), as well as being present within areas of thal­
amus (Heuser et al. I98O; Starr and Kilpatrick, I98I) 
and neocortex (Curtis and Felix, 1971; Iversen et al, 
1971) which, with their widespread cerebral inter­
connections, allow GABAergic influences to be dissem­
inated throughout the brain.
The localisation of GABA systems with the use of 
biochemical markers for GABA synthesis, release and 
re-uptake, together with the measurement of agonist- 
specific receptor binding, whilst indicating areas 
of the brain in which one or more of these parameters 
is elevated, presents a general picture of GABAergic
113
activity distributed ubiquitously (albeit heterogene­
ously) throughout the brain. The hierarchies of reg­
ional sensitivity of glucose utilisation to depression 
by the putative GABA agonists, muscimol and THIP, which 
are reported here, do not correlate in any simple 
relationship with neurochemical markers for GABAergic 
mechanisms. Thus, the alterations in regional glucose 
use are not related to the reported topography of GABA 
itself in the CNS (van der Heyden et al. 1979)j to the 
distribution of GAD, the proposed rate-limiting enzyme 
in the synthesis of GABA (Tappaz et al, 1976; Roberts, 
1979; Nieoullon and Dusticier, I98I), nor to the 
levels of GABA specific receptor sites which have been 
characterised on the basis of radioligand binding 
(Zukin et al. 197^; Guidotti et al, I98O; Young and 
Kuhar, I98O; Palacios et al, I981). Although the 
substantia nigra pars reticulata, for example, contains 
amongst the highest levels of both GABA and GAD in the 
CNS (Tappaz et al, 197^; van der Heyden et al. 1979), 
only relatively moderate alterations in glucose use 
were measured in this region following large concen­
trations of muscimol and THIP. The distribution of 
GABA agonist-induced changes in glucose utilisation 
and the distribution of muscimol recognition sites 
(Palacios et al. I98I) are similar in essence, with 
high densities of muscimol receptors detected in neo- 
cortical and thalamic areas correlating with the marked 
reductions in glucose use measured in these regions 
following systemic muscimol administration. However,
114
the relationship is by no means absolute, with a number 
of important anomalies. The low levels of muscimol 
receptors in the caudate nucleus contrast sharply with 
the pronounced reductions in glucose utilisation in 
this region resulting from muscimol administration.
Unlike investigations of marker distributions 
which produce a relatively static measure of GABA 
system activity, the 2-deoxyglucose approach provides 
a more dynamic index of the potential importance of 
functional involvement of GABAergic mechanisms in inte­
grated cerebral activity. It is of interest, therefore, 
that in the relatively few anatomical areas in which GABA 
turnover has been established (caudate nucleus, nucleus 
accumbens, globus pallidus and substantia nigra (Mao et 
al. 1978), there appears to be a good inverse correlat­
ion between GABA turnover and the magnitude of response, 
in terms of depression in- glucose use ^ measured in these 
four areas. If this relationship were to hold good for 
all of the 60 anatomical structures measured, although 
there is no compelling evidence that it should, it would 
be tempting to conclude that those areas in which glu­
cose use is most profoundly sensitive to GABAergic 
manipulation are also those in which, under normal 
circumstances, GABAergic activation is low, thus leav­
ing a greater potential for extrinsic GABA mimetics to 
exert an influence. Conversely, those areas which are 
most insensitive to change following GABA agonist admin­
istration should, following this hypothesis, be those 
in which GABAergic activation is normally: high, leaving
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little or no excess capacity for additional, extrinsic 
agents to act upon. However, it is doubtful whether 
local turnover rates alone could explain the hetero­
geneity observed in the pattern of changes in glucose 
utilisation, which is more likely to be the net result 
of both regional responses to GABAergic manipulation 
as well as the effects of changed afferent activity 
from other affected areas.
Previous neuropharmacological investigations to 
which the 2-deoxyglucose technique has been applied 
have demonstrated that alterations in glucose utilis­
ation are not restricted to those regions known to be 
rich in receptors specific for the agent being studied, 
but are also observed in areas with primary or second­
ary neuronal connections with the receptor-rich regions 
(Sokoloff, 1981). Alterations in glucose use may thus 
be associated with both the initiation of the pharmacol­
ogical response as well as in the areas linked by 
neuronal pathways which are involved functionally in 
the expression of the response. The manipulation of 
dopaminergic systems (McCulloch et al. 1979, I98O,
1981), which has profound behavioural effects, amply 
demonstrates the complexity of responses spatially 
removed from the initial sites of action, and revealed 
with the 2-deoxyglucose method. In contrast to dopa­
minergic systems (and many other neurotransmitter 
systems) which display discrete patterns of distribut­
ion, the localisation of GABAergic receptors throughout 
the brain (Zukin et al, 197^î Palacios et al, I98I)
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and the almost universal distribution of neuronal 
cells in which the firing rates can be reduced by GABA­
ergic manipulation (johnston, 1978) render difficult 
the elucidation of what are the primary and secondary 
actions of systemically administered muscimol and THIP 
upon regional glucose utilisation. However, the pres­
ent studies provide a comprehensive examination and 
description of the regional hierarchies of involvement 
in response to the systemic administration of muscimol 
and THIP, two widely used GABAergic agonists.
Cortex and Thalamus; In all of the areas of neocortex 
examined, local glucose utilisation decreased following 
the administration of either muscimol or THIP, At the 
highest dose of muscimol the response represented a 
depression from normal, resting levels of up to 6o%.
The rate of glucose use in neocortex was thus reduced 
to levels observed only in the most metabolically 
inactive regions of white matter in control animals. 
This degree of cortical depression is remarkable, bear­
ing in mind that the animals remained conscious, albeit 
apparently highly sedated, and were capable of display­
ing the appropriate startle response to mildly noxious 
auditory (sudden loud noise) or tactile stimuli (blast 
of air directed at the head). The rate of neocortical 
glucose utilisation was less than that measured during 
barbiturate anaesthesia (Siesjo, 1977).
The intracortical distributions of putative neuro­
transmitters display marked laminar as well as regional 
heterogeneity (Emson and Lindvall, 1979). In the rat.
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for example, dopamine-containing neurons and dopamin­
ergic receptor mechanisms are restricted to the deeper 
laminae (layers V and VI) of a few rostral cortical 
areas (Lindvall and BjBrklund, 1978; Emson and 
Lindvall, 1979; Murrin and Kuhar, 1979). In con­
trast, noradrenergic and serotoninergic fibres are 
present in all cortical layers throughout the entire 
neocortex, although both systems are particularly 
prevalent in the more superficial laminae (Beaudet and 
Descarries, 1978 ; Emson and Lindvall, 1979). Bio­
chemical markers for cholinergic neurons (choline 
acetyltransferase and acetylcholine esterase) are 
concentrated in layer IV of neocortex and the deeper 
portion of layer III (Beesley and Emson, 1975). These 
highly specific intracortical patterns of neurotrans­
mitter distributions are considered to be directly 
related to the functional .role played by each agent 
within the various regions of neocortex.
GABAergic processes have been proposed as the major 
inhibitory neurotransmitter system in neocortex (Dichter,
1980), and intrinsic cortical GABAergic neurons have 
been identified (Ribak, 1978). In contrast to the
laminar heterogeneity in distributions of other cortical 
transmitters, GABA has been found in all cortical laminae 
(Emson and Lindvall, 1979), and electrophysiological 
evidence confirms that GABAergic synapses are distrib­
uted in all cortical layers (Krnjevic, 197^). Moreover, 
glutamic acid decarboxylase (GAD), the enzyme required 
for GABA synthesis, can be detected throughout cortex,
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although GAD-positive perikarya are more prominent in
layers I, II and IV (Ribak, 1978). Conflicting with
the electrophysiological evidence, high affinity 
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uptake of H-GABA, which may be indicative of GABAergic 
synapses, is associated mainly with cells of laminae II 
and III (Hokfelt an.d Ljungdahl, 1972), although auto­
radiographic localisation of GABA receptors suggests a 
relative uniformity of distribution through layers I to 
IV, with concentrations in layers V and VI being con­
siderably less (Palacios et al. I981).
Although in the present study all cortical laminae 
were affected by both GABA agonists, the reductions 
were proportionately greater in layer IV than at other 
depths of cortex. In control animals, glucose utilis­
ation in cortical layer IV is approximately 25% greater 
than in other cortical laminae, possibly because of the 
high dendritic density of this region and its resultant 
relatively higher energy requirements (Schwartz et al,
1979). The greater glucose utilisation in lamina IV 
results in a readily identifiable, well defined band 
of increased optical density on the autoradiograms. 
However, following muscimol and THIP administration, 
glucose use was more homogeneous throughout the differ­
ent laminae, reflecting the quantitatively greater 
reduction in glucose use in layer IV (see Fig,15).
The importance of cortical layer IV in the response 
to GABA agonist activity may be of wider significance 
in the understanding of the complexities of both normal 
cortical function and pathological dysfunction. Many
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neocortical afférents terminate in layer IV, aa^ d the 
dense dendritic ramification allows widespread dissem­
ination of this input throughout a large area of cortex 
(Cajal, 1929; Lorente de No, 1949). Cortical layer 
IV could thus be considered as a prime site at which 
intrinsic inhibitory processes could modulate excitatory 
input aiTd thereby act to gate the levels of excitation 
within cortex. It is of interest in this context that 
seizure activity, which may be regarded as a state of 
cortical hyperexcitation, is associated with an apparent 
dysfunction of GABA systems (Ribak, 1979), and the 
epileptogenic focus in penicillin-induced models of 
seizure is primarily in the region of lamina IV (bockton 
and Holmes, I980). Furthermore, the two GABA agonists 
which this study shows to have such marked effects on 
cortical layer IV are also noted for their potent anti­
convulsant properties (Enna, I980). This distinct cell 
population of neocortex, therefore, is clearly of major 
importance in the maintenance of normal, co-ordinated 
cortical function.
Changes in the rates of glucose utilisation as 
measured using the 2-deoxyglucose technique need not, 
however, be a direct reflection of local neurochemical 
events. The actions of the GABA agonists may manifest 
themselves at the dendrites and terminals of post syn­
aptic cells, but may also have presynaptic effects, or 
may change the functional activity of distant sites 
through the integrative activity of complex neuronal 
pathways (McCulloch, I982). Thus, the drug-induced
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decreases in glucose use in cortical layer IV may be 
mimicking the activity of intrinsic GABA neurones, or 
the activity of GABA neurones within areas which send 
projection fibres to cortex. The two possibilities 
are not, of course, mutually exclusive, and the effects 
which we have measured may be the net result of both 
mechanisms acting together. The thalamus is one of 
the main sources of cortical afferent fibres and, 
whilst the non-specific thalamic nuclei project to all 
cortical layers, the afferents from the specific nuclei 
of the thalamus terminate primarily in cortical layer 
IV (Lorente de No, 194-3). Thus, changes in sensory 
input to the cortex mediated via thalamic nuclei are 
manifest more in layer IV (Kennedy et al, 1976).
Following GABAergic manipulation, a loose correlat­
ion became apparent between thalamic nuclei and the 
cortical areas to which they project. For example, 
glucose utilisation in both the anterior thalamic nuc­
leus and cingulate cortex, which have extensive recipro­
cal neuronal connections (homesick, I969; Beckstead,
1976), was reduced to a lesser extent than in the 
thalamo-cortical systems involved in the processing 
of visual (i.e., lateral geniculate - occipital cortex), 
auditory (medial geniculate - auditory cortex) and 
somatosensory information (ventral thalamus - rostral, 
dorsolateral cortex). Furthermore, the greater reduc­
tion in cortical layer IV, which is the major site of 
termination of input from specific thalamic nuclei 
(Herkenham, I980) when compared against the response
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in other cortical laminae, points to a possible inte­
grated cortico-thalamic response. The very high
levels of GABA and of muscimol binding observed in 
thalamic nuclei (Palacios et al. 1981; Starr and 
Kilpatrick, I98I), and the marked behavioural alter­
ations which can be induced by direct intrathalamic 
injections of muscimol (Di Chiara et al, 1979), 
suggest a possible primary interaction of the GABA­
ergic agonists with receptors in the thalamus to which 
changes in cortical glucose use are a secondary response 
However, whilst the acute depression in glucose use 
observed in areas of neocortex may be due to reduced 
input from a depressed thalamus, a possible role for 
intrinsic cortical GABA systems cannot be discounted.
Extrapyramidal and Motor Areas; Intensive investigat­
ion of the extrapyramidal system has revealed that the 
organisation of GABAergic systems within the basal 
ganglia play an important part in the regulation of 
motor behaviour (Okada et al. 197l), and that dys­
function of these neuronal elements is primarily 
responsible for pathological syndromes of dyskinetic 
motor behaviour (Marsden, 1978). GABAergic neurones 
have been identified projecting from the striatum to 
the globus pallidus and pars reticulata of the sub­
stantia nigra (Eonnum et al. 1978; Ribak et al. I980). 
Inhibitory GABAergic interneurones have also been 
described in both the caudate and substantia nigra 
(Ribak et al. 1979; Ribak et al. I98O). From the 
basal ganglia pallidal GABAergic efferents are directed
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to ventrolateral thalamus (Penney and Young, 1981) and 
subthalamic nucleus where terminal release of GABA 
invokes an inhibitory post-synaptic response (Rouzaire- 
Dubois et al. 1980),,whilst nigral GABAergic project­
ions proceed to the ventromedial thalamus and tectum 
(Di Chiara et al. 1979).
The regions of the extrapyramidal system which were 
analysed displayed only a moderate to minimal responsive­
ness to both muscimol and THIP, with the exception of 
the caudate nucleus in which glucose use proved to be 
amongst the most sensitive to GABAergic manipulation.
The degree of sensitivity within these structures is 
closely mirrored by the levels of high affinity GABA 
receptors (Palacios et al. I98I), i.e., the caudate
nucleus, being most sensitive to the agonists, also 
has greater concentrations of GABA receptors compared 
to pallidus and nigra, although this could possibly be 
fortuitous in view of the lack of correlation between 
these two parameters found elsewhere in the brain.
Perhaps a more interesting inverse correlation is that, 
described earlier, which exists between the response in 
terms of depression in glucose use and GABA turnover 
rates, but the lack of data for other brain areas leaves 
an element of doubt as to whether, again, this correlat­
ion is merely fortuitous.
Although the caudate nucleus in toto was found to 
be the most sensitive extrapyramidal area to GABAergic 
manipulation, there was a marked quantitative hetero­
geneity in the response between the medial and lateral
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portions of this nucleus (see Fig. l6). Previous 
investigations have emphasised the rostro—caudal 
distributions of striatal GABA systems, GAD levels in 
the tail of the caudate being found to be almost twice 
those measured in the most rostral portions (Scally 
et al. 1973). Similar non-uniform distributions of 
markers for other striatal neurotransmitter systems, 
most notably acetylcholine, dopamine, 5“hydroxytrypt- 
amine, glutamate, substance P and met-enkephalin, have 
also been reported (Fonnum and Walaas, 1978). The 
topographical organisation of these neurotransmitter 
systems may be a reflection of heterogeneous functional 
involvement of different parts of this nucleus (Tassin 
et al. 1976; Fonnum and Walaas, 1978; Scally et al.
1978), which contrasts markedly with the homogeneity of 
anatomically definable cell types. However, interact­
ions of neurotransmitter systems in the functional 
activity of the caudate nucleus are possibly much more 
complex than has hitherto been suspected from the gross 
topography of transmitter markers. The distribution 
of acetylcholine systems, which are thought to be the 
main interneuron transmitter systems (Divac and Oberg,
1979), shows a microscopic medial-lateral difference 
(Rea and Simon, I98I), whilst at a higher level of 
resolution the distribution pattern appears to be more 
of a mosaic within these regions of elevated biochem­
ical markers for acetylcholine (Graybiel and Ragsdale,
1978). Similarly, striatal projection neurons and 
cells postsynaptic to afferent terminals also appear
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to form clusters within the general cellular matrix 
(Graybiel and Ragsdale, 1978; Wright and Arbuthnott,
1981) .
The medial-lateral functional heterogeneity sugg­
ested by the present investigation cannot be explained 
simply from anatomical or neurobiochemical data avail­
able on striatal GABA systems, and the development of 
high resolution techniques with which to map the dis­
tribution of specific GABA receptors has so far failed 
to identify a heterogeneity similar to that of the 
pattern of altered glucose utilisation (Palacios et 
al. 1981). Although GABA is known to be of primary 
importance to striatal function, complex interaction 
with other neurotransmitter systems - for example, 
cholinergic neurones (Scatton and Bartholini, 1979,
1980) - makes the possibility of observing a purely 
GABAergic effect upon glucose utilisation unlikely.
The profound changes induced by GABAergic manipulation 
in areas sending projection fibres to the caudate nuc­
leus could, together with possible action upon intrinsic 
neurones and collaterals from striatal efferents (Park 
et al. 1980), summate to produce the high degree of 
responsiveness of this nucleus above all other elements 
of the extrapyramidal system. It is interesting in 
view of the medial-lateral differences in caudate 
response that whilst cingulate cortex, which was more 
resistant to the action of the agonists, has been shown 
to be functionally linked to the less responsive medial 
portion, sensory-motor cortex, which was extremely
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sensitive, has been shown to be similarly linked to 
the more responsive lateral portion (Divac and Diemer,
1980). The significance of this possible functional 
interdependence in integrated striatal activity awaits 
further elucidation.
In the major sites receiving almost exclusively 
GABAergic projections from the caudate nucleus, the 
globus pallidus and pars reticulata of the substantia 
nigra (Ribak et al. 1976), administration of the GABA 
agonists produced only moderate to minimal alterations 
in glucose utilisation. The decreases in glucose use 
observed in the present study in the pars reticulata 
are in excellent agreement with previous electrophysio­
logical measurements of reduced cell firing rates in 
this area (Grace and Bmmey, 1979 j Waszczak et al. 
19801) , both in the magnitude of the chajiges aird the 
concentration percentage response curves for both GABA 
agonists. However, in the pars compacta of the sub­
stantia nigra, systemic administration of muscimol is 
followed by an increase in firing from putatively 
dopaminergic cells (MacNiel et al. 1978 ; Grace ajid 
Bunney, 1979; Waszczak et al, 1980a) which contrasts 
with the decreases observed in the measured rates of 
glucose utilisation. It remains to be determined 
whether these apparently contradictory results are a 
reflection of differences in response between the 
conscious animals employed in this study and electro­
physiological preparations in which chloral hydrate 
was used, in a similar way to that described following
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dopaminergic manipulation (Grome and McCulloch., I98I) , 
Furthermore, general anaesthetics, most notably barbit­
urates, exert a profound influence upon GABAergic 
neurotransmission (Lodge and Curtis,, 1978; Skolnick 
et al, 1981). The use of conscious animals, which 
the 2-deoxyglucose approach facilitates, presents a 
major advance over other techniques where anaesthesia 
is a prerequisite in the investigation of CNS responses 
to GABAergic agonists.
In most motor areas outwith the basal ganglia, 
glucose utilisation was only minimally reduced by 
muscimol or THIP, In contrast to a recent report 
(Palacios et al. I98I) describing the effects of these 
two agonists upon glucose use in a limited number of 
brain structures, no increase in glucose use was obser­
ved in the present study with any dose of either agent, 
although in other brain regions - auditory cortex, 
medial geniculate and lateral habenula - the responses 
observed in both studies were in general agreement.
The difference in the response of the red nucleus may 
result from pharmacological and/or methodological 
differences between the studies, such as the apparent 
lack of restraint to allow plasma sampling, the use of 
ether anaesthesia during surgical preparation or the 
starvation of the rats prior to the experiments, with 
the attendant possibility of cerebral tissue switching 
to the use of jB-hydroxybutyrate and aceto-acetate to 
meet its energy requirements (see Ruderman et al. 1974, 
for the consequences of 24-hour starvation on energy
substrate use). The very low levels of glucoae use 
(43 +. 2 umol/lOOg/min) observed in the red nucleus of 
control animals (Palacios et al, 1981) compared to 
that noted by ourselves (73 ± 3 umol/lOOg/min) and 
others (76 + 5 umol/lOOg/min; Wechsler et al. 1979) 
could in itself be directly responsible for the appar­
ent discrepancy in the two investigations.
Of the areas involved in motor function, the 
cerebellum was the region in which glucose utilisation 
was least responsive to GABAergic manipulation. In 
keeping with the observation that the cerebellum con­
tains the greatest density of GABAergic receptors in 
the CNS (Beaumont et al. 1978), neuronal inhibition 
within cerebellar cortex appears to be mediated almost 
entirely via GABA mechanisms (Roberts, 1978). More­
over, the Purkinje cells, which are GABAergic in nature 
(Obata et al. I967), provide the sole efferent connect­
ions from cerebellar hemisphere to the underlying nuclei 
(Eccles et al. I967). Thus, the known primacy of GABA 
in the cerebellum, taken together with the minimal 
reductions in glucose use following administration of 
GABA agonists in intact, conscious rats, would appear 
to indicate that, in vivo, cerebellar GABA mechanisms 
of neurotransmission are near maximally active.
A growing number of discrepancies are being identi­
fied between the regional distribution of receptor sites 
and the topography of the relevant neurotransmitter 
systems (Palacios et al, 1979, 1980; Simantov et al.
1977). Whilst ligand binding studies provide evidence
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for possible sites of drug action, the Vmax for recep­
tor affinity upon which these approaches are based 
supplies little indication of the circumstances under 
which receptor populations will be activated in the 
intact, conscious animal. The response of cerebellar 
glucose use to GABAergic agonist administration pro­
vides an interesting insight into the interaction 
between endogenous and exogenous GABA agents, and 
stresses that the outcome of this interplay is complex 
and not easily predictable.
Primary Visual System; GABAergic activity has been 
found at all levels of the primary visual system.
Within the retina GABA is restricted to a discrete 
population of cells (Nakumara et al. I980), whilst in 
the visual cortex, although GAB activity may be local­
ised to a specific, histologically definable cell type, 
these cells are distributed throughout all cortical 
layers (Ribak, 1978). The visual relay nuclei, the 
lateral geniculate bodies and superior colliculi, both 
exhibit relatively high GAD activity (Tappaz et al, 
1976), and the inhibitory input to occipital cortex 
from the lateral geniculate utilises GABA as the syn­
aptic neurotransmitter substance (Armstrong, I968; 
Iversen et al. 1971). In the present study, local 
rates of glucose utilisation in cortex and lateral 
geniculate were at least moderately sensitive to both 
muscimol and THIP. In contrast, glucose use in the 
deep layers of the superior colliculus was relatively 
insensitive to the action of the two agonists, perhaps
Vreflecting the lesser functional involvement of this 
region in primary visual processing.
The superficial layer of the superior colliculus 
was the only area of the CNS measured in this study in 
which the response, in terms of altered glucose utilis­
ation following muscimol, was qualitatively different 
from the response following THIP, The basis for this 
disparity in the actions of the two GABAergic agonists 
upon the functional activity of the superior collic­
ulus is not immediately apparent, especially as the 
responses observed within the other, functionally 
related, primary visual areas were essentially similar 
in their patterns of depression. The laminated struct­
ure of the superior colliculus reflects a heterogeneity 
of functional activity at different depths. Not only 
is afferent input segregated into different layers 
(Lund, 1964; Casagrande et al. 1972; Sterling, 1973î 
Grofova et al, 1978), but neurotransmitter systems are 
also distributed unevenly through the layers. Although 
it may be surmised from similarities in response else­
where in the brain that input to the area is the same 
following both agonist treatments, there is a possibil­
ity that differential interaction of the GABAergic 
agents with other neurotransmitter systems could account 
for the dichotomy in the effects of muscimol and THIP 
within this region. Although in vivo experiments have 
so far failed to show any differences in the effects of 
these agents upon neuronal function (Waszczak et al.
1980), their pharmacological profiles, characterised
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in vitro, do sliow marked dissimilarities (Kr/gsgaard- 
Larsen et al. 1979)» The potential for differences 
in the pharmacological actions of muscimol and THIP 
is therefore available, although the present study 
represents the first observation of any such diverg­
ence of activity in vivo. The exact neuroanatomical 
and neurochemical conditions which are absent from 
any other region of the CNS but which prevail in the 
superficial layer of the superior colliculus, allowing 
differences in the pharmacological characteristics of 
muscimol and THIP to be manifest, remain to be deter­
mined.
Cerebrovascular System; Although investigations into 
the functional role of GABA in the brain have, in the 
main, focussed upon neuronal systems, recently a novel 
GABAergic system has been identified in association 
with the cerebral vasculature, indicating a possible 
role of GABA in cerebrovascular regulation. Unlike 
vessels taken from peripheral sources, cerebral arter­
ies, when studied in vitro, displayed a vasodilatatory 
response to GABA and putative GABA agonists (Pujiwara 
et al. 1975; Edvinsson and Krause, 1979) which was 
subject to a parallel shift to higher agonist concen­
trations in the presence of antagonists (Edvinsson and 
Krause, 1979). The contrast between peripheral and 
cerebral arteries was further emphasised by the local­
isation of glutamic acid decarboxylase (GAD), the rate- 
limiting enzyme in the synthesis of GABA, and GABA 
transaminase (GABA-T), the principal enzyme in GABA
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degradation, in large concentrations in brain vessels, 
but not in those from the periphery (von Gelder, 19685 
Krause et al, 1980a; Hamel et al, I981). The endo­
thelial location of these enzymes in the cerebral 
vasculature has gained added importance with the recent 
demonstrations of the crucial role played by endothel­
ial cells in the relaxation of arterial smooth muscle 
(Purchgott and Zawadzki, I98O), The demonstration 
of GABA specific binding sites and the correlation 
between binding affinity and potency displayed by 
pharmacological agents in eliciting a dilatatory 
response (Edvinsson and Krause, 1979; Krause et al, 
1980a,b) further indicated a possible role for intrin­
sic GABA systems in the control of cerebral vasomotor 
activity, and thereby participating in the regulation 
of cerebral tissue perfusion.
The importance of maintaining cerebral homeo­
stasis to protect normal brain function in the face of 
dramatically changing physiological conditions is wide­
ly thought to provide the driving force behind control 
of cerebral blood flow (Roy and Sherrington, I98O). 
Homeostatic conditions may, however, vary widely in 
different parts of the CNS as increases or decreases 
in activation create localised changes in the cellular 
milieu, by virtue of the altered requirements for energy 
substrates necessitated by neuronal function and the 
production of metabolites which these processes entail 
(Des Rosiers et al, 197^; Sokoloff, 1978). The develop­
ment of quantitative autoradiographic techniques allows
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functional activity and, therefore, energy demand 
(using 2-deoxyglucose), and cerebral blood flow (using 
iodoantipyrine) to be measured with a similar degree of 
spatial resolution. However, one major limitation of 
this approach is that the individual measurements of 
blood flow and glucose use cannot be performed on the 
same animals. The problems associated with statistical 
analysis of data in this form have hitherto been largely 
ignored (huschinsky et al. I98I; Ohata et al. 1981), 
but a mathematical model recently developed to accommod­
ate the interdependence of multiple regional measures 
within an individual animal, as well as the inter-animal 
variability which is concealed with the use of regress­
ion analysis, has allowed valid analysis of the results 
from the present study (McCulloch et al. 1982a).
The vascular response to GABA receptor activation 
described in vitro would, if transposed intact to the 
whole animal, result in an increase in cerebral blood 
flow through the dilated vessels. However, if this 
mechanism did indeed have a physiological role to play 
in the control of cerebral tissue perfusion, then manip­
ulation of GABA systems with systemically administered 
agonists could elicit opposing forces upon the vasculat­
ure to increase flow (direct vascular effect) or reduce 
flow (mediated via reduced metabolic demand in the 
brain). From the evidence of the present investigat­
ion it is clear that the relationship which exists 
between local blood flow and glucose utilisation in 
each region of the CNS in normal animals was unaltered
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by muscimol administration. It would thus appear 
likely that the alterations in tissue blood flow vhâeh 
obaarved --fu 11 owing musaimol administration' are a 
secondary consequence of the reductions in metabolic 
activity which result from muscimol administration. 
Moreover, the regions of the brain where the greatest 
reductions in functional activity were observed, e.g., 
neocortex and thalamus, are not necessarily the prim­
ary sites at which muscimol acts, and the observation 
that these areas were also the regions to which blood 
flow was most significantly reduced provides further 
evidence for a close link between metabolic activity 
and blood flow. However, a direct effect of muscimol 
upon the cerebral blood vessels in this animal model 
cannot be wholly discounted. A slight resetting of 
the blood flow/glucose utilisation function, which 
appears to some extent to .be dose-dependent, may 
reflect a vasodilatatory effect of muscimol tempering 
the vasoconstrictory effects of reduced metabolism.
The lack of statistical significance which may be 
attached to this effect may be a reflection of the 
degree of variability intrinsic in all blood flow 
measurements together with the relative conservatism 
of the rigorous statistical model which was used.
Contrary to a previous investigation in which 
cortical blood flow was reportedly increased by up to 
90^ by muscimol (Edvinsson et al, I98O), it was in the 
cerebral cortex that the most consistent, significant 
reductions in blood flow (and glucose utilisation)
were observed. The reason such discrepancies arise 
is difficult to define with certainty. However, the 
use of anaesthesia in the previous study may be of 
crucial importance, especially as GABAergic mechanisms 
in general are particularly sensitive to modification 
by anaesthetic agents (Curtis and Lodge, 1977). 
Similarly, the absence of any data in the previous 
report concerning metabolic alterations resulting from 
muscimol administration renders the comparison between 
the studies more difficult. The present studies, by 
eliminating some of the sources of uncertainty (anaes­
thesia, metabolic influence, heterogeneity of response), 
and by the choice of measurement techniques which we
have employed (i.e., quantitative autoradiography with
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C-iodoantipyrine and C-2-deoxyglucose), provides a
more accurate and complete description of the cerebral
circulatory consequences of administering muscimol
intravenously than does the previous report.
The exact physiological role of cerebrovascular 
GABA mechanisms remains to be determined. Clearly, 
under non-pathological conditions they are unlikely to 
be linked to neuronal GABAergic activity with the 
dichotomous effects upon blood flow which the two 
enzymes induce. Moreover, pharmacological manipulat­
ion of vascular GABA systems in the intact animal 
without concomitant, opposite effects elicited via 
metabolic influences would appear not to be feasible. 
Recently, however, a relationship has been suggested 
between GABA release and cerebrovascular disease on
the basis of increased levels of the neurotransmitter 
measured in CSP (Welch et al, 1976), although whether 
this is of vascular or neuronal origin, or whether it 
is a cause or effect of the condition, is uncertain. 
Under pathological conditions it is possible that the 
relationship between the perfusion and metabolic 
requirements of brain tissue may no longer prevail, 
and manipulation of both vascular GABA mechanisms to 
promote increases in blood flow whilst neuronal GABA 
systems are reducing metabolic demand could possibly 
be used as a prophylactic manoeuvre to reduce ischaemic 
cell damage in the management of cerebrovascular insult 
Such a possibility could be worthy of further invest­
igation,
GABAergic Interactions with Benzodiazepine ; Alter­
ations in cerebral glucose utilisation following GABA­
ergic manipulation with muscimol or THIP, when com­
pared with the pattern of changes following adminis­
tration of the benzodiazepine substance, diazepam, 
revealed a general similarity of response. With
increasing doses of the three agents, rates of glucose 
utilisation decreased throughout the brain, all funct­
ional systems being affected. This observation is in 
keeping with the common actions of GABA agonists and 
benzodiazepines in promoting hypnotic and ataxic (i.e., 
sedative) effects. Closer analysis of the results 
revealed that within the general depressant response 
the hierarchy of responsiveness to GABA agonists was 
markedly different from that following diazepam, this
despite the fact that muscimol (but not THIP) promotes 
benzodiazepine binding (Karobath et al, 1979) and should 
therefore enhance the activity of any endogenous benzo­
diazepine (Braestrup et al. I981), The hierarchies
differed in two major respects. In general, the range 
in magnitude of response to GABA agonists was greater 
than that observed following diazepam administration. 
Although a few regions of the brain were immediately 
apparent as being areas of low or high sensitivity, 
the great majority of regions appeared to be equally 
sensitive to the benzodiazepine. Moreover, in this 
majority of areas little or no further decrease in 
glucose use was observed between 0.3 and 1,0 mg/kg 
diazepam, contrasting with the generally steady, dose- 
dependent decreases observed following muscimol or 
THIP, In this instance, hierarchies based upon the 
F-ratio reveal the extent to which the depression in 
glucose use in response to diazepam is considerably 
more homogeneous than that to muscimol or THIP.
The particulars of the hierarchies of sensitivity 
were also quite different. Whilst the GABA agonists 
were most effective in reducing functional activity 
in thalamus and cortex, the areas most sensitive to 
diazepam were much more diffuse, including elements 
of the extrapyramidal motor system, the raphe nucleus 
and the mamillo-tegmental axis. Interestingly, the
cortical area least affected by GABA agonists, namely 
cingulate cortex, was amongst the areas most sensitive 
to diazepam. No correlation was evident between the
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sensitivity of glucose utilisation in any region to 
change by diazepam and the distribution of benzodiaz­
epine binding sites. For example, the amygdaloid
nuclei, which appeared to be very sensitive to the 
action of diazepam in terms of altered functional act­
ivity, have been reported to possess a dense receptor 
population (Young and Kuhar, I980). This apparent 
discrepancy has previously been discussed in full in 
relation to GABAergic manipulation.
The differences in the hierarchies of sensitivity 
to GABAergic and benzodiazepine manipulation confirm 
that the changes observed following GABAergic manipu­
lation were not explicable as being merely the product 
of generalised cerebral depression. Rather, the
altered functional activity was a direct function of 
specific GABA-mimetic activity, a specificity not 
shared by diazepam (.Gallager, 1978; Geller et al. 
1978). Conversely, the differences in the hierarch­
ies may elucidate, to some extent, the possible mode 
and site of action of benzodiazepines in producing 
anxiolytic effects specific to those agents.
The GABA receptor has been proposed to be part of 
a greater protein complex which also includes benzo­
diazepine and barbiturate recognition sites (Olsen, 
1981). However, considerable uncertainty remains 
over the extent to which these related central nervous 
system depressants rely upon modulation of the post- 
synaptic response to GABA in the expression of their 
actions (Costa and Guidotti, 1979; Haefely, 1981),
Electrophysiological investigation has indicated that 
benzodiazepines enhance post-synaptic, GABA-mediated 
inhibition, both in neuronal cell culture (MacDonald 
and Barker, 1978) and in areas of the intact brain 
(Polc and Haefely, 1976). In contrast, several stud­
ies have indicated that GABA binding to membrane 
receptors in vitro could not be significantly enhanced 
by the addition of benzodiazepines (Zukin et al. 197^? 
Mohler and Okada, 1978; Andrews and Johnston, 1979; 
Olsen, 1979), although the protocol for preparation of 
the membranes appears to be quite critical, and may 
produce opposite results (Guidotti et al. 1978). The 
reverse interaction of GABA receptor agonists in pro­
moting benzodiazepine binding could be demonstrated 
(Briley and Langer, 1978; Tallman et al. 1978; Chiu 
and Rosenberg, 1979; Karobath and Spark, 1979), this 
inverse effect being found in all brain regions (Wastek 
et al, 1978) and reversed by GABA antagonists (Tallmann. 
et al. 1978). The regional distribution of benzodiaz­
epine receptor sites in the brain, although similar to 
that of GABA receptors, is not exactly identical 
(Placheta and Karobath, 1979; Young and Kuhar, I980), 
an observation which reflects the finding that not all 
GABA receptors are coupled to benzodiazepine receptors. 
Whether the converse is valid and benzodiazepine recep­
tors are to be found in any cells which are devoid of 
GABA receptors remains an open question.
The effects of diazepam upon glucose utilisation 
in many areas of the brain analysed,presented a pattern
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of response remarkable for the apparent lack of dose- 
dependence. This may be a reflection of poor choice 
of doses, but such.changes over a semilog dose increase 
would be difficult to accommodate within any experi­
mental design. Alternatively, the alterations in 
functional activity at low doses of diazepam (O.l mg/ 
kg) may be beyond the power of the method to resolve. 
Again, this appears to be unlikely in view of the fact 
that relatively small, 8^ decreases in glucose use were 
not only detected, but were found to be statistically 
significant, such was the limited variance of the 
measurement. Such an apparent ’all or none' response 
to diazepam would be difficult to justify, given the 
range of different actions reported for benzodiazepine, 
but it is probable that, for example, only in stressed 
animals would the altered functional activity of sel­
ected brain regions truly -reflect the anxiolytic 
properties of the agent.
On the basis of receptor distributions, a tent­
ative map of brain areas involved in the different 
pharmacological effects of benzodiazepines has been 
established (Young and Kuhar, I980), On this basis, 
the amygdala and frontal cortex were proposed to be 
possible sites of anxiolytic action, both areas being 
of dense benzodiazepine receptor population. Using 
a behavioural model of anxiety in the intact animal, 
local injections of benzodiazepine into the amygdala 
(Shibata et al, 1982a) or the mamillary body (Shibata 
at al, 1982b) have indicated these areas as potential
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sites of anxiolytic action. From the present invest­
igation it is apparent that functional activity within 
amygdaloid nuclei and the deeper laminae of the frontal 
cortex is only minimally affected by diazepam adminis­
tration. Although these regions may be the site of 
primary action of the drug, in terms of receptor bind­
ing, these are patently not the areas of the brain 
where the actions are manifest. In contrast, the
mamillary body and the dorsal tegmental nucleus, which 
share reciprocal innervation (Briggs and Kaebler, 197l)j 
were amongst the areas which proved to be most sensitive 
to the action of diazepam in terms of reduced glucose 
utilisation. These two areas also display moderate 
to dense occurrence of benzodiazepine receptors (Young 
and Kuhar, I98O). It is apparent, therefore, that the 
functional responsiveness to diazepam in different areas 
of the brain does not parallel receptor distributions 
and, indeed, areas possessing similar levels of recep­
tor activity are capable of displaying widely divergent 
re sponse s,
Although these studies may present an interesting 
adjoiner to the search for the site of action of benzo­
diazepines in their capacity as antianxiety agents, 
the deoxyglucose technique (when linked with systemic 
administration) is perhaps not the most appropriate 
tool with which to analyse specific drug/receptor 
interaction. While such studies will continue to 
generate interest, providing some insight into the 
wider effects of possible therapeutic agents in the
brain, the limitations of combining 2-deoxyglucose 
technology with systemic administration as an 
approach to further understanding of basic neuronal 
mechanisms are becoming increasingly recognised 
(McCulloch, 1982),
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3. Striatal Lesioning with. Kainic Acid
3.1 General results and observations; During the 
first k8 hours after the injection of kainic acid, 
lesioned animals displayed spontaneous, predominantly 
contraversive turning, and were both aphagic and 
adipsic over the same time period. The disruption 
of feeding behaviour together with increased motor 
activity resulted in the rats suffering a substantial 
weight loss (up to ^Og in 48 hours) accompanied by a 
marked reduction in plasma glucose levels. By seven 
days, weight loss had been almost restored, but plasma 
glucose concentrations remained depressed. Ten days 
after the injection of kainic acid the weights of all 
the animals were greater than, the pre-injection values, 
and plasma glucose levels were similar to those 
observed in normal, well nourished rats. Animals 
which had received intrastriatal injections of CSP 
displayed no overt abnormalities of motor or of feed­
ing behaviour at any time over the 10 days.
Following pharmacological challenge with muscimol 
(1,5 mg/kg) the behavioural changes were exactly those 
described previously, and were the same for both sham- 
lesioned and lesioned groups of animals. The stereo­
typed behaviour observed following apomorphine (l.O 
mg/kg) conformed with that described in the literature 
for this particular, partly restrained, animal model 
(McCulloch et al. 1982c), No consistent asymmetry of
posture or orientation of responses was observed from 
the lesioned animals following either drug treatment.
3.2 Histology; Histological examination of the 
tissue sections from the group of animals which had 
been perfusion-fixed on sacrifice,revealed a pattern 
of damage which was generally restricted to the caudate 
nucleus (approximately two thirds of total volume 
affected) and the overlying cortex through which the 
needle had passed. However, in two of the animals, 
kainic acid-associated damage was observed in the 
ipsilateral hippocampus corresponding to terminal 
field CA3. No damage was observed in an.y other area 
spatially removed from the injection site, or in the 
contralateral hemisphere. In animals subjected to 
intrastriatal injections of CSP, damage was restricted 
to the needle tract.
Although the quality of frozen sections precludes 
the detection of subtle neuropathological changes in 
cellular morphology, the pattern of damage observed 
in sections taken from the 2-DG experimental animals, 
both short-term (10 days) and long-term (30 days) 
survival, and those subjected to subsequent pharmacol­
ogical challenges, closely resembled that found in the 
parallel histological study. The greatest damage 
observed was in the caudate nucleus and overlying 
cortex but, in three of the animals, a limited degree 
of damage was found in ipsilateral hippocampus. In 
CSF-injected animals, mechanical damage was evident 
around the needle tract. Frozen sections from the 
septal lesioned animal revealed extensive damage in 
the injected septum and bilaterally in hippocampus,
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but with, limited involvement of ipsilateral caudate or 
contralateral septal nuclei,
3.3 Local cerebral glucose utilisation; In animals 
which had been subjected to the stereotactic injection 
of CSF, glucose utilisation was significantly reduced 
bilaterally in a large number of functionally diverse 
structures when compared to intact, saline-injected 
control animals (Fig, 24). In some sham-lesioned
animals, the pattern of glucose utilisation in prim­
ary auditory structures was very different from intact 
controls (Fig. 24), suggested an altered sensory input, 
possibly accounting for generalised, lowered arousal.
Alterations in local cerebral glucose utilisation 
were measured in structures both ipsi- and contralateral 
to the striatal lesion site when compared with the 
corresponding side of CSF-injected controls. The
most pronounced changes, which were immediately appar­
ent from a visual inspection of the autoradiograms, 
were observed within the histologically defined limits 
of the lesion site in the caudate nucleus and in areas 
which correspond to the primary sites of striatal effer­
ent termination, in the ipsilateral globus pallidus 
(GP), entopeduncular nucleus (EP) and substantia nigra 
pars reticulata (SNR) (Fig, 25). Although diminished 
somewhat in intensity, these areas of change remained 
discernible 30 days after induction of the lesion. With­
in the histologically defined limits of the lesion site,
l4C-labelled leucine incorporation was reduced by around 
359  ^when compared to the intact striatum (Fig, 26),
Figure 2k
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Figure 25
Autoradiograms taken from coronal sections of rat brain 
following unilateral kainic acid-induced striatal lesions
Upper left; Autoradiogram at the level of the caudate 
nucleus. Marked reductions in OD are clearly visible 
in lesioned caudate (l.h.s.).
Upper riglit; Schematic diagram of extent of striatal 
damage mapped Prom cresyl violet stained sections taken 
from the same animal.
#
Lower left; Autoradiogram at the level of the globus 
pallidus. Marked increases in OD are clearly visible 
in globus pallidus ipsilateral to lesion site.
Lower right ; Autoradiogram at the level of the substantia 
nigra. Marked increases In OD are clearly visible in 
SNR ipsilateral to lesion site.
The increases in OD, in GP and SNR represented increases 
in glucose use in these areas (see Fig. 28).
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Figure 26
Coronal sections of rat brain at two levels of caudate 
nucleus following unilateral kainic acid-induced 
striatal lesions.
Leucine Uptake
m
Cresyl Violet
/ \ i4Left (upper and lower); Subtle reductions in C-leucine
accumulation in lesioned caudate nucleus (l.h.s.).
Right (upper and lower); Sections consecutive to those 
used for autoradiograms showing reduced Nissl substance 
in lesioned caudate nucleus (l.h.s.).
The limits of the areas of reduced OD and reduced Nissl 
substance are remarkably coincident.
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The uptake of leucine ipsilateral to the lesion site 
increased in GP and SNR by 10^ and 8^, respectively.
No other side-to-side differences were observed.
The pattern of response to intraseptal injection 
of kainic acid, which was also visually striking, 
involved an increase in OD in the lesioned septal 
nucleus and also bilaterally throughout all levels of 
the hippocampal formation (Fig, 27). Within both of 
these areas, microscopic analysis of the frozen sect­
ions revealed marked morphological changes associated 
with damage. However, around the injection site in 
ipsilateral caudate and contralateral septal nucleus, 
where damage was apparently minimal, OD changes were 
also observed (Fig. 27). In caudate OD was decreased, 
but was increased in septum.
Quantification of the optical density changes in 
primary striatal projection areas, ipsilateral to the 
lesioned striatum, revealed large increases in glucose 
utilisation in GP and SNR {82°/o and 7k°/o, respectively; 
see Fig. 28), but a numerically smaller increase
in the EP (Fig. 28) when compared to the appropriate 
side of the sham-lesioned brains. These increases 
were significantly less when measured 30 days after 
the placement of the lesion, but glucose use was still 
elevated by between 20^ (EP) and 50% (SNR and GP),
Despite exerting little or no effect in sham- 
lesioned rat brains, muscimol administered at 1.5 mg/ 
kg, i.v., significantly attenuated the increases in 
glucose utilisation which followed removal of striatal
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Figure 27
Autoradiograms from coronal sections of rat brain 
following injection of kainic acid into the septal 
nucleus.
k
m
Upper left : Autoradiogram taken at the level of the
caudate nucleus. Bilateral increases in OD in septal 
nuclei and small unilateral (l.h.s.) decreases in OD in 
mediodorsal caudate.
Upper right, lower left and right; Autoradiograms 
taken at different levels of the hippocampal formation 
showing marked bilateral increases in OD. These areas 
of deranged isotopic tracer accumulation were coincident 
with areas of pathological changes in cellular morphol­
ogy observed in cresyl violet stained sections.
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input to these three ipsilateral areas (Fig, 28). How­
ever, at this dose, rates of glucose use did not returp 
completely to basal levels, except in the EP which 
appeared to be more sensitive to the action of muscimol, 
being alone in displaying a small decrease at the limits 
of significance when the agent was delivered to sham- 
lesioned animals.
In contrast to the limited effects of muscimol in 
the three areas of sham-lesioned brains, apomorphine 
administration (l.O mg/kg) resulted in large, signifi­
cant increases in glucose use of l^ G^ /a in EP, 117^ in 
SNR, and 'J3‘/o in GP, which approached, or exceeded, the 
changes observed following striatal lesions alone (Fig. 
28). The two treatments together did not, however, 
produce a summation of the two responses. Although 
significant increases in the kainic acid lesion 
responses were observed in EP (33^) and SNR (23^), 
only in SNR did the two treatments (striatal lesion 
and apomorphine challenge) produce a level of glucose 
utilisation which was greater than with either treat­
ment alone (Fig. 28), whilst in the EP the presence of 
the striatal lesion in fact significantly attenuated 
the apomorphine-induced increase in glucose use (Fig.
28). In the GP of lesioned brains, apomorphine 
treatment resulted in a small, non-significant decrease 
in glucose use when compared to saline-treated lesioned 
animals (Fig. 28) .
Despite the absence of any measurable change in 
functional activity in the caudate nucleus contralateral
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Rates of glucose use in ipsilateral area of primary 
striatal projection following unilateral striatal 
lesioning (upper) and subsequent challenge with (middle) 
muscimol, 1.5 mg/kg, or (lower) apomorphine 1.0 mg/kg. 
Comparisons between sham and lesioned treatments for each 
area (*p<0.05) and between saline and drug challenges 
for each area ( ^ ^ < 0 .05).
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to the lesion site, increased glucose use was also 
measured in the contralateral GP and SNR (Fig. 29), 
but although these metabolic alterations were highly 
significant, they were quantitatively less marked (l6^ 
and 20^ in GP and SNR, respectively) than those in the 
same regions of the ipsilateral hemisphere. No sig­
nificant change was measured in the contralateral EP 
in which mean glucose use increased by less than 10^.
Whilst muscimol at the dose used merely atten­
uated the effect of striatal lesions upon ipsilateral 
GP and SNR, the contralateral increases in glucose use 
were completely eliminated by muscimol challenge (Fig,
29), to the extent that no significant differences 
could be found between the sham and lesioned groups 
which had received muscimol (of. a maintenance of a
differential ipsilaterally) . As was observed 
on the ipsilateral side, the contralateral EP of sham- 
lesioned brains displayed a decrease in glucose use in 
response to muscimol which just reached over the limits 
of significance, but in brains of lesioned aiairnals 
muscimol did not reduce glucose utilisation to the 
same low levels, although there was no significant 
difference between the two means (Fig. 29).
In animals subjected to sham-lesioning procedures, 
the large increases in glucose use which were measured 
in the ipsilateral areas of striatal projection follow­
ing apomorphine administration were also observed in 
the corresponding areas in the contralateral hemisphere 
(Fig. 29). Administration of apomorphine to lesioned
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Rates of glucose use in area of contralateral primary 
striatal projection following unilateral striatal 
lesioning (upper) and subsequent challenge with (middle) 
muscimol 1.5 mg/kg or (lower) apomorphine 1,0 mg/kg. 
Comparisons were made between sham and lesioned treat­
ment for each area (*p<0,05) and between saline and 
drug challenges for each area (jz(p< 0.05) .
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animals increased glucose use in the contralateral GP,
EP and SNR (Fig, 29) to levels above those observed 
following lesions alone, although again no summation 
of the two effects was evident. Indeed, in both GP 
and SNR no significant difference was apparent between 
sham-lesioned and lesioned brains which had been treated 
with apomorphine. Only in EP, where the effects of the 
lesion alone were least marked, was the apomorphine 
response significantly different in sham and lesioned 
groups (Fig. 29). The presence of a contralateral 
striatal lesion attenuated the apomorphine response 
in EP by 18^, a quantitatively similar response to 
the attenuation observed in the ipsilateral EP,
In contrast to the asymmetric, more marked ipsi­
lateral changes in functional activity measured in 
striatal outflow areas, the source of striatal affer­
ent connections from primarily motor areas, the pars 
compacta of the substantia nigra (SNC), parafascicular 
nucleus of the thalamus (pFN) and sensory-motor cortex 
(SMCx) displayed significant contralateral increases 
in glucose utilisation of l4^, 21^ and 15^> respect­
ively (Fig, 31). No significant changes were observed 
in these areas ipsilateral to striatal lesions (Fig. 30).
Muscimol at the dose used did not result in signif­
icantly altered glucose use in contralateral SNC of 
either sham-lesioned or lesioned animals, and thus a 
significant 20^ difference (Fig. 3I) was maintained 
between the mean values of the two groups. Signifi- 
cant attenuation of the lesion-induced increases in
Figure 30
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functional activity was evident in both. PFN and SMCx 
following muscimol administration, such that a signif­
icant difference was no longer found between sham and 
lesioned groups (Fig, 31). In view of the general 
sensitivity of thalamic areas in intact animals to the 
actions of systemically administered muscimol (see previ- 
uously reported data), it is of interest that no signif­
icant response to the drug was measured in the PFN of 
sham animals, either contralaterally or ipsilaterally 
to the site of intervention. However, a significant
decrease in glucose use from saline-injected control 
levels was found when muscimol was injected into les­
ioned animals both ipsilaterally, where the lesion 
itself had little effect, as well as contralaterally, 
where a significant lesion-induced increase in funct­
ional activity was apparent (Figs, 30 and 3l).
Apomorphine administration produced significant 
increases in glucose use in SNC, PFN and SMCx of sham- 
lesioned animals to a similar degree both ipsi- and 
contralateral to the striatal intervention site (Figs.
30 and 31). Although significant bilateral increases 
were also measured in SNC and PFN of lesioned animals, 
in PFN the apomorphine response was significantly less 
than that found in sham-operated rats (Figs. 30 and 3l)• 
Again, however, there was no evidence for summation of 
lesion-induced and drug-induced increases in glucose 
utilisation and, indeed, in PFN the response to apo­
morphine was severely attenuated from around in
the sham group to 2 3 °/o ipsiiateral and 12^ contralateral
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to the striatal lesion (Figs. 30 and 3l). The rate 
of glucose use in the SMCx of lesioned animals was not 
significantly different from that observed in the sham- 
lesioned rats, following apomorphine, but the level of 
functional activation was no greater than that measured 
following lesion alone. Thus, bilaterally in this area 
of cortex, no response to apomorphine was found follow­
ing unilateral striatal lesion (Figs, 3C and 3l).
Regions of the diencephalon, described in funct­
ional terms as subserving motor activity and which 
receive projections from the striato-pallidal~nigral 
system, showed no consistency in their responses to 
unilateral striatal lesions, despite the fact that 
increases in functional activation were apparent at 
the sources of afferent fibres in the extrapyramidal 
system. In the subthalamic nucleus (afferent connect­
ions with GP) and ventromedial thalamus (afferent 
connections with SNR) no significant response was 
observed ipsiiateral to the lesioned striatum (Fig.
32). However, within the ventrolateral thalamic 
complex (afferent connections with GP) a small (l3%), 
but significant increase in the rate of glucose util­
isation was measured ipsilaterally (Fig. 32).
As observed previously, thalamic nuclei appear to 
be very sensitive to the actions of systemically admin­
istered muscimol. In sham-operated animals a signif­
icant decrease in glucose utilisation was measured in 
both ipsiiateral ventrolateral and ventromedial thalamus 
following 1.5 mg/kg muscimol delivered intravenously
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(Fig, 32). The lesion-induced increase in glucose 
utilisation in the ventrolateral complex was attenuated 
( A- 31^) vith muscimol at this dose, such that no 
significant difference was discernible between sham 
aiad lesioned, groups following drug treatment (Fig. 32) , 
Despite the lack of any apparent change in glucose use 
in the ventromedial thalamus in response to striatal 
lesion, the decrease in functional activity following 
muscimol was significantly greater in the lesioned 
animals ( A - hy^ /o) than in those subjected to. sham 
intervention (A - 22^). No alteration in the rate of
glucose use in subthalamic nucleus was noted in response 
to muscimol at the dose used (Fig. 32).
In all three ipsiiateral diencephalic motor areas, 
glucose use was significantly increased in sham-operated 
animals following apomorphine administration (l.O mg/kg). 
The most pronounced changes were observed in the sub­
thalamic nucleus where an increase of 90^ was observed 
over saline-injected animals, but relatively large 
increases in glucose use (around 40%) were also meas­
ured in the thalamic nuclei. The response to apo­
morphine in the.subthalamic nucleus was radically 
attenuated in the absence of striatal efferent fibres, 
a much smaller (40^) increase in glucose utilisation 
being measured in lesioned animals (Fig, 32). Simi­
larly, the increased functional activity of the ventro­
medial thalamus associated with apomorphine treatment 
was significantly reduced (again by about half) in the 
presence of striatal lesions (Fig. 32), In marked
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contrast to these attenuating effects of the lesions 
upon responsiveness to apomorphine in the ventrolat­
eral thalamus, which alone displayed any significant 
alteration in glucose use following removal of striatal 
perikarya, the differential between the sham and les­
ioned groups (13%) was maintained following apomorphine 
(15^), although the greater degree of variability 
associated with the two treatments together rendered 
the difference no longer statistically significant 
(Fig. 32).
In these diencephalic regions contralateral to 
the striatal lesions, only within the ventromedial 
thalamus was any significant change in glucose use 
observed ( A+ 20^) (Fig. 33). Although the ventro­
lateral thalamic complex displayed an increase in 
glucose use of a magnitude (ll^) similar to that 
observed ipsilaterally (13^), the contralateral effects 
did not achieve statistical significance (Fig. 33).
Following systemic administration of muscimol, no 
significant difference was observed in the response 
between sham and lesioned animals in either the contra­
lateral subthalamic nucleus (A - 10^) or the ventro­
lateral thalamus ( A- 30^) (Fig. 33). However, 
muscimol not only attenuated the kainic acid lesion- 
induced increases in the rate of glucose use in the 
ventromedial thalanus ( A -  'ô2Pjo) but, as was the case 
ipsiiateral to the lesioned striatum, functional activ­
ity was reduced to a level significantly less than that 
of sham-lesioned animals following muscimol treatment
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(Pig. 33).
A similar consistency of response between sham 
and lesioned groups was found in contralateral sub­
thalamic nucleus and ventrolateral thalamus where, as 
in the ipsiiateral hemisphere, large increases in 
functional activity resulted from apomorphine adminis­
tration. Whilst glucose utilisation in the ventro­
medial thalamus of sham-operated animals was signifi­
cantly increased by apomorphine ( A + ^5^), a minimal 
( A +  lio) , non-significant increasewas found above that 
following lesion alone. The responsiveness of the 
ventromedial thalamus to apomorphine thus appears to 
be limited by contralateral striatal lesions.
Within the elements of the limbic system, which 
possess direct afferent or efferent neuronal coimeét­
ions with the extrapyramidal system, the nucleus 
accumbens (NAc), ventral tegmental area (VTA) and 
lateral habenula (LH), significant ipsiiateral increas­
es in glucose utilisation were measured following 
striatal lesions (Pig. 34). The changes ranged from 
+15% in NAc to +23% in VTA and LH where the associated 
increase in tracer accumulation was clearly discernible 
from the autoradiograms (Pig. 35).
No significant response to muscimol treatment was 
observed in these limbic areas of sham-lesioned animals. 
However, the ipsiiateral lesion-induced increases in 
glucose use were attenuated to levels equivalent to or, 
in NAc, significantly less than in the sham group (Pig. 
34), revealing a sensitivity to the G ABA agonist not in
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Figure 35
Autoradiograms from coronal sections of rat brain at 
the level of the lateral habenula.
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Cresyl Violet
Sham K-A Lesion
Upper; Cresyl violet stained section showing medial 
(mh) and bilateral (ih) habenula.
Lower left: Autoradiogram of the lateral habenular
nuclei in a sham striatal lesioned rat. Symmetrical 
OD in both nuclei (see Figs. 34 and 36).
Lower right; Autoradiogram of the lateral habenular 
nuclei in a rat with unilateral striatal lesion. A 
marked increase in OD in ipsiiateral habenula (l.h.s.) 
results in an asymmetrical pattern (see Figs. 34 and 
36).
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evidence in intact animals.
Only in LH was any significant alteration in glucose 
utilisation in response to apomorphine treatment observed 
ipsilaterally (Fig. 34). A large (30%) reduction in 
functional activity was measured in this region of sham- 
lesioned animals. A similar magnitude (-27%) of change 
was also found in response to apomorphine in lesioned 
animals, but this was sufficient to reduce glucose util­
isation to levels significantly higher than in sham, 
drug-treated animals, and which were equivalent to those 
observed in saline-treated, sham-lesioned animals.
The altered glucose utilisation in evidence ipsi­
laterally was paralleled in magnitude by significant 
contralateral changes in NCa and VTA, but not LH (Fig. 
36). The responses to pharmacological challenge were 
also similar to those measured on the ipsiiateral side, 
with attenuation of lesion-induced increases by muscimol 
and no significant response to apomorphine in either NAc 
or VTAo However, the contralateral LH displayed an 
equal degree of responsiveness to apomorphine in both 
sham (-30%) and lesioned (-29%) animals in contrast to 
the significant difference found in the ipsiiateral 
structure,
Alterations in glucose use following kainic acid- 
induced striatal lesions were also observed in some 
other brain regions, most notably the red nuclei where 
bilateral, l6% increases were measured. These results, 
as well as those from other brain areas, are shown in 
Appendix V.
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3.4 Commentary
3 .4.1 Kainic a d d  in conjunction with 2-DG autoradio­
graphy ; The development of the 2-deoxyglucose tech­
nique to map function-related glucose use (Sokoloff,
1977) and the ihtroduction of kainic acid to effect 
selective lesions of neuronal perikarya (Coyle et al.
1978) represent two major advances for neuroscience 
research in the recent past. The stereotactic inject­
ion of kainic acid, a neurotoxic analogue of glutamate, 
results in selective destruction of nerve cell bodies 
within the injected region, whilst afferents and fibres 
of passage are left largely intact (Coyle et al. 1978). 
Although the selectivity of action of kainic acid con­
stitutes a major advantage over "other lesioning tech­
niques, such as electrolytic lesioning, the frequency 
with which structural damage occurs in areas outwith 
the injection site (Coyle et al. 1978; Schwob et al. 
1980) emphasises the need for careful histological 
monitoring whenever this method is employed.
The combination of the two experimental approaches, 
whether with systemic (Collins et al. 1980) or intra­
cerebral administration of kainic acid (Kimura et al. 
I98O; Wooten and Collins, I980), results in visually 
spectacular alterations in the appearance of the auto­
radiographic pattern of deoxyglucose uptake. However, 
meaningful interpretation of these observations can 
present considerable difficulties. Strong doubt exists 
as to whether deoxyglucose accumulation in damaged CNS
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tissue truly represents the rate of glucose phosphoryl­
ation, particularly in view of the large, dynamic 
alterations in the value of the "lumped constant" (a 
crucial determinant of deoxyglucose uptake) which have 
been reported to occur in damaged tissue (Ginsberg and 
Reivich, 1979). It is tempting to conclude from the 
present study that the measured reduction (l8%) of 
glucose utilisation in the striatum into which kainic 
acid was injected 10 days previously represents a loss 
of contribution from interneurons and efferent peri­
karya to the overall energy consumption of the striatum. 
However, it is doubtful whether the measured rate of 
glucose phosphorylation is at all accurate. Even if 
the measurement was correct, it is unlikely that the 
rate of glucose utilisation in damaged tissue would 
bear a direct relationship to energy production, as it 
does in intact CNS tissue,’ in view of the accumulation 
of lactate which almost invariably occurs in damaged 
tissue (Folbegrova et al, 1974),
In a recent report (Wooten and Collins, I98O) 
widespread, pronounced alterations in deoxyglucose 
uptake were reported in the acute and sub-acute period 
following intrastriatal injections of kainic acid. 
However, widespread neuronal necrosis and glial react­
ion paralleled the disordered uptake of deoxyglucose. 
Although others have reported neuropathological changes 
in distant regions following intrastriatal application 
of kainic acid (Coyle et al. 1978 ; Schwob et al. I98O ; 
Zaczek et al. I98O), they have rarely been as extensive
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as those reported in that previous study with 2-deoxy- 
glucose,where damage involved hippocampus, nucleus 
accumbens, globus pallidus, amygdala, frontal and 
entorhinal cortices, etc. In view of the widespread 
occurrence of structural damage, interpretation of the 
measured deoxyglucose uptake in terms of glucose util­
isation is fraught with difficulties. In the present 
studies, discrete lesions restricted to the caudate 
nucleus resulted from intrastriatal injections of 
kainic acid. Damage was absent from adjacent areas 
such as the septal nucleus, globus pallidus and nucleus 
accumbens. Within a discrete region of the ipsilat- 
eral hippocampus, the dorsal aspect of terminal field 
CA3 j a limited degree of structural damage was evident 
in three of the six lesioned animals. As with the 
caudate nucleus where damage was present, it is un­
certain whether the measured alteration in deoxyglucose 
uptake accurately reflects altered glucose utilisation. 
The limited extent of damage to the hippocampus and 
the consistency in the pattern of altered glucose use 
in the extrapyramidal system, irrespective of the 
presence or absence of hippocampal damage (half of the 
experimental group in each category), allow a greater 
credibility to be attached to the measured changes in 
glucose use found in these animals. However, the 
marked differences which have been reported previously 
in the distribution of neuropathological alterations 
following intrastriatal injections of kainic acid 
emphasise the necessity for careful histological
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verification, of the extent of the lesion and. involvement 
of areas outwith the injection site. Differences in 
the extent of the lesion produced are likely to result 
from technical considerations such as the volume and 
rate of injection, dose, period during which the needle 
remains in situ, and the choice of anaesthesia. How­
ever, unexpected variables - impurities in the kainic 
acid itself, for example - may also contribute to the 
degree of resultant damage.
A major difference between the present study and 
previous investigations into the consequences of local 
kainic acid injection upon glucose use and neuronal 
damage lies in the minimal, unilateral changes observed 
in this series, and the marked bilateral increase in 
deoxyglucose uptake observed formerly in the hippo­
campus. In one additional animal the kainic acid 
injection was aimed at the. septal nucleus, which result­
ed in a discrete area of damage with minimal involvement 
of either the contralateral septum or the ipsiiateral 
striatum. In this animal, 10 days later, the bilat­
eral pattern of increased deoxyglucose uptake and 
structural damage observed in hippocampus was similar 
to those changes reported previously following putat- 
ively local intrastriatal injections of kainic acid.
Two additional features should be emphasised in 
relation to the investigation of glucose utilisation 
using stereotactic lesions within the extrapyramidal 
system. Whilst glucose utilisation constitutes, 
almost exclusively, the energy generating pathway in
cerebral tissues of well-nourished animals, kainic 
acid lesions of the striatum disrupt feeding behaviour 
(Sanberg and Fibiger, 1979)» resulting probably in 
substrates other than glucose being used to meet the 
functional demands of brain cells (Hawkins et al. 197l)• 
The aphagia and the metabolic demands of increased 
motor activity, both associated with intrastriatal 
kainic acid injections (Sanberg and Fibiger, 1979), 
resulted in severe weight loss and hypoglycaemia for 
up to seven days afterward. Functional activity 
reflects meaningfully upon glucose utilisation only 
when normal feeding has returned an.d normal glycaemic 
conditions prevail, generally about 9-10 days after 
the striatal lesion. In addition to the nutritional 
problems following kainic acid, the sham intervention 
(i.e., the injection of mock cerebrospinal fluid into 
the striatum) was associated with subtle functional 
alterations in the CNS, and consequently altered glu­
cose utilisation. Glucose use was reduced in all 
primary auditory areas of the CNS (inferior colliculus, 
medial geniculate body, auditory cortex, etc.), possib­
ly as a direct result of mechanical damage during 
placement of the ear bars for stereotactic surgery. 
Moreover, small (10-15%) reductions in glucose use in 
sham animals were observed in regions of the CNS not 
primarily concerned with processing auditory inform­
ation (e.g., mediodorsal thalamus, subthalamic nucleus 
and hippocampus) when compared with unoperated animals 
used in this laboratory. Irrespective of whether this
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subtle depression in local cerebral glucose utilisat­
ion is a consequence of the neurosurgical intervention 
(craniotomy, needle tract damage, etc.), or to the 
extensive connections auditory areas have vith non­
audit ory regions in the CNS, they emphasise the 
importance of performing rigorous control experiments, 
particularly when an investigative tool as powerful as 
2-deoxyglucose autoradiographic mapping is employed,
3.4.2 Alterations in functional activity following 
striatal lesions; Both the afferent and efferent 
connections of the caudate nucleus have been charac­
terised in some considerable detail. In the rat,
the caudate nucleus receives fibres from the cerebral 
cortex, the posterior thalamus, 'the raphe nucleus and 
pars compacta of the substantia nigra (Kemp and Powell, 
1971; Beckstead et al. 1979; van der Kooy, 1979 ; 
Veening et al. I98O). In contrast, the efferent
fibres have a restricted distribution projecting to 
only two ipsiiateral areas, the pallidal complex (both 
globus pallidus and entopeduncular nucleus) and pars 
reticulata of the substantia nigra (Kemp and Powell, 
1971; Fonnum et al, 1978 ; Nagy et al, 1978 ; Nauta 
and homesick, 1979; Veening et al, I980). In the 
present study, marked increases in glucose utilisation 
were observed in these two areas 10 days after the 
selective destruction of striatal efferents with 
kainic acid. Striatal efferents appear to exert an 
inhibitory influence upon pallidal and nigral neurons 
(Feltz, 197I; Crossman et al, 1973) and, therefore.
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the increased glucose use in these two areas is con­
sistent with the effective removal of an inhibitory 
influence upon metabolic activity within these regions.
Previous observations in a limited qualitative 
investigation failed to reveal any increases seven 
days after striatal lesions with kainic acid; indeed, 
the tendency was toward decreases in glucose use 
(Wooten and Collins, I98O). The reasons for this 
obvious dichotomy are difficult to ascertain, other 
than as a result of the difficulties associated with 
the use of kainic acid and deoxyglucose in conjunct­
ion, and the necessity for appropriate controls (see 
previous discussion), However, a recent preliminary 
report, using a qualitative approach to deoxyglucose 
autoradiography (Kimura et al, I980), demonstrated 
relative increases in deoxyglucose uptake in the 
pallidus ajid substantia nigra at approximately the 
same time after striatal kainic acid injection.
The limited studies in which leucine incorporat­
ion into protein was monitored suggest that the 
increased glucose utilisation observed in the ipsi­
iateral pallidus and substantia nigra of lesioned 
animals may not be due exclusively to altered neuronal 
firing rates. The requirement for high energy phos­
phates, and the use which may be made of intermediate 
substrates from the glycolytic pathway in the increased 
synthesis of protein in these areas, could result in an 
increased demand for glucose in the absence of alterat­
ions in cell firing. The increased incorporation of
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labelled leucine, however, amounted to only 10% over 
that of the unlesioned side, whilst changes in glucose 
utilisation were of the order of 50%. As glucose is
unlikely to provide the major source of primary sub­
strates for amino acid synthesis, 0.3% of entire 
cerebral glucose flux under normal circum stair ces 
(Siesjo, 1978), and as only a portion of the high 
energy phosphates produced from glycolysis will be 
used in the production of protein, the demand for 
glucose made by this moderate increase in protein 
synthesis would constitute only a very small fraction 
of the large increases measured in glucose utilisation. 
However, the large decreases in leucine incorporation 
evident in the lesioned caudate nucleus (around 30%) 
add further to the necessity for circumspection in 
the interpretation of altered glucose utilisation in 
this area.
The considerable derangements in measured glucose 
utilisation at the sites of primary striatal efferent 
termination are persistent, a qualitatively similar 
pattern remaining evident to visual inspection of the 
autoradiograms 30 days after the lesion. The con­
tribution to this dramatic and long-lasting response 
which may be attributable to the loss of substance P- 
(to substantia nigra; Kanazawa et al. 1977) and 
enkephalin- (to globus pallidus; Cuello and Paxinos,
1978) containing striatal efferents remains unclear.
It is not possible to speculate on the basis of the 
evidence presented here whether the effects of removal
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of inhibitory GABAergic influences would be potentiated 
if the excitatory substance P neurons (Pasik et al.
1979) were left intact. The action of enkephalin in 
the globus pallidus is complicated by its putative 
role as a modulator of GABA induced inliibition (Nicoll 
et al. 1980), although a direct post synaptic inlaibit- 
ory action has also been suggested (Nicoll et al. 1977). 
If the latter action was predominant in the globus 
pallidus, then some at least of the post-lesion activ­
ation could result from loss of inhibitory enkephalin 
innervation.
The large scale alterations in local rates of 
glucose use observed in the ipsiiateral pallidal com­
plex and SNR proved to be highly susceptible to 
pharmacological manipulation with the GABA agonist, 
muscimol. The dramatic attenuation of the lesion- 
induced increases in glucose utilisation within these 
areas, at a dose of muscimol which had only minimal 
effects in sham operated animals, adds further weight 
to the conclusion that the alterations in functional 
activity which follow removal of input from the 
striatum result, in the main, from the loss of GABA- 
ergic inhibitory influences, with the ensuing dis- 
inhibition of postsynaptic neurons increasing energy 
demand. The contrast between the limited effects of 
systemically administered muscimol upon functional 
activity in pallidus and nigra of sham lesioned 
animals (also animals subjected to no intracranial 
intervention as shown in a previous section), and the
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large reductions evident in lesioned animals, suggests 
that striatal GABAergic output fibres are near maxi­
mally activated in the intact ajiimal. Only when 
competing endogenous GABAergic influences have been 
largely removed from the pallidal complex aJid SNR, is 
the full potential of muscimol in directly reducing 
functional activity revealed. In view of the data 
presented in a previous section it must, however, be 
stressed that, following intravenous administration 
of muscimol, the effects observed in these areas may 
be a secondary expression of a primary action else­
where .
The effects of dopaminergic manipulaiion upon 
functional activity within the striato-nigral system 
have been reported in extensive detail (McCulloch et 
al, 1982c, d), aiTd the results observed in sham lesion­
ed animals (with the exception of the new finding in 
EP) were in close agreement with these previously 
published observations. However, the combination of 
striatal lesioning with subsequent apomorphine pharma­
cological challenge revealed a complex interaction 
of the drug with striatal efferent systems. The two 
factors combine to make interpretation of the results 
difficult. Firstly, whilst the effects of striatal 
lesions and muscimol treatment are opposite in direct­
ion, making analysis somewhat easier, both the lesion 
and apomorphine alone effect increases of a similar 
magnitude in the ipsiiateral sites of striatal pro­
jection. Secondly, the teclmique does not allow the
basal levels of functional activation elicited by 
striatal lesions to be determined for each animal 
before the effects of apomorphine are superimposed.
The variance of the two treatmeats cannot, tlierefore, 
be reduced by experimental design. Multiple compar­
isons between lesion and apomorphine treatment alone, 
and in combination, go some w^ ay to alleviating these 
problems.
Of the ipsiiateral areas receiving direct striatal 
input, only in the GP was no significant difference 
found between the response to selective striatal lesion 
and apomorphine in combination, and either treatment 
alone. The quantitatively similar functional respon­
ses measured in GP under all three conditions are 
indicative of a mode of action common to both striatal 
lesion and apomorphine in influencing activation of GP. 
These results are suggestive of dopaminergic inhibit­
ion of GP afferent neurons from the striatum. Thus, 
removal of inhibitory striatal efferents to GP (by 
kainic acid lesioning) or the dopaminergic inhibition 
of inhibitory striatal efferents to GP (by apomorphine 
administration) both produce the same end result, i.e., 
disinhibition of pallidal neurons.
In both EP and SNR areas ipsiiateral to the les­
ioned striatum, the combined effects with apomorphine 
administration were significantly greater than with 
lesion treatment alone. The integrity of striatal
input to these areas does not, therefore, appear 
necessary for expression of at least part of the
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responsiveness to apomorphine as measured by increased 
glucose use. However, in EP the increased functional 
activity observed in sham operated animals following 
apomorphine was significantly attenuated in the les­
ioned group, whilst in marked contrast the combined 
effects of lesion and pharmacological challenge in 
SNR resulted in a significant potentiation of the apo­
morphine response. In the intact animal the presence 
of striatal efferent, mainly GABAergic, neurons appears 
to increase the responsiveness to dopaminergic manipu­
lation in EP, but to decrease the responsiveness of 
SNR, The exact mechanism of this dopamine - GABAergic 
interaction caimot be explained as readily, as could 
the response in GP, purely in terms of events within 
the striatum itself, A further complication is the 
proposed excitatory influence exerted over both EP and 
SNR projections by dopamine activation of striatal 
efferents (Scheel-Kruger et al, I98O). A direct act­
ion. of apomorphine within the striatum should therefore 
attenuate the response in the projection areas in 
intact animals by virtue of increased GABAergic inhib­
itory activity. Wiiilst there is evidence in the data 
presented here for this being the mechanism which in 
SNR produces a potentiation of the apomorphine response 
when striatal efferent influences were removed, the 
underlying mechanism responsible for the opposite, 
attenuative response to striatal lesions in EP remains 
unresolved.
Unlike the increased glucose utilisation measured
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in the ipsilateral pallidal complex and pars reticulata 
following striatal lesions, the neuroanatomical basis 
for the subtle, significant alterations in glucose 
utilisation in specific areas of the hemisphere contra­
lateral to the lesion site is more difficult to ident­
ify, although there exists considerable biochemical 
evidence suggestive of a functional interplay between 
the two striato-nigral systems (Nieoullon et al, 1977 
and 1979; heviel et al, 1979; Andersson et al, I98O), 
Behavioural observations on the re-establishment of 
symmetrical motor activity, after the compulsive turn­
ing behaviour displayed acutely following striatal 
lesions (Coyle et al. 1979), suggest adaptive compen­
satory changes within the contralateral nigrostriatal 
system. In this context, the increased glucose util­
isation in the contralateral pars compacta of the 
substantia nigra is of considerable interest in view 
of the compensatory contralateral alterations in dop­
aminergic systems following chronic, unilateral, 
kainic acid-induced striatal lesions (Andersson et al. 
1980). Moreover, the observation of bilateral ele­
vations in the pars reticulata of the substantia 
nigra, a region implicated in the regulation of activ­
ity within the pars compacta, highlights further the 
extent of the functional adjustment in the two nigro­
striatal systems following a unilateral striatal 
lesion,
The bilateral attenuation of lesion-induced 
increases in glucose utilisation following muscimol
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treatment emphasises the degree of functional inter­
action between the two hemispheres, as well as the 
part played by GABAergic influences in the maintenance 
of symmetry. In contrast, the subtle side-to-side 
differences in response to apomorphine, particularly 
in SNR, are indicative of the importance of the inter­
play between GABA and dopamine systems in the intact 
striato-nigral activity.
Although some evidence for a direct neuronal path­
way linking the nigrostriatal systems has recently been . 
published (Fass and Butcher, I98I; Gerfen et al. I982), 
it is probable that the paucity of these connections 
reflects their limited functional importance in main­
taining symmetry of action. A number of more complex 
neuroanatomical connections have been described which 
could provide the necessary circuitry to link the two 
systems (Kemp and Powell, 1971; Nauta and Domesick,
1979). From a knowledge of the known anatomical 
connections, the ventral nuclear complex of the thal­
amus and lateral habenular nucleus of the epithalamus 
constitute two important relays in the conveyance of 
information from one nigrostriatal system to the other. 
The ventral thalamus, which has extensive reciprocal 
connections with the neocortex (Deschenes and Hammond,
1980), receives input from EP (to ventrolateral nuc­
leus) (Nauta, 1979) and from SNR (to ventromedial 
nucleus) (D1 Chiara et al. 1979). The callosal 
connections of the neocortex and its extensive effer­
ent projections (Glowinski et al. 1978) could provide
the final pathway via which functional processes in 
the two nigrostriatal systems could become integrated. 
The results of this study in which glucose use was 
elevated in the contralateral neocortex and ventro­
medial thalamus, and in the ventrolateral thalamus, 
provide some circumstajitial evidence for the involve­
ment of the thalanio-cortical route. Moreover,
increased functional activity in the contralateral 
parafascicular-centrum medianum complex, which is 
innervated by collaterals from the pallido-thalamic 
pathway, may also act directly upon striatal function 
(Nauta and Domesick, 1979) or again via neocortical 
projections (llerkenham, I98O).
An alternative pathway allowing interhemispheric 
exchange of information betweeai nigrostriatal systems 
could involve the lateral habenula in the role of 
intermediate relay nucleus, projecting bilaterally to 
SNC and receiving a major projection from the pallidal 
complex (Herkenham and Nauta, 1977 and 1979). Support 
for the possible involvement of this pathway is gained 
from the observation of increased glucose utilisation 
in the ipsilateral portion of the habenula in kainic 
acid injected rats. In view of the relative insensit­
ivity of this area to systemic muscimol treatment in 
the intact rat (described previously), despite the 
known GABAergic innervation which it receives from EP 
(Nagy et al. 1978), it is of interest that lesion- 
induced increases in functional activation could be 
attenuated by muscimol. Irrespective of which
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anatomical connections ultimately prove to be involved, 
the patterns of alteration in glucose utilisation, 
particularly within the contralateral hemisphere, 
emphasise the widespread extent of the functional 
changes which are present when the animal has adapted 
to the unilateral loss of a major portion of its 
striatal efferent fibres.
The most bilaterally consistent alterations of 
functional activity in lesioned rats were found within 
the mesolimbic system. Whilst striato-nigral activ­
ity is thought to maintain overall symmetry in motor 
behaviour, it is the mesolimbic system which promotes 
locomotion (Pycock and Marsden, 1978). The reciprocal 
neuronal connections which have been sho-wn to exist 
between elements of these two systems (Beckstead et 
al. 1979; Nauta and Domesick, 1979) may provide the 
anatomical basis for circling behaviour in response 
to specific extrapyramidal lesions (Pycock and Marsden,
1978), Although at ten days after the induction of 
striatal lesions asymmetry of functional activity in 
the striato-nigral pathways was still apparent, the 
symmetrically.increased mesolimbic activation could 
possibly explain why this residual side-to-side 
difference was no longer expressed in compulsive 
circling. Once again, the lateral habenula may be 
involved in integrating information from striatal and 
limbic forebrain areas (Herkenham and Nauta, 1977 and 
1979; Wang and Aghajanian, 1977) and, together with 
its connections with VTA, may provide the route through
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which the nucleus accumbens is functionally affected in 
response to unilateral lesioning of striatal efferents.
The unilateral loss of striatal post-synaptic dop­
amine receptors with any functional role could possibly 
raise an a priori expectation of asymmetrical motor 
activity following apomorphine treatment. The fact 
that no such asymmetry was observed may be due to the 
lack of expertise in behavioural monitoring, or to 
artefact in the restrained animal. However, the 
symmetry of functional activity maintained in the meso­
limbic system, and also in the globus pallidus which 
has been implicated in circling behaviour (Slater, 
1982), suggests that the behavioural observations are 
at least consistent with the measured cerebral funct­
ional activity. Elsewhere in the brain, the actions 
of apomorphine in lesioned animals proved to be very 
complex. The response to lesion alone could, in the 
main, be rationalised in terms of known anatomical 
connections. Subsequent challenge with muscimol, in 
attenuating lesion-induced increases in functional 
activity, provides support for the conclusion that the 
responses were due largely to loss of an endogenous 
GABA system. The effects of apomorphine in the 
absence of striatal efferent neurons reveals a complex­
ity of interaction between G ABA and dopamine which has 
hitherto not been appreciated in the description of 
dopamine agonist effects (McGulloch et al. 1982b ).
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4. Intrastriatal Injection of Muscimol
4.1 General results and observations: No changes in
overt behaviour were observed following unilateral intra­
striatal injections of 100 ng of muscimol. Following 
injections of 500 ng of muscimol, intermittent jaw move­
ments were evident at random intervals throughout the 
period of measurement. The movements involved gaping, 
licking, .and grinding of the teeth in no co-ordinated 
order. The animals showed no apparent stress, plasma 
glucose remaining stable at levels comparable with 
restrained animals with no intracranial intervention.
On sectioning of the brains for autoradiography, 
the spread of Evans blue was noted. Without except­
ion, the inert dye was visibly evident only within the 
limits of the caudate nucleus. No marker was ever to 
be seen in the needle tract through overlying neocortex 
or subcortical white matter. Within the striatum the 
maximum spread of dye visible extended to a diameter of 
1,8 mm from the epicentre of the injection as located 
by the needle tract. The injection needle fell within 
the dorsomedial quadrant of the caudate in all animals.
4.2 Local cerebral glucose utilisation; All animals 
subjected to intrastriatal intervention displayed a 
disordered pattern of 2-deoxyglucose uptake associated 
with the needle tract and injection site (Fig. 37).
The tract itself appeared on the autoradiographs as a 
column of decreased optical density, penetrating 
through sensory-motor cortex and into the body of the
Figure 37
Autoradiograms from coronal sections of rat brain at 
the level of the caudate nucleus.
I n t r a s t r i a t a l  C S F
I n t r a s t r i a t a l  M u s c i m o l
Upper ; Punctate areas of increased optical density 
associated with the needle trace in cortex and caudate 
nucleus (l.h.s.). Note generalised reductions in OD 
in hemisphere subjected to intracranial intervention.
Lower : Decreased optical density in the caudate nucleus
associated with intrastriatal injection of muscimol 
(500 n g ) .
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striatum. At the end of the tract, but also sometimes 
at discrete points along its length, small, punctate 
areas of increased optical density were observed.
These areas were observed only in association with the 
tract, never at any distance from the injection site, 
and the frequency with which they corresponded to 
visible sites of localised haemorrhage make it highly 
likely that this autoradiographic pattern was due to 
structural damage caused by the insertion of the needle. 
In both CSF and muscimol injected animals a generalised 
depression in glucose utilisation was evident ipsilat­
eral to the site of intervention, which resulted in a 
degree of asymmetry between the hemispheres. These 
non-specific effects were most marked in neocortex and 
thalamus.
Significant alterations in local cerebral glucose 
use were limited to a very few regions following intra­
striatal injection of 100 ng of muscimol. Within the 
ipsilateral caudate nucleus itself, glucose use was 
decreased by around l4^ in an area extending approxim­
ately 1.2 mm from the injection site to either side 
in the rostro-caudal axis. In areas of the nucleus 
removed from the injection site, no changes in glucose 
use'were observed (Fig, 38). Contralateral to the
injection, alterations in the rate of glucose use were 
only measured in an area roughly corresponding to the 
area of decrease found ipsilaterally. On this side, 
however, the smaller 8^ decrease was not significant.
Although small in absolute magnitude, significant
Figure 38
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Figure 39
Autoradiograms from coronal sections of rat brain 
taken at different levels following intrastriatal 
injection of muscimol (500 ng).
Globus Pallidus Entopeduncular N.
SNC SNR
Upper l^ft; Increased OD in globus pallidus ipsilateral 
to injection site (l.h.s.).
Upper right; Increased OD in entopeduncular nucleus, and 
decreased OD in ventrolateral thalamus ipsilateral to 
injection site (l.h.s.).
Lower left: Increased OD in substantia nigra pars
compacta ipsilateral to injection site (l.h.s.).
Lower riglit; Increased OD in lateral portion of pars 
reticulata ipsilateral to injection site (l.h.s.).
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20^ increases in glucose use were measured in ipsi­
lateral entopeduncular nucleus, the only primary 
striatal projection area to show any response at this 
dose. In no other area, either ipsilateral or contra­
lateral to the injection site, were any significant 
changes in glucose utilisation observed following 
striatal injections of 100 ng of muscimol. In view 
of the entopeduncular changes in glucose use, it is 
interesting that in the ipsilateral lateral habenula 
a moderate, 10^ increase in glucose use just failed 
to reach the critical value for significance in the 
statistical analysis.
Following unilateral injection of 500 ng muscimol 
into the striatum, widespread alterations in functional 
activity were observed, some of which were apparent 
from visual inspection of the autoradiograms (Figs. 37 
and 39). Within the injected caudate nucleus large, 
33^ decreases in glucose use were observed at all 
levels of the nucleus (Fig. 38), in marked contrast 
to the effects of 100 ng muscimol which were much more 
localised around the injection site. Contralateral to 
the injection, mean glucose utilisation in the caudate 
nucleus was depressed by around 15?^ , but this did not 
achieve statistical significance.
In areas which receive the primary output of the 
striatum, both segments of the ipsilateral pallidal 
complex showed increased rates of glucose utilisation 
of around 30^ following muscimol (Figs, 39 and 4 o ) ,
The ipsilateral pars reticulata of the substantia
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nigra was particularly responsive to striatal muscimol 
at the higher dose, with a measurable difference between 
the rostral "(38^ increase) and caudal (46^ increase) 
parts of the region (Fig. 4q). Moreover, the area of 
increase was highly localised and did not include the 
whole of the SNR visible in some sections (Fig. 39)*
In motor areas of the brain sending projections to 
the striatum, a 20^ increase in glucose utilisation was 
measured in the pars compacta of the substantia nigra 
(Figs, 39 and 4l). From the autoradiograms it appeared 
that the changes were most pronounced in the more rostral 
parts of the SNC, but this impression was not sustained 
by the quantification. It is likely that the lesser 
response in SNR in its rostral parts provided greater 
contrast, allowing better visual discrimination than 
was possible in the caudal parts. The considerable 
42^ reductions in glucose use in sensory-motor cortex, 
measured at sites removed from the physical damage 
associated with the needle tract (Fig. 4l), were 
suggestive of possible direct action of the GABA agon­
ist by leakage back up the needle tract. However, in 
one preliminary animal in which the guide cannula had 
been misaligned, and in which excess volume (4 pi) had 
been injected into neocortex such that leakage had 
occurred to cover a portion of the cortical surface, 
the same degree of reduced glucose use was not in 
evidence. In particular, cortical layer IV was still 
clearly discernible on the autoradiograms, but was 
definitely not apparent when the injection was limited
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to the striatum alone (Fig. 37)• Only minor, non­
significant changes were measured in the parafascicular 
nucleus of the thalamus (Fig. 4l) which sends project­
ions to the striatum.
In areas of the diencephalon linked by efferent 
fibres to the pallidal complex, decreases in glucose 
use of 18^ in subthalamic nucleus and kofo in ventro­
lateral thalamus were measured (Figs. 39 and 42).
In contrast, the ventromedial nucleus of the thalamus, 
which is connected by afferent neurons with the sub­
stantia nigra, showed only non-significant decreases 
in functional activity (Fig. 42). Of the contra­
lateral areas examined at 500 ng muscimol, throughout 
the brains only the ventrolateral thalamic nucleus 
displayed any significant alterations in glucose util­
isation. However, the 17^ decrease measured was less 
than half the response found in the corresponding ipsi­
lateral nucleus.
Of the limbic areas closely associated with extra- 
pyramidal function, no significant changes in funct­
ional activity were measured in the nucleus accumbens, 
but a small decrease was found in the ventral tegmental 
area following unilateral injection of muscimol into 
the caudate nucleus (Fig. 43). A moderate, though 
significant, l6^ increase in glucose use was found in 
the lateral habenula (Fig. 43). This unilateral 
response was again easily discernible from a visual 
inspection of the autoradiogram (Fig. 44),
The only other alteration in glucose use resulting
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Figure 44
Autoradiograms from coronal sections of rat brain at 
the level of the habenula.
I n t r a s t r i a t a l  C S F
'•
X:
I n t r a s t r i a t a l  M u s c i m o l
Upper; Similar OD in lateral habenula ipsi- and 
contralateral to intrastriatal injection of CSF 
giving symmetrical appearance.
Lower; Higher OD in lateral habenula ipsilateral to 
intrastriatal injection of muscimol (500 ng) giving 
asymmetrical appearance.
ofrom striatal injection of muscimol was found in the 
deep layers of the superior colliculus, where a uni­
lateral decrease of 18^ was evident ipsilaterally.
These results, and all those from other brain areas 
analysed, are presented in Appendix VI,
4,3 Commentary; Several putative neurotransmitters 
have been identified within the neostriatum of adult 
rats (Fonnum and Walaas, 1979)» but the inhibitory 
neurotransmitter, GABA, participates at two levels 
in the functional operation of the striatum. Bio­
chemical and morphological studies (McGeer and McGeer, 
1975; Hassler et al. 1977; Ribalc et al. 1979) have 
indicated the existence of GABAergic nerve terminals 
of both intrinsic striatal neurons and collateral 
fibres from neostriatal projection neurons to globus 
pallidus and substantia nigra (Ribak et al. 1979).
Thus, GABA neurons may both control neuronal excit­
ability within the caudate nucleus (Norcross and 
Spehlman, 198l) and carry messages initiated in the 
striatum to exert inhibitory influences at distant 
terminal sites.
The majority of neostriatal neurons are of the 
same morphological type, characterised by their medium 
size and high density of dendritic spines (Kemp and 
Powell, 1977). Previously, neuronal cell bodies of 
this type were considered to be local striatal circuit 
neurons (Kemp and Powell, 197l)» but subsequent refine­
ments in fibre tracing techniques indicated that these 
neurons are the origin of the bulk of neostriatal
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efferents (Somogyi and Smith, 1979» Preston e t a l .
1980). Although the presence of striatal GABAergic: 
aspinous interneurons has been confirmed, it now 
appears likely that much of the GABA release within 
the caudate is from terminals of an extensive network 
of axon collaterals (Wilson, 1979; Preston et al.
1980) projecting to a radius of 250 pm from the soma. 
The dense packing of medium spiney neurons suggests 
that cells brought into contact with collaterals will 
also be of the same morphological cell type. The 
resulting interaction of collaterals and dendrites may 
result in recurrent inhibition mediated by terminal 
GABA release, a possibility which has gained experi­
mental support (Park et al. I98O). However, whether 
the effects of GABA in reducing caudate cell firing 
(Norcross and Spehlman, I98I) are due to the action 
of the transmitter at interneuron terminals or collat­
eral terminals, the effect upon activity in striatal 
efferent neurons would be essentially similar.
The decreased rate of glucose utilisation observed 
in the caudate nucleus following intrastriatal inject­
ions of muscimol are compatible with the electro- 
physiologically measured depression of neuronal firing 
reported in response to GABA itself (Norcross and 
Spehlman, I98I; Misgeld et al. I982). The direct 
application of muscimol into the brain does not suffer 
from the same potential limitation as does peripheral 
administration of this GABA agonist, in that meta­
bolic breakdown of the drug is very much less
V V
pronounced within the brain than is the case in the
periphery (Baraldi et al. 1979) and, therefore,
complicating effects of possibly active products of
metabolism do not arise. Indeed, the pharmacology
of muscimol, the avidity with which it binds to GABA
glutamate
receptors and its resistance to GABAiy^transaminase, maltes 
it a more suitable pharmacological tool than GABA 
itself for injection into the striatum.
The area of decrease in striatal functional act­
ivity following injection of 2 p i  containing 100 ng 
muscimol was highly localised, spreading no further 
than could be predicted on the basis of diffusion of 
this volume through brain tissue (Myers, I966). 
Assuming a simplistic uniform distribution throughout 
the volume of diffusion, the effective concentration
-4of muscimol would be 10 M over the first 10 to 15 
minutes of the deoxyglucose experiment. The major­
ity of the caudate, rostral and caudal to the centre 
of the injection, showed no change in glucose use 
following muscimol, and within the area of moderate 
metabolic depression glucose use was uniform. In 
marked contrast, the effects of injecting 5OO ng of 
muscimol were both more marked and more widespread, 
despite the similar degree of spread noted in the 
diffusion of Evans blue dye. It is fair to assume 
that even if muscimol were to diffuse at a faster 
rate and over greater distances than the marker dye, 
it is unlikely that the whole rostro-caudal extent 
of the caudate covering some 5 mm would contain
Z u i
sufficient agent to effect these changes. It is poss­
ible that this higher dose of muscimol is present in 
sufficient quantities over the diffusion area to prod­
uce inhibition of caudate neurons far removed from the 
injectate through the interconnections of interneurons 
and collateral fibres. The uniformity of the reduct­
ions in functional activity suggests that the responses 
observed close to the injection site, and at a distance, 
are similar in the underlying mechanisms responsible, 
involving mainly GABAergic neuron systems.
Intrinsic striatal GABA neurons would appear to 
be capable of exerting their effects throughout the 
caudate nucleus, with no apparent topographical organ­
isation, This is in contrast to the heterogeneous 
distribution patterns of other neurotransmitters which 
form histochemically distinct compartments within a 
complex matrix (Goldman and Nauta, 1977; Graybiel and 
Ragsdale, 1978, 1981; Herkenham an.d Peart, I98I;
Wright and Arbuthnott, 198I ) . The intricate organis­
ation of patches has been suggested as reflecting the 
high degree of integration which is performed within 
the neostriatum, but to date there is no evidence that 
these histologically defined subunits of the caudate 
do indeed represent areas with discrete functional 
roles. Recently, however, We have provided evidence 
that the response within the caudate to local inject­
ions of the putative neurotransmitter/neuromodulator, 
VIP, in terms of alterations in functional activity, 
is organised in a punctate manner. The areas of
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increased glucose use observed corresponded closely in 
their dimensions to those described for histocheraical 
patches (Edvinsson et al. I982), No such intricate 
organisation of responses to muscimol was noted in any 
part of the striatum at either of the doses used.
Although an injection of 100 ng of muscimol into 
caudate had no measurable effects outwith the nucleus., 
the acute local injection of 5OO ng of muscimol into 
the caudate induced a response in striatal projection 
areas with marked similarities to the chronic pattern 
observed following kainic acid induced lesions of the 
caudate nucleus. Whilst the lesioning procedure 
removed striatal efferent, inhibitory effects in the 
pallidal complex and SNR, the injection of the GABA 
agonist effectively induced an inhibition of efferent 
inhibitory projection. In both cases the net result 
was an disinhibition of postsynaptic neurons at the 
terminal sites, which was manifest in an increase in 
functional activity.
Although the area of striatal involvement was 
very similar in both lesion and local injection stud­
ies, subtle differences were observed in the pattern of 
response in SNR. Following kainic acid lesions of the 
caudate, glucose utilisation was diffusely increased 
throughout the whole extent of SNR. In contrast, 
striatal muscimol injection resulted in an increased 
glucose use which was more marked caudally than in 
more rostral portions of the region, and was also more 
intense in the ventromedial parts. On this basis it
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would, appear that, although functional activity is 
reduced equally throughout the caudate nucleus by 500 
ng of muscimol, not all efferent neurons are equally 
affected. From the known topographical arrangement 
of striatal efferents to SNR (Tulloch et al. 1978;
Nauta and Domesick, 1979) it is apparent that the 
greatest effects of the muscimol were centred around 
the injection site, as it is from this mediodorsal 
area of the caudate that neurons originate which inner­
vate that part of SNR displaying the largest increases 
in functional activity. It is not an unreasonable 
suggestion that as the injectate diffuses away from 
the centre and becomes more dilute, then the effects 
of muscimol upon efferent fibres becomes less intense. 
Injections of 100 ng muscimol had no discernible effect 
upon striatal efferent activity, and dilution of the 
higher dose to these levels by diffusion would presum­
ably be similarly ineffective. Superimposed upon the 
direct effects of muscimol upon efferent neurons will 
be the effects mediated via intrinsic neurons dissemin­
ating the effects throughout striatum. No topograph­
ical organisation of response in either GP or EP was 
observed with respect to the positioning of the inject­
ion, in keeping with the generalised decrease in 
striatal function observed. The differences in degree 
of involvement in the pallidal complex response and 
that in SNR further reflects the complexity of inte­
gration of which the caudate nucleus is capable.
The functional response of the pars compacta of
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the substantia nigra to altered striatal activation is 
of particular interest in view of the controversy which 
continues to surround tl%e exact role of reciprocal 
striato-nigral innervation (Nauta and Domesick, 1979). 
Although a few striatal GABAergic efferent fibres do 
terminate in the pars compacta, the majority synapse 
within the pars reticulata (Fonnum et al. 1974; Ribak 
et al, 1976). Reciprocal innervation of the caudate 
originates in the pars compacta. These dopaminergic 
neurons form synapses with both intrinsic cholinergic 
and GABAergic neurons, as well as directly on to 
dendrites of striatal efferent neurons (Pasik et al. 
1979). Activation of striatal afferents originating 
from SNC induces post-synaptic excitatory potentials 
(Wilson et al. 1982), whilst stimulation of the caudate 
nucleus produces GABA mediated inhibition of nigral 
cells (Precht and Yoshida, 1971» Yoshida and Precht,
1971). This inhibition has been shown to affect 
nigral dopaminergic cells (Feltz, 1971; Crossman et 
al. 1973)» and on this basis an inli^ibitory feedback 
loop was postulated (Dray and Straughan, 197&). The 
functional interaction of GABAergic input to SNR with 
the dopaminergic outflow from SNC is, however, proving 
to be more complex than originally envisaged, A 
paradoxical increase in SNC cell activity has been 
measured behaviourally (Martin and Haubrich, 1978) and 
electrophysiologically (Grace and Bunney, 1979) In 
response to local injections of GABA or muscimol into 
SNR. This response has been explained by the proposed
presence of inhibitory neurons interposed between SNR 
and SNC (Grace and Bunney, 1979)» although these 
intrinsic neurons have not been characterised histo­
logically, In contrast, current evidence points to a 
monosynaptic link between GABAergic afferents and dend­
rites of dopamine neurons which penetrate the reticulata 
from cell bodies located in the pars compacta (Wassef 
et al, 1981), However, the interaction of GABAergic 
and dopaminergic neurons is further complicated by the 
dendritic release of dopamine in the SNR which can activ­
ate synaptic receptors coupled to a dopamine-sensitive 
adenyl cyclase. These receptors are localised on GABA 
(but not substance P) striato-nigral fibres (see Cheramy 
et al, 1981, for review).
The increase in glucose utilisation measured in 
SNC paralleled the changes observed in SNR following 
intrastriatal injection of muscimol. Thus it would 
appear that, in this conscious rat preparation, neuro­
chemical inhibition of neuronal projections from 
striatum to nigra allows an increase in functional 
activity in both parts of the nigra. These results 
therefore support the idea that, under normal condit­
ions in the intact animal, striatal efferents exert an 
inhibitory influence not only upon the SNR where the 
majority of fibres terminate, but also in SNC, possibly 
through direct synapses with dendrites of dopaminergic 
cells originating in the compacta. It should be 
stressed again that nigral activity would appear to be 
influenced to a high degree by anaesthetic agents
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(Grome and McCulloch, I981), so that the animal prepar­
ation used to study nigral function may influence the 
results and final conclusions arrived at. This is one 
factor which may be the underlying cause of so much 
contradictory experimental evidence on the interaction 
between SNR and SNC in extrapyramidal motor function. 
Although the changes in glucose use observed 
within the basal ganglia following intrastriatal musc­
imol represented increases in functional activity which 
may be subject to credible interpretation in terras of 
known GABAergic afferent innervation, the decreased 
glucose use in neocortex and thalamus must be inter­
preted with some caution. Both the generalised neo- 
cortical depression invariably observed with this 
preparation (compare the CSP injected animals in this 
study with similar results reported for both intra­
striatal and intracortical CSF reported previously) 
(Edvinsson et al, I982) and the possibility of direct 
effects of muscimol through leakage back up the needle 
tract, which cannot be totally discounted, are sources 
of artefact which together could add to, if not account 
for, the decreases in measured glucose use. The 
problem of cortical depression by intracranial inter­
vention may be alleviated in the experimental design 
by comparing ipsilateral sides in both CSF and muscimol 
injected animals. Attempts were made to prevent the 
leakage of injectate into overlying neocortex by con­
structing the guide cannula such that only the much 
thinner injection needle penetrated through cortex at
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the time of injection. After the injection the needle
was left in situ for the course of the whole measurement 
period to prevent the injectate being dragged back up 
the tract during withdrawl. However, due to the sens­
itivity of cortex to the action of G ABA agonists and 
antagonists, possibly only very small amounts of musc­
imol would be necessary to cause large scale decreases 
in functional activity. One might expect, however, 
that leakage into cortex would result in a much more 
focal response than that observed here. Using a sim­
ilar experimental protocol to examine the effects of 
leakage of picrotoxin from a striatal injection site 
into cortex, a very well defined behavioural syndrome 
was observed, and not the seizure activity which would 
accompany any wide diffusion of this potent GABA ant­
agonist (Edvinsson et al, I982), In contrast, the 
striatal injection of muscimol produced widespread 
reductions in functional activity in areas of sensory- 
motor cortex far removed from the injection site. It 
is possible, therefore, that a significant, but not 
necessarily greater part of the reductions in motor 
cortex, and areas of thalamus with which there are 
neuronal connections, was the result of functional 
changes in complex pathways originating from striatum, 
and was not due to direct cortical action alone.
Bearing in mind the limitations of the experi­
mental approach as outlined above, the changes in 
functional activity observed within the diencephalon 
following intrastriatal muscimol nevertheless provide
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an interesting insight into the interactive role of 
striatal output in the overall co-ordination of motor 
activity. GABAergic projections have been postulated 
from GP to the subthalamic nucleus (Ponnum et al.1978; 
Rouzaire-Bubois et al. 1980), from EP to the ventro­
lateral thalamic complex (Pennay and Young, I981), and 
from SNR to the ventromedial thalamus (Di Chiara et al.
1979), and these .pathways displayed a quantitative 
pattern of response which was common to all three.
The extrapyramidal source of diencephalic, afferents 
showed marked increases in functional activity (as 
described previously), whilst decreases were observed 
to a greater or lesser extent in the thalamic and sub­
thalamic nuclei. The most pronounced alterations in 
functional activity were observed in the ventrolateral 
thalamus (A - 46^), which could account for at least 
part of the profound changes in glucose utilisation 
measured in sensory-motor cortex to which this area 
of thalamus projects ( Nauta and Domesick, 1979).
The neuronal connections between GABAergic input to 
pallidus and nigra from striatum and the efferent 
neurons from these areas to thalamus and subthalamus 
have not yet been clearly established. If, however, 
a direct synaptic contact is made between these two 
GABAergic systems, then activation of striatal effer­
ents would result in disinhibition of the thalamic 
nuclei (Roberts, 197^). The net effect, therefore, 
would be to activate thalamic neurons. The results 
of the present studies do add support to this possible
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mode of interaction. Muscimol-induced inhibition of 
striatum resulted in increased functional activity 
within pallidus and nigra and also, apparently, in the 
projection neurons to thalamus where decreased funct­
ional activity was observed. This observation is in 
keeping with the occurrence of the two GABAergic systems 
in series through which activation of striatal efferents 
can disinhibit the thalamus.
A similar pattern of innervation has been suggested 
as providing a pathway between striatum and lateral 
habenula via pallidus (EP), again with two GABAergic 
projections in series (Nagy et al. 1978; Gottesfeld 
et al. 1980). It is therefore interesting to observe 
that, in these studies, an increase in EP activity was 
accompanied not by depression of glucose use in the 
lateral habenula but, instead, by a moderate, but sig­
nificant increase. On the basis of arguments advanced 
so far, it would appear unlikely that striatal inputs 
to pallidus synapse directly on to the efferent neurons 
which, in turn, project to habenula. Rather, it would 
seem that a degree of interaction occurs within EP, 
with intrinsic neurons interposed between afferents 
from striatum and efferents to habenula. The possib­
ility of interaction of input from EP and from other 
sources (Herkenham and Nauta, 1977) to elicit the net 
response measured in habenula cannot be discounted, 
but the involvement of the lateral habenula in extra- 
pyramidal function (Nauta, 1974),- providing a relay 
between limbic and motor systems, is further supported
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by these studies. In this context the observed decr­
ease in ventral tegmental area, to which the habenula 
sends projections, perhaps provides evidence of the 
importance of this pathway in the further integration 
of activity in the two functional systems, although the 
apparent lack of involvement of the nucleus accumbens 
prevents development of proposed functional pathways 
beyond this stage.
The limited number of areas of the brain in which 
measurable alterations were observed following direct 
pharmacological manipulation of striatum with muscimol 
provides a novel insight into the integrated response 
of striatofugal pathways one, two, and possibly more 
synapses removed from the initial neuronal stimulation.
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CHAPTER IV
DISCUSSION
The 2-deoxyglucose technique (Sokoloff et al.
1977) is proving to be an extremely potent tool in 
the neurosciences (for reviews see Sokoloff, I98O; 
McCulloch, 1982), The close coupling which has been 
demonstrated between rates of energy generation and 
functional activity within areas of the CNS (Sokoloff,
1977), taken together with the capacity to localise 
and quantify changes in metabolic demand autoradio- 
graphically, has provided the basis of a rigorous 
method with which to map the simultaneous involvement 
of all the anatomical components which take up any 
functionally integrated neuronal pathway (Kennedy et 
al. 1975; Sokoloff, 1977). Although widely used 
with experimental rodent models of cerebral function, 
the technique has also been used to provide an index 
of functional activity in single molluscan neurons 
(Sejnowski et al. 1980) and mouse neurons in culture 
(Ornberg et al. 1979), in the Drosophila visual system 
(Buchner et al. 1979) and teleost retina (Basinger et 
al. 1979). In higher order mammals, the 2-deoxy- 
glucose autoradiographic method has been employed to 
measure rates of glucose utilisation in monkey brain 
(Kennedy et al. 1978), but perhaps the most exciting
recent development has been the fluorodeoxyglucose 
technique which, when combined with positron emission 
tomographic scanning, allows changes in cerebral 
functional activity of human subjects to be monitored 
(Reivich et al, 1979).
Functional mapping of integrated neuronal path­
ways in the intact mammalian brain has proved to be 
particularly successful in describing responses to 
clearly defined sensory stimuli which, by virtue of 
their limited access.to the CNS via specific sensory 
receptors, may be easily controlled (see Sokoloff,
1980). Alterations in functional activity in ele­
ments of the primary visual system in response to 
specific visual stimulation have been extensively 
documented (Kennedy et al. 197^; Batipps et al. I98I; 
Toga and Collins, I981). Although the activation of 
functional pathways involved in the processing of 
input from other sensory modalities has received less 
attention, responses to auditory (Wilson et al. I98O; 
Hungerbuhler et al, I98I; Ryan et al. I982), olfactory 
(Lancet et al, I982) and somataesthetic stimuli (Hand 
et al. 1978) have been mapped using 2-deoxyglucose 
autoradiography. Other stimuli which have been 
employed to elicit alterations in cerebral activity, 
from which functional pathways may be determined, have 
included passive (Sharp, 1976) and active locomotion 
(Schwartzman et al. I98I; Monamaur et al. I982), acute 
hypotension (Savaki et al, 1982b), as well as direct 
electrical stimulation of cerebellum (Schim et al. I98I)
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and motor cortex (Goldberg et al, I980).
In the field of neuropharmacology, the pharmacol­
ogical stimuli used in eliciting the functional changes 
to be subsequently mapped with 2-deoxyglucose auto­
radiography have, in general, been much less specific 
than those used in more physiological studies. The 
most widely used approach to date has been to deliver 
pharmacologically active agents systemically, and then 
to analyse the effects throughout the brain. In this 
manner, dopaminergic (McCulloch et al, 1982b) , chol­
inergic (Nelson et al, 1978; Weinberger et al. 1979), 
adrenergic (Savaki et al, 1982a) and serotonergic 
neurotransmitter systems (Grome and Harper, I98I,
1982) have been subjected to analysis. Although the 
2-deoxyglucose technique does constitute an advance 
over classical electrophysiological methods of meas­
uring drug action in that a larger number of brain 
regions may be studied simultaneously, the understand­
ing of the primary sites at which a pharmacological 
agent may exert its influence has not been significant­
ly advanced by this innovative technique in conjunction 
with such a diffuse manipulation as is systemic admin­
istration. If anything, these studies have served to 
emphasise that the normal brain functions in a complete­
ly interactive way with no clearly delineated or totally 
independent functional subunits,
A greater degree of specificity of pharmacological 
action has been introduced by either electrically stim­
ulating cell populations of known neurotransmitter
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functions (Schim et al. I98I), or by inducing lesions 
at the sites of origin or along the course of project­
ion neurons (Schwartz, 1978; Steward and Smith, I98O; 
Wooten and Collins, I98O, I981), thus removing neuro­
transmitter influences at the sites of termination.
An added refinement to these 2-deoxyglucose studies 
was the subsequent pharmacological challenge of les- 
ioned animals with appropriate agents (Kozlowski and 
Marshall, I98O; Sagar and Snodgrass, I98O) to allow 
greater insight into the relative importance of the 
lesion sites to the pattern of response observed in 
the intact animal. The most specific and direct 
method of pharmacological manipulation in the brain, 
i.e., localised injections of agents directly into 
areas of the brain, although extensively used in 
behavioural studies, has not been used in conjunction 
with 2-deoxyglucose technology to any great extent 
(Sakurada et al. 1978),
Despite the undoubted power of the 2-deoxyglucose 
technique, the approach has not as yet been widely 
adopted as a routine method in neuropharmacology.
The similar degree of spatial resolution afforded by 
other autoradiographic approaches, in particular the 
visualisation of receptor distributions (Palacios et 
al. I98O; Young and Kuhar, I98O), appear to have been 
accepted as a genuine and worthwhile advance, despite 
a requirement for expertise and technological hardware 
no less than that demanded by the 2-deoxyglucose method.
A survey of the literature on GABA systems, which remains
an ever expanding field, reveals the extent to which 
the 2-deoxyglucose technique has failed to a large 
extent to penetrate into neuropharmacology. Using 
the approaches to pharmacological manipulation of 
brain function outlined above, i.e., systemic admin­
istration of GABAergic agents, induction of specific 
lesions in a known GABAergic pathway (striato-nigral 
pathway) and local injection of a GABA agonist into 
an area of GABAergic activity, in conjunction with 
2-deoxyglucose quantitative autoradiography, the stud­
ies which have been described in this thesis provide 
a comprehensive analysis of the role of GABAergic 
activity in influencing aspects of cerebral function. 
Such descriptions have hitherto not been possible 
using classical biochemical and physiological approach­
es of measuring cerebral function, many of which are 
static rather than dynamic measures, require the 
complicating factor of anaesthesia, lack the same 
degree of spatial resolution and are devoid of any 
understanding of events spatially removed from the 
primary site of interest.
Although the basic premise underlying functional 
mapping, that altered rates of glucose utilisation 
reflect dynamic changes in cerebral activity, has been 
validated under a number of conditions (Kennedy et al. 
1975; Schwartz et al. 1979; Mata et al, I98O; 
Schoppmann and Stryker, I981), it should be remembered 
that glucose is involved in the intermediary metabol­
ism of the brain in pathways quite distinct from its
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primary role in the generation of energy. Glucose 
provides a source of carbon for lipid and protein 
synthesis, although under normal steady-state condit­
ions only a small fraction of the entire cerebral 
glucose flux is directed towards lipid and protein 
production (approximately 2°Jo and 0.3^», respectively) 
(Maker et al, 1972; Siesjo, 1978). Of particular 
relevance to investigations which have been described 
is the involvement of glucose as a substrate in the 
synthesis of acetylcholine and GABA (Maker et al.
1972), especially in view of regional alterations in 
the rates of synthesis and turnover of these neuro­
transmitters reported to occur following muscimol 
administration (Zsilpa et al, 1976; Moroni et al. 
1979; Scatton and Bartholini, 1979), and presumably 
any other form of GABAergic manipulation.
Acetylcholine synthesis, at its maximum possible 
rate, has been estimated to require only 1^ of the 
total pyruvate generated from glucose and, as the 
normal rate of synthesis is only 10^ of its maximum 
level (Gibson et al. 1975), even large changes in 
production would contribute minimally to the measured 
rates of glucose utilisation. A much larger fract­
ion of the total pyruvate (approximately 8^) passes 
via the "GABA shunt pathway" under normal conditions, 
with a resultant small loss to the maximum total 
available energy generation from glucose (Maker et al. 
1972; Siesj8, 1978). Dynamic alterations in GABA 
turnover following muscimol administration (Moroni et
Zi y
el. 1979)» occurring during the measurement of glucose 
utilisation, might affect the relationship between 
energy generation and total glucose phosphorylation. 
Under steady-state conditions, the importance of 
increased energy-generating capacity resulting from 
decreased flux through the GABA shunt is likely to 
be minimal, as the catabolic products of GABA (mainly 
succinate semialdehyde) would anyway be returned to 
the tricarboxylic acid cycle at the succinate level 
(Maker et al. 1972; Siesjo, 1978). However, GABA 
synthesis and catabolism may be physically located 
within different cells in the brain, and although the 
energetic cost of the GABA shunt to the brain taken 
as a whole may indeed be quite small, neuronal GABA 
synthesis and release could represent a net energy 
loss to the neurons with an almost equal energy gain 
by the glial elements. The neuronal cells and their 
processes have greater energetic requirements than 
other cell types (Schwartz et al. 1979), and so any 
decrease in GABA turnover elicited by muscimol admin­
istration, by reducing the loss of energy-generating 
substrates from the neuron, could decrease the meas­
ured rate of glucose phosphorylation independently of 
altered functional activity.
Two lines of evidence indicate against altered 
flux through the GABA shunt being a major contributory 
factor in the decreased rates of glucose utilisation 
measured following systemic muscimol administration. 
Firstly, one could justifiably assume that areas of
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high GABA turnover would have a greater potential for 
energy conservation were the GABA shunt to be bypassed. 
As has been discussed in the appropriate commentary 
(pll4), there appears to be an inverse correlation 
between regional rates of GABA turnover (Mao et al,
1978) and magnitude of decreased glucose use in 
response to muscimol. Secondly, only where glial 
cells are responsible for a large part of the re-uptake 
of synaptic GABA should neurons suffer anything other 
than a minimal loss of energy substrates to the glial 
element under normal conditions. This reduced flux 
through the GABA shunt, if this were the sole mechan­
ism by which cerebral glucose utilisation decreased 
following muscimol, should result in greater reduct­
ions in glucose use in areas where glial re-uptake is . 
most apparent. However, no direct correlation is 
evident between the cerebral regions which are most 
sensitive to muscimol in terms of reduced glucose 
utilisation and those in which glial cells contribute 
substantially to GABA re-uptake (Moroni et al. I982).
It can be concluded, therefore, that the decreases in 
glucose utilisation observed following systemic musc­
imol or THIP are a true reflection of altered funct­
ional activity with the concomitant effects upon the 
intermediary metabolism of glucose via the GABA shunt 
contributing only minimally to the overall effect.
Following the systemic administration of the 
putative GABA agonists, muscimol and THIP, the hetero­
geneous distribution of reduced rates of glucose
6 * a
utilisation measured in the brain provides a novel in­
sight into the relative sensitivities of functionally 
diverse regions to GABA influences. These results 
could not have been predicted on the basis of prev­
iously determined data. Although the effects of 
muscimol and THIP upon glucose use in the substantia 
nigra were in close agreement with the responses meas­
ured electrophysiologically (Vaszcak et al. I980), data 
of this nature is not available on all of the regions 
analysed simultaneously with the 2-deoxyglucose tech­
nique. A comparison with results from methods with a 
similar degree of spatial resolution and global analysis 
(e.g., GABA receptor distributions) (Palacios et al.
1981) reveals no good correlation between GABA binding 
potential and sensitivity of regional glucose use to 
the effects of the agonists. The dichotomy is partic­
ularly marked in a comparison of the alterations in 
glucose use observed in cerebral cortex and cerebellum, 
which both display similar distributions of biochemical 
and histological markers for GABA systems (Tappaz et al. 
1976; van der Heyden and Korf, 1978), and yet which 
are at opposite extremes of sensitivity to the agonists.
Previous investigations of the functional role of 
GABA in the brain have concentrated in the main upon 
cerebellar, extrapyramidal and hippocampal functions 
(kr^gsgaard-Larsen et al. 1979). Although GABAergic 
synapses are known to constitute the principal inhib­
itory mechanism in cerebral cortex (Roberts, 1978), 
the extent to which the thalamo-cortical axis has the
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potential to be influenced by GABAergic mechanisms has 
never before been fully appreciated. The particular 
susceptibility of functional activity in neocortical 
lamina IV may be indicative of a primary role of this 
region in the organisation of cortical function, with 
GABAergic neuronal mechanisms available to inhibit 
both cortical input and local circuit neurons.
The profound effects of exogenous GABAergic agents 
in cortex would tend to suggest that whilst there is a 
large potential for the expression of inhibitory influ­
ences in cortex, there is a relatively low activation 
of endogenous GABAergic neuronal systems under normal 
conditions. It is possible that cortical GABA systems 
are input stimulus-dependent, being activated to their 
full potential only in response to excitatory input 
into cortex. Such a scheme of functional organisat­
ion in cortex is not, however, compatible with the 
proposal of disinhibition as a general organising 
principle (Roberts, 1978), In contrast, in the 
extrapyramidal system where GABAergic neurons have 
been extensively characterised (Ponnum et al. 1978), 
the minimal effects-of the GABA agonists on functional 
activity as reflected in rates of glucose utilisation 
suggest a higher steady-state activation of endogenous 
GABAergic neurons. In this instance, the possibility 
of disinhibition becoming a factor in the organisation 
of function becomes tenable.
The role of GABAergic neurons in the extrapyramidal 
system became apparent only when striatal efferents.
Ct A,
mainly GABAergic, were removed by kainic acid-induced 
lesions of the caudate nucleus. With the removal of 
inhibitory influences, functional activity in primary 
projection areas was markedly increased. The apparent 
disinhibition of those areas was reduced by systemic- 
ally administered muscimol at a dose which had only 
moderate effects in intact animals. However, the 
relatively high dose used (l.5 mg/kg) was not suffic­
ient to reduce the levels of functional activity to 
those in intact control animals. It would appear 
from this observation that endogenous GABA project­
ions are both extremely potent and very active in the 
intact animal in their inhibitory influences.
In the extrapyramidal system contralateral to the 
site of striatal lesion, the significant alterations 
in functional activity which were apparent revealed 
the capacity of disinhibitory processes to provide an 
appropriate, organised response to altered functional 
needs; in this instance, the restoration of symmetry 
or posture and locomotion. That this response was 
indeed the result of subtle alterations in contralat­
eral striatal GABAergic input into pallidus and nigra 
was further suggested by the action of muscimol in 
totally eliminating post-lesion increases in function­
al activity, presumably by compensating for reduced 
endogenous GABA-release. A lability of inhibitory
influences of this nature would undoubtedly be necess­
ary for disinhibition to be a viable means of organis­
ing extrapyramidal function.
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Although, the results described from lesion studies 
provide evidence for an important role for modulation 
of GABAergic neuronal activity as an organising princ­
iple, it is not clear what constitutes the necessary 
stimulus to promote attenuation of active GABAergic 
projections. Neither the anatomical pathways nor the 
neurotransmitter systems involved in induction of the 
contralateral responses to striatal lesion were immed­
iately apparent, although some possibilities were dis­
cussed in the appropriate commentary. In the intact 
animal the striatum receives dopaminergic input from 
the pars compacta of the substantia nigra, seroton­
ergic input from the raphe nucleus, and glutaminergic 
input from neocortex. GABAergic innervation of 
striatum arises in the thalamus, but GABA neurons are 
also found intrinsic to the caudate nucleus, as are 
cholinergic neurons (Valaas and Fonnum, 1979). Thus, 
a complex interaction may exist between striatal affer­
ent systems and interneurons to affect the output of 
caudate nucleus and, ultimately, the disinhibition of 
globus pallidus and nigra. To determine the mechan­
isms and stimuli which alter striatal influences in 
the brain would present an extensive project in itself, 
but the data from this thesis does provide some insight 
into the mechanisms which promote disinhibition of 
striatal outflow areas.
The actions of the dopaminergic agonist, apomorph- 
ine, upon the extrapyramidal system of intact rats 
produced large increases in functional activity within
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the globus pallidus and entopeduncular nucleus, and the 
substantia nigra. That these effects are a result of 
disinhibitory factors is clearly demonstrated by the 
attenuation of aporaorphine effects in animals which 
lack striatal GABAergic efferents. Thus, it is poss­
ible to suggest that endogenous dopaminergic input into 
the caudate nucleus is integrated within the region, 
and results in decreased activity in striatal efferents 
which, in turn, allows areas receiving efferents to 
become disinhibited, A similar pattern of response 
ensued when a GABA agonist was injected directly into 
the striatum. Pallidps and nigra both displayed con­
siderable increases in functional activation, presum­
ably once again because of decreased activity in 
inhibitory efferents. It has been shown, therefore, 
that both dopaminergic striatal afferents and intrin­
sic GABAergic neurons have the potential to modulate 
disinhibitory influences. Although the net effects 
in the extrapyramidal system were essentially similar, 
the two treatments, systemic apomorphine and local 
injection of muscimol, produced opposite effects in 
the caudate nucleus itself. Whilst apomorphine 
increased striatal functional activity, as measured 
by the local rate of glucose utilisation, local appli­
cation of muscimol reduced functional activity. If 
the caudate was examined without a knowledge of events 
elsewhere in the extrapyramidal system, it could be 
concluded that these two treatments may have opposite 
effects.
The 2-deoxyglucose technique should have an 
important role to play in future neuropharmacological 
studies. The data and discussions presented in this 
thesis have shown that the method is wholly applicable 
to studies of cerebral GABA systems, not only supply­
ing novel insights into specific GABAergic functions 
in the brain, as discussed in the commentaries, but 
also may provide an understanding of more general 
organising principles pertinent to cerebral function 
in the brain.
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APPENDICES
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APPENDIX I
Manufacture and Calibration of Standards for 
Quantitative Autoradiography.
A volume of 50 ml of Spurr's resin was mixed from 
its constituent parts in accordance with the manufact­
urer's instructions. To 25 ml was added 100 uGi of
C^^cjj benzoic acid. The liquid resin was heated
slightly and mixed with a magnetic stirrer for 60 min­
utes. Volumes of the radioactive resin mixture were 
added to varying quantities of the remaining non­
radioactive stock and again mixed thoroughly. The 
resulting E^^cJ-containing resins were poured individ­
ually into a well greased metal mould and cured over­
night in an oven at 70°C. The following morning the 
mould was opened, the sheet of solid resin removed, 
and applied to X-ray film for seven days. Only if 
no heterogeneity of CD was observed in the image of 
the sheets on X-ray film, were the large squares cut 
into small, 0.5 cm squares.
Five standards of different E^^cH concentrations 
were calibrated according to the method of Reivich et 
al. (1969). These standards, together with the other 
nine which were made, were calibrated against those 
precalibrated and used in Sokoloff's laboratory (these 
had also been calibrated according to the Reivich
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method). The five standards calibrated by both 
methods produced values which were essentially simi­
lar (jh h^/o) , although the range of values generated 
by reference to Sokoloff*s standards were those 
which were adopted.
APPENDIX II
Rates of Glucose Utilisation Following Systemic 
Injection of Muscimol and THIP.
Glucose utilisation was measured in conscious 
rats following intravenous administration of saline 
(n=9), muscimol at doses of 0.15 (n=4), 0.5 (n=4), 
1.5 (n=4) and 3*0 mg/kg (n=3)» or THIP at doses of 
1.0 (n=4), 3.0 (n=4) and 10.0 mg/kg (n=4),
The data are presented as mean glucose use 
(pmol.lOOg ^min ^ ^  SEM in the subsequent five 
tables. * p < 0 .03.
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APPENDIX III
Local Cerebral Blood Flow and Local Cerebral Glucose 
Utilisation Following Systemic Injection of Muscimol.
Blood flow and glucose use were measured in differ­
ent groups of rats following 0,5 and 1.5 mg/kg muscimol 
(for N values see following tables).
The data are presented as mean blood flow (ml.lOOg ^ 
min jf SEM and mean glucose use (pmol.lOOg ^min ^
SEM in the subsequent two tables, *pc0.05»
oAPPENDIX III (a)
l o c a l  CEREBRAL BLOOD FLOW AND LOCAL CEREBRAL GLUCOSE 
u t i l i z a t i o n  FOLLOWING SYSTEMIC ADMINISTRATION OF THE 
PUTATIVE GABAERGIC AGONIST MUSCTMOT..
ml
Blood
.100g‘
Plow
'^min-l
Glucose Use 
umol.lOOe ^min ^
Mu scimol mg/kg Muscimol mg/kg
Region Saline 0.5 1.5 Saline 0.5 1 .5
Neoto'rtex 
Visual cortex 143+ 9 138+ 6 85+14* 83+ 3 67+ 4* 51 + 1*
Auditory cortex 264+14 225+21 177+20 118+ 5 97+ 6* 74+ 3*
Parietal cortex 136+ 5 127+ 6 87+10* 90+ 3 69;^  4* 48+ 2*
Sensory-motor cortex 138+ 4 128+ 2 92+ 6* 98+ 3 73+ 3* 51+ 2*
Frontal cortex 122+ 5 110+ 5 80+ 5* 91+ 3 71+ 3* 52+ 2*
Prefrontal cortex 150+ 7 144+13 121+ 7* 119+ 6 94+ 5* 72+ 3*
Olfactory cortex 97+ 4 96_+ 5 93+10 81+ 3 74+ 5 59+ 3*
Diencephalon 
Thalamus t
Mediodorsal nucleus 131+10 121+ 2 103+ 8 105+ 3 85j+ 4* 68+ 3*
Thalamus :
Ventrolateral nucleus 113+ 7 103+ 3 100+ 3 79+ 4 68+ 3 47+ 2*
Medial geniculate 
body 209+15 166+^ 3 139+15* 108+ 3 94+ 8 94+ 4*
Lateral geniculate 
body 11-4+ 4 105+ 7 80+ 7* 78+ 3 60+ 4 49+ 3*
Lateral habenula 155+ 5 153+ 5 145+13 112+ 5 98+ 6 98+ 3
Subthalamic nucleus 127+ 5 133+ 1 121+ 8 85+ 3 74+ 2 71+ 3*
Hypothalamus 86+_ 4 87+ 5 72+ 4 53+ 2 47+ 2 46jh 2
Telencephalon 
Nucleus accumbens ll6+ 8 118+ 5 119+ 7 84+ 2 74+ 5 65+ 2*
Caudate nucleus 121+ 3 111+ 3 93+ 7* 105+ 3 88+ 3* 61+ 2*
Septal nucleus 79+ 4 81+ 4 73+ 5 51+ 2 45+ 2 46^ 3
Globus pallidus 63+ 2 63+ 1 48+ 5* 52+ 2 49+ 3 38+ 4*
Amygdala 71+ 4 73+ 2 69hh 6 43+ 1 43+ 3 37+ 1
Hippocampus 104+ 7 104+ 4 101+ 7 80+ 3 69+ 5 65+ 2*
Dentate gyrus 98+ 5 97+ 2 95+ 6 67+ 2 61+ 5 58+ 1*
Contd./.
APPENDIX III (b)
Z'âb
Blood Flow 
ml.lOOg ^min ^
Glucose Use
-1 -1 pmol.lOOg min
Muscimol mg/kg Muscimol rag/kg
Region Saline 0.5 1.5 Saline 0.5 1.5
Mesencephalon 
Superior colliculus 133+ 6 117+ 5
■
91+ 9* 83+ 3 72+ 6 671 3*
Inferior colliculus 244+13 235+19 249+17 177+ 5 156+ 5 163+14
Red nucleus 122+ 8 111+ 5 116+10 73+ 3 66+, 4 62+ 4*
Substantia nigra: 
pars compacta 97+ 5 97+ 3 85+ 5 71+ 3 60+ 3 57+ 1
pars reticulata 79+ 3 76+ 2 65+ 5 55+ 2 45+ 4 44+ 2*
Lateral lemniscus 163+ 8 147+ 4 167+10 107+ 5 95+ 5 95+ 6
Cerebellum: 
Hemisphere 86+ 3 84+ 4 77+ 6 54+ 2 50+ 4 47+ 1
Nuclei 154+ 9 130+ 7 151+12 94+ 3 83+10 81+ 4
White matter 46+ 1 4l+ 2 37+ 3 36+ 1 34+ 2 34+ 3
Vestibular nucleus 171+10 170+10 178+11 115+ 3 102+10 100+ 2*
Cochlear nucleus 167+10 162+ 8 169+15 125+ 6 99+ 7 97+ 5
Superior olivary 
nucleus 194+12 171+ 5 191+15 l42jt 6 130+ 7 108+11
Inferior olivary 
nucleus 105+ 8 101+ 3 110+ 8 73+ 3 63+: 4* 61+ 3+
Pons 94+ 3 90+ 4 91+ 7 58+ 2 51+ 4 51+ 4
Myelinated Fibre 
Tracts
Corpus callosum 37+ 1 38+ 3 34+ 2 36+ 2 30+ 3 31+ 2
Genu 41+ 2 42+ 2 37+ 3 36+ 3 30+ 2 30+ 2
Internal capsule 46+ 2 47+ 1 40+ 2 33+ 1 29+ 3 28+, 2
n 7 4 5 9 4 4
APPENDIX IV
Rates of Glucose Utilisation Following 
Systemic Injection of Diazepam.
Glucose utilisation was measured in conscious 
rats following intravenous administration of saline 
or diazepam at doses of 0,1, 0.3 or 1,0 mg/kg (n=5 
for each group).
The data are presented as mean glucose use 
(pmol.lOOg ^min ^) _+ SEM in the subsequent five 
tables. *p-<0.05.
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APPENDIX V
Rates of Glucose Utilisation Following Striatal 
Lesions with Kainic Acid and Subsequent 
Pharmacological Challenges.
Glucose utilisation was measured in conscious rats 
10 days after unilateral striatal lesions with kainic 
acid or sham lesions, and following either intravenous 
injection of saline, 1.5 mg/kg muscimol, or 1.0 mg/kg 
apomorphine (n=5 for each group).
Data are presented as mean glucose use (pmol.lOOg ^ 
min ^ SEM in the subsequent six tables. * p 4^ 0.05
for comparison between sham and lesion treatments; 
}zip<.0.05 for comparison between saline injected and 
drug injected treatments.
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APPENDIX VI
Rates of Glucose Utilisation Following 
Intrastriatal Injections of Muscimol.
Glucose utilisation was measured in conscious rats 
following a single intrastriatal injection of artific­
ial CSF, 100 ng muscimol or 500 ng muscimol (n=5 in 
each, group) .
The data are presented as mean glucose use (pmol.
-1 -1 \
lOOg min ) ■+ SEM in the subsequent three tables. 
*p-<0.05. (+) Densitometrio readings for this nucleus
were made on the mid-line; therefore, ipsi- and contra­
lateral values are equal.
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